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Inhaltsangabe 
Die Entwicklung neuer Phosphane und ihre Anwendung in der Katalyse sind ein wichtiger 
Forschungsschwerpunkt in den letzten Jahrzehnten gewesen. Trotz der strukturellen Vielfalt 
der heutzutage bekannten und verfügbaren Phosphane kann man die meisten dieser Liganden 
im besten Falle als moderate π-Akkzeptoren klassifizieren. Solange solche elektronischen 
Eigenschaften für die jeweiligen Anwendungen ausreichend sind, sind mehr als genug 
Beispiele für (solche) P-zentrierte Verbindungen mit unterschiedlichen sterischen 
Eigenschaften, verfügbar.  
Allerdings existieren einige katalytische Reaktionen, die die Gegenwart von Liganden mit 
sehr starkem π-Akkzeptor Charakter erfordern. In diesen Fällen gibt es nur wenige 
kommerziell verfügbare, neutrale P-zentrierte Liganden mit solchen Eigenschaften (PF3, 
P(CF3)3 und PCl3). Unglücklicherweise sind diese Verbindungen in der Regel toxisch und 
feuchtigkeitsempfindlich, was problematisch für ihre Anwendung in der Katalyse ist.  
Aus diesem Grund bleibt die Entwicklung neuer π-Akkzeptor Liganden eine 
Herausforderung. In unserer Herangehensweise wurden zwei Cyclopropenium-Substituenten 
an das Phosphoratom des hergestellten Phosphins gebunden, um einen verstärkten π-
Akkzeptor Charakter einzuführen. Diese synthetisierten Biscyclopropeniumphosphine waren 
luftstabil im Gegensatz zu ihren polyhalogenierten Analogen. Die Variation des dritten (nicht-
kationischen) Substituenten, der an das Phosphoratom des dikationischen Phosphins 
gebunden ist, erlaubt die Modifikation der elektronischen Eigenschaften der jeweiligen 
Verbindung. Die Anbringung längerer aliphatischer Ketten an die Cyclopropeniumeinheit 
ermöglicht die vollständige Lösung des dikationischen Phosphins in nicht-polaren 
Lösungsmitteln wie Toluol. Außerdem wurde für einige der hergestellten Phosphine das BF4
- 
Gegenion für SbF6
-
 ausgetauscht, um später seinen Einfluss auf die Reakivität in der Katalyse 
zu untersuchen. 
Die anschließende Koordinierung dieser dikationischen Phosphine an Übergangsmetalle 
resultierte in der Isolation der jeweiligen Au(I)-, Pt(II)-, Ir(I)- und Ag(I)- Komplexe. 
Die Reaktivität der hergestellten Au(I)-präkatalysatoren wurde in der Cycloisomerisierung 
von Biphenyl-Alkinen mit zwei Substituenten in internen Postionen zu den jeweiligen 
Phenanthrenderivaten untersucht. Nach erfolgreicher Optimierung wurde diese Methodik in 
der Synthese von Calanchinon C angewendet. 
  
Schließlich wurde der Anwendungsbereich der verwendeten Au(I)-präkatalysatoren von der 
Synthese von Phenanthrenderivaten zur Herstellung von Naphto-furanen erweitert.
  
Abstract 
The development of new phosphines and their application in catalysis has been a major 
research topic during the last decades. Despite the structural variety of the known and 
available phosphines, nowadays, most of these ligands can be classified as moderate π-
acceptors at best. As long as such electronic properties are sufficient for the derived 
applications, more than enough examples depicting different steric parameters are available.  
However, some catalytic reactions require the presence of ancillary ligands with very strong 
π-acceptor character. In these cases only few commercially available neutral P-centered 
ligands exist (PF3, P(CF3)3 and PCl3). Unforunately, these compounds are usually both toxic 
and moisture sensitive, which represents a strong limitation for their application in catalysis.  
Therefore, the design of new π‐acceptor ligands is still a challenge. In our approach two 
cyclopropenium substituents were attached to the phosphorus atom of the phosphine in order 
to introduce enhanced π-acceptor character. These biscyclopropenium phosphines, unlike 
their polyhalogenated analogues, were air stable. While the variation of the third (non-
cationic) substituent attached to the phosphorus of the dicationic phosphine allowed further 
modification of its electronic properties, the decoration of one cyclopropenium unit with 
longer aliphatic chains facilitated the solution of the charged species in non-polar solvents like 
toluene. Furthermore, the BF4
-
 counter-ion of some of the prepared phosphines was 
exchanged for SbF6
-
 in order to investigate its influence on the reactivity in catalysis later on. 
Subsequent coordination of these dicationic phosphines to various transition metals afforded 
the corresponding Au(I), Pt(II), Ir(I) and Ag(I) complexes.  
The reactivity of the prepared dicationic Au(I)-precatalysts was investigated in the 6-endo-dig 
cycolisomerization of biphenyl-alkynes with two substituents in internal positions to their 
corresponding phenanthrene derivatives. After successful optimization, this methodology was 
applied in the synthesis Calanquinone C.  
Finally, the substrate scope of the utilized Au(I)-precatalysts was expanded from the synthesis 
of phenanthrene derivatives to the preparation of naphto-furans.  
  
 
 
 
 
 
 
 
 
 
Experience is the teacher of all things. 
-Julius Caesar 
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1 Introduction 
Phosphorus does not exist in nature in its elemental form as it is easily oxidized. It can be 
found in the earth crust in form of the salts derived from phosphoric acid, such as apatite  
(3 Ca3(PO4)2
.
Ca(OH, F, Cl)2), or in the biosphere as derivatives of phosphoric esters and 
phosphates. Overall, its natural occurrence sums up to 0.1% (m/w%) of the total mass of the 
litho- and biosphere.
[1]
 Elemental phosphorus is accessible in industrial scale by the reduction 
of the afore mentioned apatite with coke in the presence of silica at 1400-1500 °C in an arc 
furnace affording elemental P2, which dimerizes to P4 (white phosphorus) upon cooling. 
 
Scheme 1-1: Reductions of phosphates to elemental phosphorus. 
White phosphorus has a tetrahedral structure with P-P bond lengths in between 2.20 and 
2.21 Å. It is extremely reactive, up to the point that it spontaneously ignites at room 
temperatures upon exposure to oxygen in a highly exothermic reaction.
[1] 
Despite of that, 
white phosphorus is the key starting material for the preparation of bulk phosphorus 
chemicals like PCl3, PH3 and their commercial derivatives, which in turn, are used to access 
most of the known P-ligands in organometallic chemistry such as phosphines, phosphites and 
phosphoramidites.
[1] 
Phosphorus derived ligands have found a wide range of applications, in particular in 
coordination chemistry and catalysis. Examples for this privileged use as ligands can be found 
in many coupling (Scheme 1-2),
 [2,3,4]
 metathesis or hydrogenation reactions, among others.  
 
Scheme 1-2: Suzuki-cross coupling in the presence of PPh3 as ligand. a) 0.1 equiv. mol% Pd(PPh3)4, 2 equiv. 
NaOEt, benzene, 70 °C, 2 h. 
For example, in order to improve all relevant reaction parameters of cross-couplings, such as 
selectivity, conversion-rate, functional group tolerance and catalyst loading, a lot of effort was 
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2 
invested mainly into the design of new phosphorus based ligands modifying their structural 
and electronic properties. Thus, the evolution of P-based ligands in this area led to the 
synthesis of biphenylphosphines, which were first developed by S. L. Buchwald et al. for 
coupling reactions and later have been applied in a broad range of different reactions 
including Suzuki-Miyaura couplings (4 and 5),
[5a, 5b]
 α-arylations of aldehydes (4 and 5),[5c] 
Negishi-couplings (6),
[5d]
 fluorination reactions (7),
[5e]
 arylations of hindered primary amines 
(8),
[5f]
 hydroxylations of aryl/hetereoaryl halides (9)
[5g]
 and cyanation of aryl/heteroaryl 
halides (10, Figure 1-1).
[5h] 
 
Figure 1-1: Lewis-structures of biphenyl phosphines developed by S. L. Buchwald et al and John-Phos 11. 
Despite of the fact that cross-couplings are one of the prominent fields for the application of 
phosphorus ligands like phosphines, there are many other catalytic reactions where such 
compounds are applied. John-Phos 11, one of the simplest Buchwald type phosphines, has 
been also successfully used in Au(I)-catalyzed processes. The cycloisomerization of enyne 12 
to cyclobutene 13 reported by R. A. Widenhöfer et al. (Scheme 1-3) can be used as an 
illustrative example for this chemistry.
[6]
 
 
Scheme 1-3: Au(I)-catalyzed cycloisomerization of enyne 12. a) 0.05 equiv. AuCl(11), 0.05 equiv. AgSbF6, 
DCM r.t.. 
Another interesting advantage of the utilization of phosphines as ancillary ligands derives 
from the relative facility to prepare chiral, enantiopure derivatives that expand the scope of 
their use to asymmetric synthesis. BINAP 14,
[7] 
chiral phosphoramidite 15
[8]
 and chiral 
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phosphine phosphite
[9]
 such as 16 are excellent examples of chiral P-based ligands (Figure 1-
3), which have demonstrated extraordinary levels of enantioinduction in several interesting 
processes.  
 
Figure 1-2: Examples for chiral P-centered pro-ligands. 
BINAP 14 has been utilized with great success in the asymmetric Ru-catalyzed hydrogenation 
of α,β-unsaturated carboxylic acids,[7b] allylic alcohols,[7c] enamides[7d] and ketones [7e] by R. 
Noyori et al. For example, the use of (R)-BINAP in the Ru(II)-catalyzed enantioselective 
hydrogenation of substituted enamides 17 provided the corresponding enantioenriched 
(protected) α-or β-amino acids 18 with up to 96% ee (Scheme 1-4).[7d] 
.  
Scheme 1-4: Noyori-reduction of enamides 17 to their respective α-or β-amino acids 18. a) 0.005 equiv. 
Rh(OAc)2(14), H2 (1 atm), MeOH, r.t.. 
Additionally, chiral phosphoramidite 15 was used by B. L. Feringa et al. with great success, 
for example, as a ligand in the Cu(I)-catalyzed asymmetric 1,4-addition of Grignard reagents 
to allylic gem-dichlorides 19. The desired 1,4-addition products 20 were obtained in good 
yields (up to 74%), remarkable ees (up to 98%) and almost complete Z-selectivity (Scheme 1-
5).
[8] 
 
Scheme 1-5: Asymmetric 1,4-addition of Grignard reagents to allylic gem-dichlorides 19 by B. L. Feringa. a) 
0.05 equiv. Cu(I)TC, 0.055 equiv. 15, 1.5 equiv. R-MgBr, DCM, -78 °C, 4 h (TC = tiophene-2-carboxylate). 
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Another type of asymmetric reaction, which in this case was made possible by employing 
TADDOL-derived phosphine-phosphite ligand 16, is the enantioselective Rh(I)-catalyzed 
[4+2] cycloaddition of trienes of type 21. The enanatioenriched bicyclic products of type 22 
were obtained in good yields (up to 83%) and up to 90% ee (Scheme 1-6).
[9] 
 
Scheme 1-6: [4+2] Cycloaddtion of trienes 21 to their respective bicyclic products 22 by H.-G. Schmalz et al.. a) 
0.03 equiv. [RhCl(NBD)]2(NBD = norbornadiene), 0.06 equiv. AgSbF6, 0.072 equiv. 16, EtOAc, 50 °C 
(microwave), 1-3 days. 
While this is only a brief survey on the different P-centered ligands employed in catalysis, it 
clearly demonstrates the incredible power of ligand design. However, it has to be noted that 
most of the known P-based compounds, which were mentioned afore can be classified as 
poor-to-moderate π-acceptors and good-to-moderate σ-donors. As long as such electronic 
properties are sufficient, additional modification of the ligands remains unnecessary. 
However, when strong π-acceptor properties become necessary to facilitate a certain reaction, 
only PCl3, PF3 and P(CF3)3 are readily available as these are the only phosphorus compounds 
possessing stronger π-acceptor properties than phosphites (e.g. P(OPh)3). These phosphines 
and their respective transition metal complexes are unfortunately highly air and moisture-
sensitive, which makes them not the most adequate choices as ligands for catalysis.
[10]
 For this 
reason, the development of new strategies to improve π-acceptor properties of the P-center of 
phosphines is still necessary.  
1.1 Phosphines with peripheral charges 
Homogenous transition-metal catalysis has grown in importance in both, academic and in 
industrial applications. Asymmetric hydrogenation, cross-couplings and hydroformylation are 
good examples for noteworthy applications with organophosphorus compounds playing a key 
role as ligands. However, the use of homogenous catalysts presents a challenge in their 
implementation on industrial scale. The separation of the catalyst from the product after the 
reaction is finished may not be straightforward. An elegant solution to this problem consists 
of the use water as a solvent for the reaction, if non-polar products are fromed that are easy to 
separate from this solvent due to their hydrophobic nature. In order to facilitate this separation 
even more, the catalyst should ideally remain in the aqueous phase after the reaction is 
…………………………………………………………………………………1. Introduction 
 
5 
finished. A trick often used to increase the hydrophilicity of the catalyst consists of the 
introduction a positive or negative charge on the periphery of the ligand. This charge should 
be placed at a relative distance from the phosphorus to avoid changes on the electronic 
properties of the respective phosphine. Several phosphines containing positively charged 
moieties on their periphery have been developed with this objective in mind, and a selection 
of them is illustrated in Figure 1-3.
[11] 
 
Figure 1-3: Examples for phosphines possessing peripheral charges. 
A good example for such a hydrophilic P-centered ligand with a peripheral positive charge is 
1-Methyl-1,3,5-triaza-7-phosphaadamantan-1-ium iodide 23 (Figure 1-3), which was prepared 
by the methylation of the corresponding amine. By treatment of 23 with [(RhCl(CO)2]2 and 
[(Rh(I)(CO)2]2, complexes of type RhX(CO)L2 (X = Cl, I) were obtained and utilized in the 
hydroformylation of alkenes or in the reduction of aldehydes.
[12]
 
Another example for such a charged phosphine is ben-Dendriphos 24 (Figure 1-3), which was 
used successfully by G. van Koten et al. in a Suzuki-Miyaura cross-coupling of various aryl 
bromides 27 with the corresponding boronic acids 28 in aqueous media, affording the 
coupling products 29 in moderate to good yields (57-99%, Scheme 1-7). A broad range of 
different functional groups (Scheme 1-7) is tolerated by this protocol, and the employed 
hexacationic ligand shows even higher reactivity than PPh3 under the evaluated conditions 
(aqueous media). Furthermore, it could be concluded that ben-Dendriphos 24 stabilizes the 
Pd(0)-intermediate without inhibiting the reactivity. This was rationalized by suggesting that 
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ligand  24 favors the formation of a coordinatively unsaturated 16e
-
-complex, which is 
probably facilitated by a combination of steric and Coulombic repulsions of the charged 
ammonium groups that avoids the coordination of a second phosphine to the metal center.
[13] 
 
Scheme 1-7: Suzuki-coupling in the presence of ben-Dendriphos 24 by G. van Koten et al. a) 0.01 equiv. 
Pd(dba)2, 0.04 equiv. 24, MeOH/H2O, 65 °C. 
Olefin metathesis has also benefitted from the use of cationic phosphines such as 25. In 
particular, this ligand has been useful in the evaluation of the ring-opening metathesis 
mechanism via ESI-MS spectrometry (Scheme 1-8).
 [14] 
The inactive precatalyst 30, the active 
monocationic species 31 as well as intermediates 32 and 33 were detectable in the MS-
spectrometry utilizing this methodology. 
 
Scheme 1-8: Intermediates 32 and 33 formed in the ring opening metathesis polymerization of cyclic alkenes in 
the gas-phase. 
A very original additional application of the use of organophosphorus compounds with 
peripheral charges was recently reported by T. Ooi et al. (Scheme 1-9). He described a Pd(0)-
catalyzed asymmetric allylation of α-nitrocarboxylate derivatives 34 with allyl carbonates 35 
utilizing the ion-paired chiral ligand 26 (Figure 1-4 and Scheme 1-9). 
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The developed methodology delivered the enantio-enriched products 36 in excellent yields 
(up to 99%) and remarkable enantioselectivity of up to 97% ee. According to the authors, the 
Coulomb interactions between the charged phosphine and a chiral counter-anion, in this case 
binaphtolate, induce the observed enantioselectivity.
[15]
 
 
Scheme 1-9: Pd(0)-catalyzed asymmetric allylation of α-nitrocarboxylate derivatives 34 with 2-en-1-yl 
derivatives 35 by T. Ooi. a) 0.0125 equiv. Pd2(dba)3, 0.05 equiv. 26, toluene/H2O, r.t.  
The reaction itself follows a pattern similar to the Tsuji-Trost reaction as the initial steps is 
suggested to be the insertion of the [Pd(0)(26)2] species on the allylic carbonate resulting in 
the formation of π-allyl-Pd(II) complex. This structure would be maintained as the 
deprotonated nitro-ester is delivered via a hydrogen-bonding interaction to the phenolic 
proton of the binaphtolate anion. The organization of this intermediate through Coulombic 
interactions would be essential to produce the obtained enantioselectivity during addition of 
the pro-chiral nucleophile to the formed π-allyl-Pd(II) complex (Figure 1-4).[15] 
 
Figure 1-4: Proposed catalytic cycle for enantioselective alkylation catalyzed by an ion-pair catalyst. 
1.2 Phosphines with charges directly attached to the P-center. 
1.2.1 Introduction 
It was already mentioned in section 1.1, that the variety of neutral P-centered compounds, 
which can act as strong π-acceptor ligands is very limited and mainly restricted to halogenated 
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phosphines. However, these halogenated compounds are usually labile, air/moisture-sensitive 
and therefore difficult to handle. An alternative approach to obtain the desired π-acceptor 
properties consists of the introduction of positively charged moieties in close proximity to the 
P-center. In contrast to compounds where the charge is attached on the periphery of the 
ligand, the new charges would not only result in a significant change of their solubility, but 
also in a modification of their electronic properties.  
It is well known that in phosphines, the electron pair located on the P-center accounts for the 
σ-donor ability of the respective compound, while the σ*(P-C) orbitals govern its π-acceptor 
properties. A strong electron-withdrawing and positively charged group R’ attached to the P-
atom, will decrease the energy of all molecular orbitals of the corresponding phosphine, 
including those responsible for its π-acceptor properties. For this reason, the resulting cationic 
phosphine should depict poorer electron donor and improved π-acceptor character when 
compared to their neutral counterparts.
[16] 
 
 
Figure 1-5: simplified molecular orbital diagram for PR3 diagram and the perturbation occasioned when one R 
group is substituted with one electron-withdrawing group R’.[16a, 16b] 
Additionally, it has to be taken into consideration that most organic cationic substituents that 
can be introduced as electron-withdrawing groups R’ are aromatic rings, which already 
possess empty low lying π* orbitals. These π*-orbitals are also able to overlap with occupied 
orbitals on the P-center of suitable symmetry. Two of these secondary interactions are of high 
relevance for the evaluation of the electronic properties of the respective phosphines.  
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First, the orbital responsible for the σ-component of the P-M bond may delocalize electron 
density on the π-system of the aromatic ring, if the π system of the aromatic system is in plane 
with orbital containing the electron lone pair located on the P-center (Figure 1-6, A). As this 
interaction stabilizes the electron pair, it decreases the interaction with the orbitals of the 
metal. Due to this effect the σ-component of the P-M bond is weakened.  
Second, an empty π-system which could interact with the orbital of 2a’’ symmetry of the 
phosphine, lowers the energy of that orbital additionally, as a consequence, it leads to an 
amplification of the π-acceptor properties of the respective ligand (Figure 1-6, B).[16a] 
 
Figure 1-6: Secondary interactions A and B between phosphines and positively charged aromatic substituents, 
The strength of both interactions depends on the relative energy level of the LUMO of the 
charged fragment as well as its orientation. As a result, different cationic substituents will 
have different effects. It can be concluded that the cationic substituent with the lowest LUMO 
should be able to maximize these secondary interactions and therefore, enhance the π-acceptor 
properties of the respective ligand significantly.  
Our theoretical department calculated the LUMOs of the most common charged aromatic 
substituents at the B3LYP/6-31G* level (Figure 1-7). A comparison of the respective energy 
values, illustrates that the tropylium cation 37 possesses the lowest LUMO with -0.2817 eV 
while the cyclopropenium cation 38 possesses the highest one with -0.1388 eV. Therefore, 
phosphines with tropylium 37 as an electron-withdrawing substituent should possess the 
strongest π-acceptor properties and the weakest σ-donor abilities.[16a]  
 
 
Figure 1-7: Calculated energy levels of the LUMOs of the most common cations, which can be used as 
substituents of phosphorus on theB3LYP/6-31G* level.
[16a] 
decreasing LUMO energy 
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Finally, there are two more factors, which have to be considered. First, the reduction of the σ-
donation from the P atom to the metal due to the attachment of a positive charge is not 
completely compensated by the back-donation, resulting in a weaker M-P bond. This can lead 
to a complete disappearance of the coordinating properties of the ligand. Second, the presence 
of charged moieties on the coordinated ligand, results in Coulomb interactions between the 
respective ligand moieties and also between the ligand and the metal if both are charged. This 
will also drastically influence the stability of the complex.
[16] 
1.2.1.1 Evaluation of electronic properties 
The traditional method to obtain information about the π-acceptor character of a ligand 
consists of the measurement of the carbonyl stretching frequency (ῦCO) of a metal-carbonyl 
complex, which is coordinated to the ligand under study. This is done normally using 
[Ni(CO)3L] complexes (Tolman method). Carbonyl ligands possess an empty, low lying π*-
orbital (LUMO), which is capable of accepting electron density from an occupied metal d-
orbital of suitable symmetry. If the phosphine coordinated to the same metal is a good σ‐
donor, the metal has more electron density to back‐donate into the aforementioned LUMO of 
the CO-ligand. As a consequence the carbonyl triple bond is weakened, resulting in a 
decreased wavenumber for the stretching frequency measured via infrared spectroscopy 
(Figure 1-8). The opposite can be observed, if the ligand under study is a good π-acceptor 
ligand. In such a case, back-donation from the filled metal d-orbital to the empty σ*(P-R)-
orbital of the phosphine increases and, as a consequence, the metal has less electron density to 
share with the π*-orbital of the CO ligand. Due to this, the strength of the carbonyl triple bond 
does not diminish strongly and as a consequence the measured ῦCO value is similar to the one 
of free CO.  
σ* (P-R) π*
 
Figure 1-8: Relevant orbital interactions between the CO and PR3 Ligands of a Ni(CO)3L 
While it is also possible to use other metal fragments like [(L)Rh(Cl)(CO)2] or 
[(L)2Rh(Cl)CO] to determine this value, it must be considered that for complexes of type 
[(L)2Rh(Cl)CO] a tetrahedral distortion of the square-planar geometry is often observed, 
especially when bulky ligands are employed. This makes the comparison of ῦCO for the 
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different [(L)2Rh(Cl)CO] compounds increasingly difficult.
[16b]
 As an alternative, the σ-donor 
properties of P-centered ligands can also be determined by the measurement of the oxidation 
potential Ep(Ox) by cyclic voltammetry. The electron richness on the P-center (where the 
ligand-HOMO is preferentially located) is inversely proportional to this value.
[16b] 
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1.2.2 Monocationic phosphines 
1.2.2.1 Synthesis of monocationic phosphines 
Apart from the covalent description used up to now, most α-cationic phosphines can be 
additionally described as Lewis-acid-base adducts between a phosphenium cation and an 
appropriate Lewis base. The Lewis base can be another phosphine, a heteroaromatic ring or, as 
discussed in this thesis, a carbene (Figure 1-9). From this point of view, the synthetic 
approaches developed to prepare these compounds are obvious. 
 
Figure 1-9: Up: Covalent model for phosphenium cation stabilized by a Lewis base as well the dative model. 
Down Left: Preparation of phosphino-phosphenium compounds 48-49 and possible subsequent ligand exchange 
reactions. Down Right: Accessible products 48-51 through ligand-exchange. 
 
Hence, N. Burford et al. developed a synthesis of phosphino-phosphenium compounds 48-49 
starting with the abstraction of one chloride from a chlorophosphine 45, this leads to the in 
situ formation of a phosphenium cation 46, which was stabilized by the mesomeric 
delocalization of the positive charge, when aromatic groups like phenyls were attached to the 
P-center (Figure 1-9). Addition of an equivalent amount of a phosphine 47 leads to the 
formation of the corresponding Lewis-acid-base adduct 48-49 in good yield (77-88%), which 
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highlights the synthetic use of this procedure in the P-P bond formation.
[17] 
Compounds 48-49 
can be submitted to a subsequent ligand exchange using other ligands with better σ-donor 
properties (compounds 50-51, Figure 1-9). It has to be highlighted that it is possible to prepare 
the monocationic imidazolium phosphine 51 as well as the pyridine-phosphenium complex 50 
following this route.
[18] 
Imidazolium phosphine 51 was prepared for the first time by N. Kuhn et al. in 1999, by a 
condensation of an N-heterocyclic carbene of type 52 (R
1
 = i-Pr, R
2 
= Me) with 
chlorodiphenylphosphine 45, affording the desired product 51 in very good yield (87%, 
Scheme 1-10).
[19] 
The carbene itself was prepared from the corresponding thioureas in a two-
step sequence.  
While the protocol for the preparation of imidazolium phosphines 51 is quite reproducible, it 
requires careful handling of free carbenes, which are air sensitive species. In order to avoid 
this problem M. Azouri et al. devised an alternative route to access imidazolium phosphines of 
type 53a employing carboxylate derivative 54 as starting material (Scheme 1-10). In the 
presence of chlorodiphenylphosphine, 45 eliminates CO2 and the free carbene formed in situ 
reacts with chlorophosphines to afford imidazolium phosphine 53 in moderate to excellent 
yield after ion-exchange (58-91% yield).
[20] 
 
Another possible route to monocationic phosphines of type 53 involves the condensation of 
dihydroimidazolium chlorides 55b with the respective secondary phosphines (Scheme 1-10, 
route d). This methodology has been successfully applied in our work-group for the 
preparation of dihydroimidazolium 53b and formamidinium substituted phosphines.
[21]  
N. Kuhn et al. also managed to prepare the first transition metal complexes of these 
imidazolium phosphines in 1999 using PtCl2(MeCN)2 and PdCl2(MeCN)2 as a metal-sources, 
which gave the Pd(II)-complex 56 and Pt(II)-complex 57.
[22]  
Furthermore,
 
the synthesis and coordination chemistry of dihydroimidazolium phosphines was 
also first described in our work-group. Coordination of Au(I) and Rh(I) to those α-cationic 
phosphines afforded Au(I)-complex 58 and Rh(I)-complex 59 (Scheme 1-10).
[22]  
The measurement of the CO-stretching frequency (ῦCO) of the Ni(CO)3L complex 60 provided 
a value of ῦCO =2082 cm
-1
, which classifies imidazolium phosphines of type 53a as moderate 
π-acceptors, similarly to phosphites, with ῦCO around 2085 cm
-1
.
[16a]
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Scheme 1-10: Left up: Possible pathways for the synthesis of diimidazolium phosphines 53a/53b. Left down: 
Possible mechanism for the formation of imidazolium phosphine 53a from the carboxylate 54 upon addition of 
PPh2Cl according to M. Azouri et al.. Right: Metal complexes of diimidazolium phosphines 53a/53b. a) 1.0 
equiv. PPh2Cl, Et2O, r.t, 1 h .; b) 1.0 equiv. PPh2Cl, DCM, r.t., 4 h; c) 1.25 equiv. KPF6, acetone, r.t., 2 days; d) 
2.0 equiv. R
3
2PH, THF, reflux, 24 h. 
Our work-group has also recently developed two additional families of monocationic 
phosphines with intersting π-acceptor properties: cyclopropenium phosphines of type 61[23] 
and pyridinium phosphines of type 62
[24]
 (Scheme 1-11), both prepared by condensation of 
the corresponding chloro cyclopropenium 63
[25]
 or chloro pyridinium salt 64 respectively, 
with secondary phosphines (Scheme 1-11). The pyridinium phosphines 62 showed stronger π-
acceptor and weaker σ-donor character as deduced from the carbonyl-stretching frequencies 
(ῦCO) of the corresponding Ni(CO)3L complexes and the oxidation potentials Ep(Ox ) of the 
free ligands (66 and 67):  
ῦCO (Ni(CO)3(67)) = 2094 cm
-1
> ῦCO (Ni(CO)3(66)) = 2082;  
Ep(Ox, 67) = 1.398 V >Ep(Ox, 66) = 1.207 V. 
The increase of the π-acceptor properties of the pyridinium phosphines 62 compared to the 
cyclopropenium phosphines 61 was expected since the LUMO of the pyrdinium moiety lies 
much lower in energy than the LUMO of the cyclopropenium ring.  
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Scheme 1-11: Left up: Synthesis of chloro cyclopropenium salt 63 by Weiss et al. Right up: Synthesis of 
chloro pyridnium salts 64 by M. Alcarazo et al. Middle down: Synthesis of cyclopropenium phosphines 61/ 
pyridinium phosphines 62 by M. Alcarazo et al. Right: Examples for both ligand types. a) 4 equiv. (i-Pr)2NH, 
DCM, r.t., overnight; b) 1.0 equiv. R
1
3OBF4, DCM, r.t. c) 2.0 equiv. H-PR
2
2, 1.0 equiv. 63/64, THF, reflux, 24-
72 h. 
 
Figure 1-10: Transition metal complexes prepared from monocationic phosphines 67 and 68. 
Phosphines 61 and 62 were successfully coordinated to Pt(II), Au(I), Rh(I) and Cu(I) (only 
61), affording the corresponding metal complexes 68-71 (Figure 1-10).
[26, 27]
 The chemistry 
and applications of monocyclopropenium phosphines is described in detail in the Ph.D. theses 
of J. Petšukova and Á. Kozma and only a short summary is given here. 
1.2.2.2 Applications of monocationic phosphines 
A good example for the application of imidazolium phosphines like 72 as ligands in catalysis 
is the Pd-catalyzed Negishi cross-coupling reaction developed by P. Knochel et al. The 
reacction tolerates a broad range of different functional groups (R
1
 = COOMe, OMe, OTIPS, 
Cl, CN, thiophene-ZnBr, (C6H5)-CH2-ZnBr; R
2
 = COOEt, NO2, OAc,  
OMe). Furthermore, the utilization of a ([bdmim][BF4])/toluene solvent mixture allowed an 
easy separation of the synthesized biphenyls 73 from the catalyst, thus allowing the re-use of 
the catalyst in further catalytic cycles (Scheme 1-12).
[28] 
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Scheme 1-12: Negishi cross-coupling in an ionic liquid utilizing ligand 72. a) 0.02 equiv. Pd(dba)2, 0.04 equiv. 
72; toluene/[bdmim][BF4], r.t..
 
A second application reported by X. Li et al. describes the Rh(I)-catalyzed hydrosilation of 
alkenes. The authors demonstrated that [RhCl(76)3] (Scheme 1-13) show a significantly 
higher activity and β-selectivity in the hydrosilation of terminal alkenes 77 ([bmim][PF6] as a 
solvent) than RhCl(PPh3)3. TONs of up to 20000 were measured. It is suggested in their 
publication that the close proximity of the positive charge to the P-atom greatly enhances the 
catalytic activity. Moreover, it was possible to re-use the ionic liquid containing the Rh(I)-
catalyst for at least four cycles without a significant drop in activity.
[29]
 
 
Scheme 1-13: Rh(I)-catalyzed Hydrosilation of Alkenes in ([bmim][PF6]) utilizing ligand 76 by X. Li et al. 
 a) 0.00005-0.0002 equiv. Rh(I)(76)3Cl, ([bmim][PF6]), 70 °C. 
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1.3 Dicationic phosphines 
The list of dicationic phosphines that are known in literature is significantly shorter than that 
of the monocationic analogues. One example is bisimidazolium phosphine 81, which was 
prepared from carboxylate 54 using the same protocol, which was employed for the synthesis 
of the monocationic analogues 53a. In this case two equivalents of 54 and only one of 
dichlorophenylphosphine afforded the desired dicationic phosphine 81 in very good yield 
(81%; Scheme 1-14; for the mechanism Scheme 1-10).
[30]  
Another bisimidazolium phosphine, which is accessible from dichlorophenylphosphine, is 
compound 82. This phosphine was prepared by R. Chauvin et al. from 1,2-di(1H-imidazol-1-
yl)benzene 83 in a three step sequence (Scheme 1-14), which includes deprotonation of the 
bisimidazol species, followed by a condensation with dichlorophenylphosphine, and selective 
methylation at both N-atoms.
[31]
 While the calculated carbonyl stretching frequency ῦCO 
= 2115 cm
-1
 of compound 81 implies that it is an extreme π-acceptor ligand, the measured 
oxidation potential Ep(Ox) = 2.330 V of compound 82 shows that bisimidazolium phosphines 
should be extremely poor σ-donors. Due to this, it is not surprising that no metal complex 
derivatives from 81 and 82 are known.
[16,30,31] 
 
Scheme 1-14: Up: Synthesis of diimidazoliumphosphine 81 by M. Azouri et al.. Down: Synthesis of  
diimidazoliumphosphines 82 by R. Chauvin et al. a) 0.5 equiv. PPhCl2, DCM, r.t. 18 h; b) 2.5 equiv. KPF6, 
EtOH, 24 h; c) 2.0 equiv. n-BuLi, THF, -78 °C, -78 °C to r.t., r.t., 4 h; d) 0.5 equiv. PPhCl2, THF, - 78 °C, -78 °C 
to 60 °C, 60 °C, 2 h; e) 2.0 equiv. MeOTf, DCM, r.t. 
Dicationic chlorobisimidazoliumphosphine salt 85 has been prepared by a protocol published 
by J. J. Weigand et al. The key step in this reaction was the nucleophilic substitution of two 
chlorides in trichlorophosphine by the silyl protected carbene 86. Depending on the 
stoichiometry, either dichloroimidazoliumphosphine 87 or chlorodiimidazoliumphosphine 85 
1. Introduction   ………………………………………………………………………………… 
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were accessible in quantitative yields (85: 99%; 87: 98%; Scheme 1-15). These compounds 
could be used as [PCl2]
+ 
and [PCl]
2+
 synthons, in fact, it was possible to exchange the chloride 
substituent by either CN
-
 or N3
-
 groups.
[32]
 Silyl imidazolium 86 itself was prepared by 
silylation of the free carbene. It has to be highlighted that the utilization of silyl protected 
carbenes was essential to obtain compounds 85/87 without undesired side reactions. It is 
known that the treatment of trichlorophosphine with NHC 51 results in the formation of 88 
and 89 through a redox process besides the expected condensation (Scheme 1-15).
 
 
Scheme 1-15: Up: Synthesis dichloroimidazoliumphosphine 87 or chlorodiimidazoliumphosphine 85 by J. J. 
Weigand et al. Down: Possible side reaction in the condensation of carbene 51 and PCl3. a) 1.5 equiv. PCl3, 
fluorobenzene, 50 °C, ultrasound bath, 10 h; b) 2.0 equiv. PCl3, fluorobenzene, 50 °C, ultrasound bath, 24 h. 
The first and only dicationic phosphine capable of coordinating transition metals prior to this 
work was prepared by M. P. Coles et al. from the bicyclic guanidine 90 in a two-step 
sequence (Scheme 1-16). First, 1,3,4,6,7,8-hexa-hydro-2H-pyrimido[1,2-a]pyrimidine 90 was 
submitted to deprotonation generating an amide, which reacted with DCM to yield the CH2 
bridged species 91. Secondly, the condensation of 91 with chlorodiphenylphospane afforded 
the desired dionium-phosphine 92. Interestingly, it was possible to treat this charged 
phosphine 92 with [PtCl2(PEt3)-µ-(Cl)]2 to form the Pt(II)-complex 93, which upon heating to 
50 C,exchanged the PEt3 ligand by one of the Cl
-
 counter ions affording the desired 
complex 94. A structural confirmation of the constitution of the free phosphine 92, as well as 
Pt-complex 94, was achieved via XRD-analysis.
[33] 
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Scheme 1-16: Up: Synthesis of dionio-substituted phosphines 92 by M. P. Coles et al. Down: Formation of 
corresponding Pt-complexes 93 and 94. a) 1.1 equiv. NaH, 0.5 equiv. DCM, THF, r.t.; b) 1.0 equiv. Ph2P-CL, 
DCM c) 1.0 equiv. [PtCl2(PEt3)-µ-(Cl)]2, DCM, r.t.; d) 50 °C, 24h (yields were not described by the authors for 
steps b-d). 
Finally, another example of a dicationic phosphine capable of coordinating transition metals 
was prepared by J. Petuškova in our work-group. A cyclopropenium unit was utilized as a 
positively charged moiety in these compounds. Biscyclopropenium phosphine 95a was 
accessed in moderate yield (Scheme 1-17) over two steps from the chloro cyclopropenium salt 
63.
[34]
 The synthetic sequence included a condensation with a primary phosphine to first yield 
monocationic phosphine 96a. Subsequent deprotonation with a strong base afforded a 
phosphaalkene, which was then reacted in situ with a second equivalent of the chloro 
cyclopropenium salt 63. Interestingly, it was possible to coordinate phosphine 95a to Au(I), 
Pt(II) and Pd(II), resulting in the formation of complexes 97-99 (Scheme 1-17). 
The use of these dicationic phosphines as ancillary ligands in catalysis is the main topic of 
this thesis. Therefore, their stereoelectronic attributes will be evaluated in more detail in the 
discussion part of this work.  
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Scheme 1-17: Up: Synthesis of biscyclopropenium phosphine 95a by M. Alcarazo et al.. Down: Transition-
metal complexes of dicationic phosphine 95a. a) 2.5 equiv. PhPH2, THF, 24 h; b) 1.0 equiv. KHMDS, -40°C, 2h, 
1.0 equiv. 63, -40°C to r.t., overnight. 
1.4 Tricationic phosphines 
The first tricationic phosphines 100a/b capable of coordinating transition metals were also 
prepared in our work group by J. Petuškova by condensation of tris(trimethylsilylphosphine) 
with the corresponding cyclopropenium salts 63/101 in poor to moderate yields (22-68%, 
Scheme 1-18). When the steric demand of the alkyl residues attached to the N-atoms of the 
cyclopropenium moieties was small enough, coordination of these compounds to Pt(II) and 
Pd(II) (102, 103, Scheme 1-18) was possible. However, all of them all failed to coordinate 
Au(I) or Rh(I)-centers at room temperature.
[35] 
 The calculated carbonyl stretching frequency 
of the Ni(CO)3L complex of tricationic phosphine 100a has a value of value of ῦCO(100a) = 
2111 cm
-1
 and the measured oxidation potential is Ep(Ox) = 2.062 V.
[16a]
 While the carbonyl 
stretching frequency shows that the tricationic phosphine is indeed a very strong π-acceptor 
(comparable with PF3), it is easier to oxidize than the bisimidazolium phosphines 81/82, 
which can be explained by the fact that the LUMO (-0.1388 eV) of one cyclopropenium 
cation lies much higher in energy than the corresponding LUMO of an imidazolium unit  
(-0.1847 eV). As a result, the electron withdrawing effect of the respective cationic moieties is 
more pronounced for phosphines bearing imidazolium rings as substituents, than for those 
with cyclopropenium units. 
Furthermore, Pt-complex 102 has been successfully used as a precatalyst for the 6-endo-dig 
cycloisomerization of binaphtyl alkyne 104a (Scheme 1-19) by J. Carreras in our working-
group.
[36]
 This reaction had been already discovered by A. Fürstner et al.,
[37]
 but the levels of 
reactivity achieved using ligand 100a clearly surpassed those previously reported (Scheme 1-
19, Figure 1-11). Using precatalyst 102, 22 different substrates were submitted to the 
optimized cycloisomerization conditions, affording the desired 6-endo-dig product in good to 
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excellent yields (75-97%). Furthermore, the functional group tolerance of this reaction was 
also remarkable and functionalities such as -CF3, -F, -alkyl,-naphtyl, thiophene, -OMe, -SiMe3 
and –COOMe were tolerated. 
 
Scheme 1-18: Left up: Synthesis of tricyclopropenium phosphine 101a/b by M. Alcarazo et al. Right up: 
Isolated metal complexes of tricyclopropenium phosphine 101a. Down: Synthesis of chloro cyclopropenium salt 
102 by M. Alcarazo et al. a) 0.33 equiv. P(SiMe3)3, fluorobenzene, 60 °C, 3 days; b) 3.6-4.0 equiv. H-NMe2, 
DCM, -78 °C, 5 h, -78 °C to 0 °C, 1 h, 0 °C to r.t., overnight, reflux, 3 h; c) 10 equiv. KOH(aq), 65 °C, 2 h; d) 
3.2 equiv. (COCl)2, DCM, 0 °C, r.t., 15 min; e) 0.5 equiv. Mg(ClO4)2, CH3CN, r.t., overnight. 
 
 
Scheme 1-19: Cycloisomerization of binaphtyl alkyne 104b by M. Alcarazo et al. a) 0.05 equiv. PtCl3L (L: 
66/95a/100a), 0.05 equiv. Ag(CB11H6Cl6), 1,2-DCE, 80 °C; b) 0.05 equiv. PtCl2, 0.05 equiv. PR3, 1,2-DCE, 
80 °C. 
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Figure 1-11: Ligand effect on the cycloisomerization of binaphtyl alkyne 104a.
[36] 
A more recent example for a tricationic phosphine was provided by J. J. Weigand et al. in the 
form of trisimidazolium phosphine 108. This compound was prepared from the silyl 
carbenoid 109 and PCl3 in excellent yield (95%, Scheme 1-20). In order to force the reaction 
to full conversion a temperature of 140 °C was required. The silyl carbenoid 109 itself was 
accessible in moderate yield (64%, Scheme 1-20) from the respective free carbene 110 upon 
reaction with Me3Si-OTf. While structurally quite interesting no coordination compounds of 
this tricharged phosphine have been described.
[38] 
 
Scheme 1-20: Up: Preparation of silyl carbenoid. Down: Synthesis of triimidazolium phosphine 108 by J. J. 
Weigand et al.. a) 1.3 equiv. Me3Si-OTf fluorobenzene, 1h, r.t.; b) 140 °C, 3 h. 
. 
PtCl2 
PtCl2/PPh3 
 
PtCl2/P(OPh)3 
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2 Motivation 
It was mentioned in the previous section that the utilization of tricationic phosphines of type 
100a in the Pt(II)-catalyzed 6-endo-dig cycloisomerization of biphenyl/binaphtyl-alkynes 
provided high reactivity as well as a broad substrate scope. Despite of this, the employed 
cycloisomerization methodology presented several drawbacks. For example, the presence of 
(two) substituents in C-6 (R
3
) and C-2’ (R4) positions on a biphenyl-alkyne substrate resulted 
often in an incomplete conversion to the desired product (R
1
, R
2
 in Scheme 2-1). 
 
Scheme 2-1: Left: Cycloisomerization of biphenyl-alkynes 104b and 104 in the presence of Pt-cat. 102; 
Middle: Pt-precatalyst 102; Right: possible alternative Au(I)-precatalyst 97.
 
In order to solve this problem, we first decided to utilize a more π-acidic metal center like 
Au(I) in combination with 100a. However as already mentioned, tricationic phosphine 100a 
did not form a stable Au(I) complex.
[35, 39] 
For this
 
reason we decided to test if the use of 
Au(I)-complexes of biscyclopropenium phosphines such as 95a could solve the problem. It 
has to be mentioned here that Au(I)-complex 97a is stable in solution at room temperature. As 
a consequence several Au-precatalysts of type 97 were prepared and evaluated for the 
cycloisomerization of these problematic substrates (104b, 104c).  
Another key issue, which is addressed in this thesis is the improvement of the solubility of the 
prepared dicationic phosphines as well as their respective Au(I)-complexes. Polycationic 
catalysts are usually only soluble in polar solvents like acetonitrile, DCM or 1,2-DCE. It was 
envisioned that the utilization of halide-free solvents like toluene would be beneficial in terms 
of environmental reasons. Moreover, solvents such as toluene could possibly stabilize the 
activated Au-complex by π-coordination to the vacant site of the catalyst. This should result 
in an extended stability of the catalytic system and may allow the use of lower catalyst 
loading.  
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In order to increase the solubility of dicationic phosphines and their corresponding complexes 
in apolar solvents, it was decided to exchange the aliphatic residues (R
2
) on the N-atoms of 
the cyclopropenium by longer aliphatic chains. Moreover, the effect of the counter ion has 
also been studied (Figure 2-1). 
 
Figure 2-1: General Scheme of a dicationic cyclopropenium phosphine.
 
After establishing an optimized catalytic system for the cycloisomerization of biphenyl-
alkynes 104 with two internal substituents, the synthetic value of the developed methodology 
will be demonstrated in the preparation of a natural product, which depicts a phenanthrene 
architecture. 
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3 Synthesis and Evaluation of dicationic phosphines 
3.1 Synthesis of dicationic phosphines 
Dicationic phosphines of the general formula 95 were prepared from the respective 
cyclopropenium salts 63, 111 or 112 (Scheme 3-1), which are accessible from either 
tetrachlorocyclopropene 68 or pentachlorocyclopropane 113, both commercially available 
compounds. Reaction of those starting materials with an excess of HNR2 yielded either 63 
(82% yield) or the triaminocyclopropenium salts 114 and 115 respectively, depending on the 
steric bulk of the used amine. In order to transform 114 and 115 to the synthetically more 
useful chloro cyclopropenium salts 111 and 112, controlled hydrolysis of 114 and 115 under 
basic conditions was carried out to afford the lipophilic ketones 116 and 117 in moderate 
yield over two steps (40-67%). Subsequently, these compounds were treated with 3.1 
equivalents of oxalyl chloride to obtain the corresponding chloro cyclopropenium salts 111 
and 112 in good yields (68-83%).
[39,40]
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Scheme 3-1: Synthesis of cyclopropenium salts 63, 111, 112. a) 7.8 equiv. HN(n-Bu)2, 0 °C, 4 h, RT, 18 h, 
reflux, 5 h, DCM;
[40]
 b) 10 equiv. KOH, MeOH, H2O, 60°C, 16 h; c) 3.1 equiv. (COCl)2, 0°C, 0°C to r.t., r.t., 
1 h; d) 4.0 equiv. HN(n-Hex)2, -78 °C, 1h, 0 °C, 4 h, r.t., 18 h, DCM; e) 4.0 eqiv. HN(i-Pr)2, -78 °C, r.t., 18 h, 
DCM.
[25] 
With these cyclopropenium salts in hand, the dicationic phosphines of type 95 were prepared, 
in collaboration with G. Mehler, in low to moderate isolated yields (22-52%) following the 
already described two steps sequence from the corresponding primary phosphines (Scheme 3-
2). Thus, condensation of the cyclopropenium salt 63 and the desired primary phosphine 
afforded the monocationic secondary phosphine intermediate 96, which was subsequently 
condensed with a second equivalent of the chloro cyclopropenium salt under basic conditions 
to yield 95.  
Successful formation of intermediate 96 could be confirmed by measuring the 
31
P{
1
H}-NMR 
resonance, which experienced a considerable downfield shift compared to the measured 
values of the corresponding primary phosphines. All 
31
P{
1
H}-NMR signals are in the range of 
-94 ppm to -45 ppm (Scheme 3-2).
[41] 
Furthermore, signals of aromatic protons (if present) 
also shifted downfield in the 
1
H-NMR spectrum when the first condensation product 96 is 
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compared with the free phosphine. A final confirmation of the general structure of 
monocationic intermediates 96 was achieved by successful XRD analysis of compound 96a 
(section 3.2). 
31P{1H}-NMR δ = -78.0 ppm
31P{1H}-NMR δ = -94.4 ppm
31P{1H}-NMR δ = -59.4 ppm
31P{1H}-NMR δ = -44.5 ppm
31P{1H}-NMR δ = -54.7 ppm[b]
31P{1H}-NMR δ = -64.7 ppm[c]
31P{1H}-NMR δ = -43.7 ppm[c]
31P{1H}-NMR δ = -21.8 ppm[c]
31P{1H}-NMR δ = -52.6 ppm
31P{1H}-NMR δ = -51.3 ppm
31P{1H}-NMR δ = -70.0 ppm
31P{1H}-NMR δ = -47.2 ppm
 
Scheme 3-2: Modular synthesis of dicationic cyclopropenium phosphines 95a-g. All NMR spectra were 
measured in CDCl3 unless stated otherwise. 
[a]
: provided by G. Mehler; 
[b]
: measured in CD3CN; 
[c]
:measured in 
CD2Cl2. a) 2.5 equiv. R
1
-PH2, THF (or diglyme), 60 °C (or 100 °C), 24 h; b) 1.0 equiv. KHMDS, -40 °C, 2h, 1.0 
equiv. of 63, 111 or 112 -40 °C to r.t., overnight. 
The isolated secondary phosphines were deprotonated by a strong base (KHMDS) generating 
a phosphalkene in situ, which then reacted with a second equivalent of the desired 
cyclopropenium salt (63, 111 or 112) affording the desired dicationic phosphines 95a-g in 
moderate yields (32-68%). The attachment of a second cyclopropenium unit displaces the 
chemical shift of the 
31
P{
1
H}-NMR resonance further downfield into the range of -65 ppm to 
-21 ppm (Scheme 3-2).
[41] 
These observed chemical shifts of the 
31
P{
1
H}-resonance were in 
line with the corresponding values which were measured for the bisimidazolium phosphines 
81 and 82 (δ = -54 and -76 ppm respectively).[30, 31] 
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Dicationic phosphines thus prepared are slightly soluble in THF. As this solvent proved to be 
indispensable to wash the crude product to obtain pure materials, the moderate yields are not 
surprising. Furthermore, it should be mentioned that the solubility of the prepared 
biscyclopropenium phosphines 95 is highly dependent on the aliphatic residues R
2 
attached to 
the N-atoms of the cyclopropenium moieties (Scheme 3-2). All dicationic phosphines, which 
have exclusively i-Pr substituents, are only soluble in polar solvents such as DCM or 
acetonitrile. However, as soon as the R
2
 residues on one of the cyclopropenium units are 
exchanged for n-Bu or n-Hex, the resulting dicationic ligands become soluble in non-polar 
solvents such as toluene or diethyl ether. Due to this remarkable solubility the work-up of 
phosphines 95f and 95g had to be adjusted. In the case of 95f the crude material was 
repeatedly washed with pentane, while 95g had to be purified by column chromatography, 
because no precipitation was observed in THF.  
Finally, an ion exchange was performed for two of the prepared phosphines using an excess 
of NaSbF6 in acetonitrile (Scheme 3-3, 95h, 95i). While the absence of BF4
-
 was easily 
confirmed by 
19
F-NMR and 
11
B-NMR spectroscopy, the presence of the SbF6
-
 counter ion 
was also proven by 
19
F{
1
H}-NMR spectrum (δ = 124 (sext., JF-Sb(l=5/2) = 1930.5 Hz, JF-
Sb(l=7/2) =  1054.7 Hz) and negative MS spectrometry (m/z = 234.9 [SbF6
-
]) and IR (strong 
band at 652 cm
-1
). Final confirmation of the successful ion-exchange was achieved by XRD-
analysis of 95i. (Scheme 3-3).  
 
Scheme 3-3: Ion exchange. a) 7.0 equiv. NaSbF6, CH3CN, r.t., overnight. 
                                                                   3. Synthesis and evaluation of dicationic phosphines 
 
29 
3.2 Structural properties of dicationic phosphines 
Single crystals suitable for XRD analysis were obtained for secondary phosphine 96a, the 
dicationic phosphine 95b (R
1
 = o-biPh, R
2
 = i-Pr, X = BF4) and the lipophilic analogue 95i 
(R
1
 = Ph, R
2
 = n-Hex, X = SbF6
-
).
 
These structures could be compared among them and with 
the already known dicationic phosphine 95a (R
1
 = Ph, R
2
 = i-Pr, X = BF4
-
, Figure 3-1, Table 
3-1).
[41a, ,42]
 
 
Figure 3-1: X-Rays of monocationic secondary phosphine 96a, dicationic Phosphine 95a, 95b and 95i. For 96a: 
α(H1-P1-C1) = 104(2)°, β(C1-P1-C4) = 103.04(11)°, γ (C4-P1-H1) = 100(2)°. For 95a: α(C1-P1-
C2) = 98.38(11), β(C2-P1-C3) = 100.53(11)°, γ(C3-P1-C1) = 102.36(11)°. For 95b: α(C1-P1-C4) = 100.68(18)°, 
β(C4-P1-C7) = 104.09(18)°, γ(C7-P1-C1) = 103.21(18)°. For 95i: α(C1-P1-C4) = 102.23(11)°, β(C4-P1-C7) = 
100.59(11)°, γ(C7-P1-C1) = 103.17(11)°. Anisotropic displacements shown at 50% probability level, counter-
ions and hydrogens (except the one the P-center of 96a) omitted for clarity purposes. 
96a 95a 
95i 95b 
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Table 3-1: Comparison of bond lengths d and pyramidalization degrees [PD]
[43]
 for different charged and neutral 
phosphines. 
Entry phosphine d (P-H) 
[Å] 
d (CPh-P) 
[Å] 
d (CCpr-P)
[a]
 
[Å] 
d ((C-C)CPr)
[b]
 
[Å] 
PD 
[%]
[c] 
1 95b - 1.826(3) 1.787(4)- 
1.795(4) 
1.383(6)-
1.409(6) 
57.8 
2 95i - 1.827(3) 1.798(2)-
1.804(3) 
1.377(3)-
1.415(3) 
60.0 
3 95a
[42] 
- 1.821(4) 1.805(3) 1.374(5)-
1.414(4) 
65.3 
4 96a 1.46(6) 1.826(2) 1.797(3) 1.377(3)-
1.405(3) 
58.2 
5 PPh3
[44] 
- 1.828(2)-
1.834(2)
 
- 1.370(3)-
1.395(3)
[d] 
56.7 
6 Ph2P-H
[45] 
1.42 1.830(6)-
1.831(6)
 
- 1.402(3)
[d] 
/ 
[a]
: d(CCpr-P) refers to the bond length in between the P-center and cyclopropenium C-atom directly attached to 
this P-atom. 
[b]
: d((C-C)Cpr) refers to the C-C bond distance between two neighboring C-atoms in the 
cyclopropenium ring 
[c]
: PD refers to the calculated pyramidalization degree. 
[d]
: As these compounds do not 
possess a cyclopropenium moiety, the given values refer to C-C bond distances in between the aromatic carbons 
of the phenyl residues.  
The measured P-CCPr bond-distances in 95b of (1.787(4)-1.795(4) Å), 95i (1.798(2)-
1.804(3) Å) and 95a (1.805(3) Å) are shorter than the respective P-CPh bonds in the same 
molecule. This can be rationalized by the electron-withdrawing nature of the cyclopropenium 
moieties and the resulting back-donation form the P-center to these charged units. However, 
these distances are still by far longer than a true P=C double bond (i.e. d(C=P) =1.662(8) Å in 
an unstabilized ylide Ph3P=CH2)
[46]
 and indicate mainly single-bond character.
[41]
 
The bond lengths in between the P-center and the aromatic carbon (Table 3-1, d(CPh-P); 
Figure 3-1) of the aryl group bound to the phosphorus are virtually identical for the 
intermediate 96a and all dicationic phosphines (95a, 95b, 95i) with values around 1.821(4)-
1.827(3) Å. These are in line with the measured CPh-P distances of PPh3 (c.f. 1.828(2)-
1.834(2) Å) or Ph2P-H (c.f. 1.830(6)-1.831(6) Å).  
The C-C bond-distances d(C-C)Cpr (1.370(3)-1.415(5) Å) between the neighboring C-atoms 
constituting the cyclopropenium rings of the analyzed cationic phosphines (96a, 95a, 95b, 
95i) have similar values. Because these bond-lengths are significantly shorter than the typical 
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C-C single bond (1.54 Å),
[47]
 but slightly longer than a true C=C (1.34 Å)
[47] 
double bond, 
they indicate aromaticity in these three membered rings (Table 3-1).  
Finally, the pyramidalization degree [PD] on the P-center depends on the overall charge and 
sterical demand of the residues attached to the P-atom. On the one hand, the pyramidalization 
is augmented with increasing charge as it can be observed in the comparison of monocationic 
intermediate 96a with the dicationic phosphine 95a. The [PD] value increases from 57.8% 
(96a) to 65.3% (95a) by exchanging the proton bound to phosphorus (96a) for one additional 
cyclopropenium unit (95a).  
On the other hand, an enhancement of the steric bulk lowers the [PD] value. By increasing the 
steric demand of the aliphatic substituents R
2
 (Scheme 3-3, Figure 3-1, Table 3-1) bound to 
the N-atoms of the cyclopropenium units a slight decrease of the pyramidalization can be 
observed, which becomes apparent when the [PD] value of dicationic phosphine 95a (R
2
 = i-
Pr, [PD] = 65.3°) is compared with the corresponding value of 95i (R
2
 = n-Hex, 
[PD] = 60.0°). A similar effect is noticed when the steric demand of the aryl-residue R
1
 
(Scheme 3-3), bound to the P-atom of the respective dicationic phosphine, is increased (95a: 
R
1
 = Ph, [PD] = 65.3%; 95i: R
1
 = o-biPh, [PD] = 58.2%). 
Overall, the pyramidalization degrees [PD] of the analyzed dicationic phosphines are similar 
to the known value for PPh3 ([PD] = 56.7°), which is in agreement with the conclusion that 
the back-donation from the P-atom to the cationic moieties is marginal. Otherwise an 
increased flattening of the structure should have been observed after sequential addition of 
new charged cyclopropenium moieties to the phosphorus. The weak back-donation form the 
P-atom to the charged moieties can be rationalized by an inefficient orbital-overlap between 
occupied non-bonding sp
3
 orbital of the phosphine and the π*-orbitals of the bound 
cyclopropenium unit.  
These results could be reproduced by the DFT calculations (B3LYP/6-31G*) performed for 
dicationic phosphine 95a and carried out at our department of theoretical chemistry (Table 3-
2).
[34]
 Because the prepared dicationic phosphine 95i is almost identical with the dicationic 
phosphine 95a from an electronic as well as from a structural standpoint, the calculated data 
for 95a can be considered also valid for 95i. The calculated Wiberg index for the CCPr-P bond 
of 0.909 supports the conclusion that the back-donation from the P-center to the 
cyclopropenium moiety is negligible. Furthermore, the calculated bond lengths for P-CCPr- 
3. Synthesis and evaluation of dicationic phosphines                                           ………………  
 
32 
and CPh-P of 95a are in agreement with obtained experimental data for 95b and 95i (Table 3-
2).
[34] 
Due to the experimental results the covalent model structure 95-I (Scheme 3-4) seems to be 
more suitable to describe the bonding situation in these dicationic phosphines, but a natural 
population analysis (B3LYP/6-311+G**//6-31G*) reveals a charge Q of +0.88 assigned to the 
P-center of 95a.
[34] 
Due to this, the true nature of ligand 95a (as well 95i) lies in between 
structures 95-I and 95-II (Scheme 3-4), with a slight emphasis on model 95-I. 
Table 3-2: Comparison of experimental and calculated bond lengths and corresponding Wiberg bond orders at 
(B3LYP/6-31G*).
[34] 
 Bond length d [Å] Bond order 
95a 
 
 experimental calculated 
95a 95i 95a 
CCPr-P 1.798(2)-
1.804(3) 
1.805(3) 1.83 0.909 
CPh-P 1.827(3) 1.821(4) 1.84 0.911 
 
 
Scheme 3-4: Possible model structures for dicationic phosphines 95. 
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3.3 Evaluation of π-acceptor properties 
A frontier orbital analysis (B3LYP/6-311+G**//6-31G*, calculations performed at our 
department of theoretical chemistry) of 95a showed that its HOMO is lowered in energy (E 
(HOMO) =-11.50 eV) when compared to that of the monocationic phosphine 66 (E 
(HOMO)=-9.02 eV). However the shape of both oribtals is nearly identical and it depicts 
significant lone pair character centered on the phosphorus with an orbital occupancy of 1.87e 
(Figure 3-2). This allows the ligand to display some Lewis-basicity despite of the two positive 
charges that it bears. The calculated LUMO (E(LUMO)= -6.79 eV) lies considerably lower in 
energy than the LUMO of commercially available electron poor phosphines (e.g. P(C6F5)3, 
(E(LUMO)= -2.44 eV)) or phosphites (e.g. P(OMe)3, (E(LUMO)= -0.03 eV), which should 
result in a great enhancement of its π-acceptor properties.[34, 36] 
 
Figure 3-2: Representation of the calculated HOMO (left) and LUMO (right) for 95a. 
Overall, the calculations confirm that the successive attachment of electron withdrawing 
substituents directly to a phosphorus center leads to a decrease of the σ-donating properties 
and an increase the of π-acceptor properties of the resulting phosphine. (Figure 3-3).[34, 36] 
 
Figure 3-3: Increasing π-acceptor properties among cationic cyclopropenium phosphines with increasing charge. 
The LUMOs for 66, 95a, 100a were calculated by B3LYP/6-311+G**//6-31G*.
[34, 36] 
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3.4 Evaluation of steric properties 
One of the most common ways to determine the steric as well as the electronic properties of a 
P-centered compound, is the Tolman analysis, which studies the CO-stretching frequency 
(ῦCO) of [Ni(CO)3L] complexes and the cone angles of the ligands (L).
[16a, 48]
 As it was already 
explained in section 1.2.1.1 the CO-stretching frequency of the [Ni(CO)3L] complex increases 
with rising π-acceptor/decreasing σ-donor properties of the used ligand. Due to this, it is a 
good indicator for the electronic nature of the investigated ligand.  
The Tolman cone angle (Ɵ) is defined as the apex angle of a cylindrical cone centered 2.28 Å 
away from the center of the P-atom, which just touches the van-der-Waals radii of the 
outermost atoms of the substituents attached to the P-center (Figure 3-4). Due to the fact that 
the three substituents of the phosphine might not be identical, half-angles Ɵi are utilized for 
the determination of the aforementioned cone angles Ɵ employing equation 3-1.[48]  



3
1 23
2
i
i                                                                                                               Equation 3-1 
 
Figure 3-4: Representation of the Tolman cone for and unsymmetrical P-centered ligand. 
By depicting ῦCO of the Ni(CO)3L complexes against the cone angle Ɵ of the corresponding 
P-centered ligand a map is obtained, which provides information about the electronic nature 
of the used ligand as well as its sterical demand (Figure 3-5). The main disadvantage of this 
method is the preparation of the necessary metal complexes using the highly toxic and volatile 
Ni(CO)4. For this reason Tolman electronic parameters (TEP) of strong π-acceptor ligands are 
not always available. Complementary data can be obtained in these cases with the help of 
theoretical chemistry. Gusev has implemented a method to determine these values.
[49]
 This 
methodology is capable of reproducing the known values accurately and, therefore, it seems 
reasonable to accept that the predicted values for those phosphorus compounds, whose 
Tolman electronic parameters has not been measured, are correct.
.[16a, 49] 
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Figure 3-5: Comparison of Tolman angles for different P-centered ligands (experimental values are shown in red 
and calculated values in blue).
[16a, 48a, 49] 
Representation of the aforementioned values in the stereoelectronic map demonstrates the 
significant effect of an additional positive charge attached to the P-center. The monocationic 
cyclopropenium phosphine 66 has a wavenumber in the range of phosphites, being a moderate 
π-acceptor ligand with a TEP of 2082 cm-1. However, if one of the phenyl groups is 
exchanged for an additional cyclopropenium moiety, the resulting dicationic phosphine 95a is 
elevated into the range of strong π-acceptor ligands (i.e. P(CF)3 and PF3) with a wavenumber 
of 2101 cm
-1
. In fact, 95a is only surpassed in its π-acceptor properties by a 
tricyclopropenium phosphine 100a with a carbonyl stretching frequency of  
ῦCO = 2111 cm
-1
.
[16a] 
An alternative method to evaluate the σ-donor properties of P-centered ligands is the 
measurement of their oxidation potential Ep(Ox) by cyclic voltammetry since the donor ability 
of a phosphine is inversely proportional to this value.  
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Figure 3-6: Structures of phosphines evaluated by cyclic voltammetry. Oxidation peak potential reported in V. 
Calibrated versus ferrocene/ferrocenium (E1/2 = 0), Bu4NPF6 (0.1 M) in DCM. 
[a]
measured in acetonitrile. 
Credits for measurements go to C. Wille.
[16]
 
 
The measured oxidation potentials (Figure 3-6) are in agreement with the results obtained 
from the Tolman stereoelectronic map and further confirm the decrease of the σ-donating 
abilities by introduction of an additional cyclopropenium unit on the phosphorus center. 
Furthermore, the oxidation potentials (Ep(Ox)) of the prepared biscyclopropenium phosphines 
95a-e show that they are even weaker σ-donors than phosphites, but at the same time, they 
provide σ-donor capabilities which are significantly greater than the bisimidazolium ligand 
82, which is not capable to coordinate metals.
[16a, 31] 
When the oxidation potentials of dicationic phosphines of similar structure are compared with 
each other, the influence of the residue R on the electronic properties becomes evident. In 
general, alkyl phosphines are more electron-donating than aryl-phosphines, because of the 
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possibility of the electron lone pair at the P-center to be delocalized on the π-system of the 
aryl group.
[50]
 
Moreover, when two aryl-phosphines are compared with each other, the effect of the 
substitution pattern on the aromatic ring attached to the P-atom can be evaluated. For 
example, when the Ep(Ox) = 1.541 V of 95a (R = Ph,) is compared with Ep(Ox) = 1.425 V of 
95b (R = o-biPh), it becomes evident that the presence of an additional phenyl group on the 
primary phenyl group attached to the P-center leads to an increase of the electron density on 
the phosphorus and an augmentation of the σ-donor properties of 95a. A possible 
rationalization of this observation is the positive mesomeric effect of the secondary phenyl 
group.
[51]
 
For alkyl phosphines the σ-donor character of the phosphorus increases with the number of 
alkyl substituents attached to the C-atom, which is bound to the P-center due the positive 
inductive effect of alkyl groups. Due to this, the following hierarchy among the donor-ability 
of the measured dicationic phosphines is found: 95b (o-biPh) > 95e (R = Ad) > 95d (R = Cy) 
> 95a (R = Ph)
 
(Figure 3-6).
[16a]
 
3.5 Summary 
The synthesis of seven different dicationic phosphines (95a-95g) was accomplished in 22-
49% yield over two steps in a modular fashion from the respective chloro cyclopropenium 
salts (63, 111, 112). Subsequent ion-exchange was performed for two of those compounds in 
order to obtain the analogues of those dicationic phosphines with SbF6
-
 as a counter-ion. The 
structure of these ligands was confirmed by full characterization and in addition, XRD-
analysis of 96a, 95a and 95i.  
All CCpr-P bond lengths,
[52]
 the aromatic nature of the C-C bond lengths within the 
cyclopropenium moiety and the pyramidalization at P suggest that the lone pair of electrons is 
still localized on the phosphorus. 
Finally, the Tolman electronic parameters (TEP) fit the expectations. Enhanced π-acceptor 
properties are obtained by increasing the number of charged moieties attached to the P-center. 
Cyclic voltammetry measurements of the oxidation potential of the prepared dicationic 
phosphines 95a-95e showed that the nature of R
1
 influences this value and thus, the electron 
releasing properties of the corresponding phosphine 95 (Scheme 3-3).  
. 
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4 Coordination chemistry 
4.1 Coordination to Au(I) 
In order to check the coordinative properties of the dicationic phosphines (95a-g) they were 
treated with one equivalent of AuCl
.
(SMe2) at -20 °C in DCM. The corresponding Au(I)-
complexes 97a-h were obtained as air stable solids in good to excellent yields (78-95%, 
Scheme 4-1). Moreover, all these compounds were stable in solid state as well as in solution 
at room temperature. Complexes 97a-e were only soluble in polar solvents such as DCM, 
DMSO or acetonitrile, while compounds 97f, 97g and 97h bearing n-butyl and n-hexyl chains 
(for R
2
) were soluble in diethyl ether and toluene. This proved to be useful to avoid 
halogenated solvents in our catalytic systems.  
The formation of the desired Au(I)-complexes was easily confirmed by 
31
P{
1
H}-NMR 
spectroscopy. After coordination to Au(I) the 
31
P-resonance of the corresponding dicationic 
phosphines undergo a significant downfield shift in the 
31
P{
1
H}-NMR spectrum appearing in 
the range between -23.8 ppm (97h, R
1
 = Ph, R
2
 = n-Hex, SbF6, CDCl3) and 12.2 ppm (97e, 
R
1
 = Ad, R
2
 = i-Pr, BF4
-
, CD3CN). 
Despite the generality of this coordination procedure (Scheme 4-1), the mesitylene substituted 
phosphine 95c did not coordinate to the Au(I)-center under the reported conditions. Probably, 
the steric demand of the mesitylene group hinders the formation of the desired complex.  
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31P{1H}-NMR δ = -8.8 ppm 31P{1H}-NMR δ = -17.9 ppm31P{1H}-NMR δ = -9.9 ppm 31P{1H}-NMR δ = -9.9 ppm
31P{1H}-NMR δ = -20.5 ppm 31P{1H}-NMR δ = -23.3 ppm 31P{1H}-NMR δ = -23.8 ppm31P{1H}-NMR δ = 12.2 ppm
 
Scheme 4-1: Coordination of different dicationic ligands 95a-i to Au(I). a) 1.0 equiv. AuCl
.
SMe2, DCM, -20 °C, 
30 min, -20 °C to r.t., r.t., 30 min. 
In order to study the counter ion-effect on catalysis, which will be discussed in detail in 
section 5, an ion exchange was performed for Au(I)-complex 97f (Scheme 4-2). 5 equivalents 
of NaSbF6 per equivalent of BF4
- 
were needed to ensure that no signals corresponding to BF4
- 
were detectable in the 
19
F{
1
H}-NMR spectrum of the product.  
 
Scheme 4-2: Ion exchange for compound 96f. a) 10.0 equiv. NaSbF6, CH3CN, r.t., overnight. 
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A final confirmation for the coordination of Au(I) to our dicationic ligands was achieved by 
the XRD-analysis of single crystals of compounds 97b (Figure 4-1) and 97c (Figure 4-2), 
which were obtained by diffusion of diethyl ether in acetonitrile solutions of these 
compounds. 
 
Figure 4-1: X-Ray of Au-complex 97b. Anisotropic displacements shown at 50% probability level, counter-ions 
and hydrogens omitted for clarity purposes. 
 
 
Figure 4-2: X-Ray of Au-complex 97c. Anisotropic displacements shown at 50% probability level, counter-ions 
and hydrogens omitted for clarity purposes. 
97b 
97c 
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Table 4-1: Comparison of bond lengths of 97b and 97c to AuCl(PPh3) and AuCl(P(OPh)3).
[53, 54] 
Entry AuCl(L) d (P-Au) 
[Å] 
d (Au-Cl) [Å] d (CPh-P) [Å]
[a] 
d(CCPr-P) [Å]
[b] 
1 97b 2.2257(14) 2.2835(15) 1.805(6) 1.786(6)- 
1.789(6) 
2 97c 2.2224(10) 2.2763(10) 1.819(4) 1.791(4)- 
1.794(4) 
3 PPh3
[53] 
2.2308(5) 2.2915(5) 1.8091(15)- 
1.8116(15) 
none 
4 P(OPh)3
[54] 
2.192(5) 2.273(5) none none 
[a]
: d(CPh-P) refers to the bond distance in between the P-center and the quaternary C-atom of the Aryl residue 
bound to the phosphorus;
[b]
: d(CCPr-P) refers to the bond distance in between the P-center and C-atom of the 
cyclopropenium moiety bound to the P-center. 
Both complexes 97b (R = Ph, X = SbF6
-
) and 97c (R = o-biPh, X = BF4
-
) have a linear 
coordination sphere around the Au-atom with only a slight distortion in the solid state. The 
P1-Au1-Cl1 angle in 97b is 177.23°, while in 97c the same parameter shows a value of 
173.0°. The enhanced distortion in the case of 97c is probably the result of the increased steric 
bulk of the biphenyl residue attached to the P-center, when compared with 97b.  
Both P-Au bond lengths (97b: d(P-Au) = 2.2257(14) Å; 97c: d(P-Au) =  2.2224(10) Å) are 
crystallographically indistinguishable and in the same range of typical P-Au(I) bonds. 
 Compound 97c depicts however an interesting feature. The carbon C13 (Figure 4-2) shows a 
short contact with the Au(I)-atom (d(C13-Au1) = 3.250 Å). This could be beneficial for future 
catalytic applications as such an interaction could stabilize the Au(I) center after the Cl atom 
is abstracted to form the active catalyst. As a consequence a longer lifetime of the catalyst in 
solution might be possible.  
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4.2 Coordination to Pt(II) 
The coordination of monocationic imidazolium phosphines to Pt(II) utilizing K2PtCl4 as a 
metal source was reported for the first time by N. Kuhn as mentioned in section 1.2.
[19]
 Prior 
to the preparation of biscyclopropenium phosphine 95a (R
1
 = Ph, R
2
 = i-Pr, X = BF4
-
) by J. 
Petuškova in our work-group the only dicationic phosphine capable of coordinating Pt(II) was 
the guanidine derived species 92 synthesized by M. P. Coles in 2004
[33]
 (section 1.3).  
As in the case of the Au(I)-compounds, the 
31
P{
1
H}-NMR signal of the dicationic phosphine 
experiences a significant downfield shift to -23.4 ppm (
1
JPt-P = 3997 Hz) upon coordination to 
Pt(II), which is consistent with the formation of the platinum complex.
[41] 
Moreover, the Pt-P 
satellites of 98 provide a larger coupling constant than those reported for Pt-complex 125 
(
1
JPt-P = 3425 Hz),
[20]
 which can be explained by a stronger back-donation from the Pt-center 
to the P-atom in our case,  probably due to the increased charge of the ligand (Scheme 4-3).  
Precatalyst 98 was submitted to ion-exchange and gave the desired product 126 with SbF6
-
 as 
a counter anion in good yield (68%). The ion exchange had to be performed at this stage as 
previous attempts to react K2PtCl4 with the biscyclopropenium phosphine 95h (R
1
 = Ph, R
2
 = 
i-Pr, X = SbF6
-
) already bearing the SbF6
-
 counter ion failed, probably due to the low 
solubility of the ligand.  
 
Scheme 4-3: Left: Coordination of Pt(II) by dicationic ligand 95a with subsequent ion exchange. Right: Pt(II)-
complex 1325 by M. Azouri et al., a) 1.0 equiv. K2PtCl4, CH3CN, r.t., overnight; b) 3.5 equiv. NaSbF6, CH3CN, 
r.t., overnight. 
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4.3 Coordination to Ag(I) 
The coordination of dicationic phosphine 95a to AgBF4 in DCM at -25 °C resulted in the 
formation of a new Ag(I)-complex 127, whose structure could not be unambiguously 
determined. A priori two possible structures (monocoordinated or biscoordinated Ag(I) 
complexes) can be proposed for 127 as shown in Scheme 4-4.  
 
Scheme 4-4: Coordination of Ag(I) by dicationic ligand 95a. a) 1.0 equiv. AgBF4, DCM, -25 °C, 30 min, -25 °C 
to r.t., 1.5 h. 
Coordination of Ag(I) is evident by the appearance of a new 
31
P{
1
H}-NMR signal at  
-32.6 ppm as a broad singlet (Figure 4-3). Because Ag possesses two NMR active isotopes, 
namely 
107
Ag and 
109
Ag both with l=1/2, two doublets should be expected in the 
31
P{
1
H}-
NMR spectrum for the respective resonance. However, it is also known from literature that 
most 
31
P-NMR resonances of unhindered Ag(I)-phosphine complexes appear as broad singlets 
as a result of fast ligand exchange, which is in agreement with the observed 
31
P{
1
H}-NMR 
spectrum.
[55] 
While HRMS spectrometry confirmed the presence of a Ag(I)-complex with one 
attached phosphine (m/z = 861.373040 [M-BF4
-
]
+
), it does not exclude the possibility that the 
monocoordinated species was formed during the measurement via dissociation of the 
biscoordinated analogue, especially, since it is known that monocoordinated Ag(I)-complexes 
like 128 are in equilibrium with their biscoordinated analogues 129 (Scheme 4-5), which 
makes a clear statement on the structure of the compound 127a/b difficult.
[56]
 
 
Scheme 4-5: Equilibrium between monocoordinated Ag(I) complex 128 and biscoordinated Ag(I) complex 
129.
[56] 
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Figure 4-3:
31
P{
1
H}-NMR of compound 127 (measured in CD2Cl2). 
4.4 Coordination to Cu(I) and Rh(I) 
It has been known from the work of J. Petuškova that it is possible to coordinate 
monocationic cyclopropenium substituted phosphine 66 to Cu(I) and Rh(I) (Figure 4-4).
[34, 41b]
 
However, the coordination ability of the analogous dicationic phosphines towards these two 
metals had not been evaluated so far. 
 
 
Figure 4-4: Prepared monocationic Cu(I) (130) and Rh(I) (131) complexes by J. Petuškova. 
After the successful coordination of dicationic phosphine 95a to Au(I) and Pt(II) we 
attempted to coordinate the very same ligand to Cu(I) and Rh(I) under similar conditions. 
However, the measurement of the 
31
P{
1
H}-NMR spectrum showed only the 
31
P-resonance of 
the free ligand 95a even when several Cu(I) salts (i.e. CuCl
.
SMe2, CuCl and CuBr) and 
[RhCl(COD)]2 were used. Since steric repulsion should not be an issue, at least in the case of 
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Cu(I) complexes, it has to be concluded that the utilized dicationic phosphine 95a is probably 
too electron deficient to coordinate these metals.
 
 
Scheme 4-6: Attempted coordination of dicationic cyclopropenium phosphine 95a to Cu(I) and Rh(I). a) 1.0 
equiv. CuX, DCM (or THF) , -20 °C, 30 min, -20 °C to r.t. and then r.t., 1h. b) 0.5 equiv. [RhCl(COD)]2, DCM, -
20 °C, 30 min, -20 °C to r.t. and then r.t., 1h. 
4.5 Coordination to Ir(I)  
In contrast to the Rh(I) analogue 133, the dicationic Ir(I)-complex 134 could be prepared in 
good yield (84%) from the dicationic phosphine 95a and [IrCl(COD)]2 at -25 °C in DCM 
(Scheme 4-7). However, 134 is thermally labile and dissociates into the starting materials at 
room temperature even in the solid state (Scheme 4-8). 
 
Scheme 4-7: Coordination of dicationic cyclopropenium phosphine 95a to [IrCl(COD)]2. a) 0.5 equiv. 
[IrCl(COD)]2, DCM, -25 °C, 1 h. 
For this reason the complete work-up, including the solvent removal as well as subsequent 
NMR measurements, had to be performed at -20 °C. As usual, a confirmation of the 
coordination was achieved by measuring a 
31
P-NMR spectrum at -20 °C. The 
31
P resonance of 
the dicationic phosphine experiences a downfield shift to -18.7 ppm (Figure 4-5) upon 
coordination. The significant peak broadening observed for this signal at -20 °C can be 
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attributed to the hindered P-Ir rotation at this temperature (resulting in a loss of symmetry) 
and also to a coordination-decoordination equilibrium (Scheme 4-8) of compound 134 in 
solution. 
 
 
Scheme 4-8: Observed equilibrium for compound 134. 
 
Figure 4-5: 
31
P-NMR of compound 134 (measured at 0 °C and -20 °C in CDCl3). 
The identity of compound 134 was confirmed by 
1
H-NMR, 
13
C-NMR (one quaternary C-
signal is missing due to peak broadening) and HRMS spectrometry (m/z = 1003.491794 [M-
BF4
-
]
+
). However, the observed thermal instability of compound 134 precludes its use as a 
catalyst.  
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Unfortunately, it was not possible to coordinate 95a to [Cp*IrCl2]2 under similar conditions 
possibly due to a combination of electronic and steric reasons (steric repulsion with Cp* could 
be a problem). 
4.6 Summary 
After successful synthesis of biscyclopropenium phosphines 95a-g, those compounds were 
treated with AuCl
.
(SMe2) in order gain access to the corresponding dicationic Au(I)-
complexes. With the exception of 95c (R
1
 = Mes, R
2
 = i-Pr, X = BF4
-
), all employed 
phosphines 95a/95b/95d-h were successfully coordinated to Au(I) affording the desired 
coordination compounds 97a-h in good to excellent yields. The solid-state structure of Au(I)-
complexes 97b and 97c was confirmed by XRD analysis. 
Additionally, it was possible to coordinate phosphine 95a (R
1
 = Ph, R
2
 = i-Pr, X = BF4
-
) to 
Pt(II) as well as Ir(I) under similar conditions affording compounds 98 and 134 in good 
yields. It has to be highlighted that the isolated Ir(I)-complex 134 is only stable at -20 °C and 
decomposes even in solid state at room temperature.  
Interestingly, treatment of AgBF4 with 95a resulted in a downfield shift of the 
31
P-signal in 
the corresponding spectrum, which indicates a successful coordination. This is supported by 
HRMS spectrometry, as the m/z ratio is in agreement with the coordination to Ag(I). 
However, without XRD-analysis of the isolated compound 127 no definitive statement 
concerning the structure of the isolated Ag(I)-complex is possible.  
Finally, no complexation was observed for the treatment of the utilized Rh(I), Cu(I) and Ir(III) 
sources with dicationic phosphine 95a as a result of steric and probably also electronic 
reasons. 
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5 Applications in catalysis 
5.1 Introduction 
 
Scheme 5-1: Scope and limitations of the Pt(II)-precatalyst 102 on the 6-endo-dig cycloisomerization of 
biphenyl alkynes. a) 0.05 equiv. 102, 0.05 equiv. Ag(CB11H6Cl6), 1,2-DCE, 80 °C. 
It has been already mentioned in section 1.4 that Pt(II)-complex 102 containing the tricationic 
phosphine 100a was successfully applied as catalyst in our work-group on the 6-endo-dig 
cyclization of biphenyl/binaphtyl-alkynes 104a/d/e (Scheme 5-1).
[36]
 Although 22 different 
substrates were prepared with a remarkable tolerance towards different functional groups, this 
methodology still had limitations as previously mentioned (section 2). The presence of (two) 
substituents in C-6 (R
3
) and C-2’ (R4) positions of the substrate resulted in low conversion of 
the starting material to the desired product (104b, 104c) or no reaction at all. In order test the 
reactivity profile of Au(I)-complexes 97a-h in the same process, alkynes 104c, 104f and 
104g, all of which are difficult substrates for 100a, were prepared as test substrates (Figure 5-
1). 
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Figure 5-1: Employed model substrates for the investigation of the cycloisomerization of biphenyl-alkynes. 
5.2 Synthesis of phenanthrene derivatives  
5.2.1 Preliminary Studies 
At the beginning 2-ethynyl-2'-phenyl-biphenyl 104c was used as a model substrate. This 
alkyne could be transformed to the phenanthrene 107c in only 23% yield in the presence of 
the Pt(II)-tricationic phosphine complex 102 (section 2, Scheme 2-1).  
However, after optimization experiments of the solvent and the Ag(I)-salt screening, the 
desired cycloisomerization of 2-ethynyl-2'-phenyl-biphenyl 104c could be performed in 
excellent yield in only 10-15 minutes employing 2 mol% 97a and 2 mol% AgSbF6  in DCM at 
room temperature (substrate concentration of 0.05 M, Scheme 5-2).  
 
Scheme 5-2: Cycloisomerization of 2-ethynyl-2'-phenyl-biphenyl 104c into 107c in the presence of precatalyst 
97a. a) 0.02 equiv. Au-cat., 0.02 equiv. AgSbF6, DCM, r.t. 
5.2.2 Investigating the ligand effect 
Once the optimal reaction conditions for this difficult cycloisomerization were established, 
traditional ligands were also used in this transformation in order to better understand the 
effect of our ligands. 2-Ethynyl-2’,6-dimethylbiphenyl 104f was employed as substrate, 
because its two methyl groups in C-6 and C-2’ postions make the cycloisomerization more 
difficult. Therefore, this substrate is an ideal candidate to demonstrate the performance of our 
catalysts in comparison to traditional ones (Scheme 5-3).  
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Scheme 5-3: Cycloisomerization of 2-ethynyl-2’,6-dimethylbiphenyl 104f in the presence of different Au(I)-
precatalysts. a) 0.02 equiv. Au-cat., 0.02 equiv. AgSbF6, DCM, r.t. 
 
 
Figure 5-2: Ligand effect on the conversion rate for the cycloisomerization of 2-ethynyl-2’,6-dimethylbiphenyl 
104f. 
Figure 5-2 shows that the reaction rate is highly dependent on the π-acceptor properties of the 
phosphine attached to the Au(I)-center of the corresponding catalyst, it increased when strong 
π-acceptor ligands are coordinated to Au(I). Precatalyst 97a performs much better in this 
reaction than any Au-precatalysts derived from commercial P-centered compounds. Thus, it 
was possible to transform the alkyne 104f to the 6-endo-product 107f within 10 to 15 minutes. 
These results make us believe that the attack of the upper aryl-ring on the activated alkyne is 
probably the rate-determing step. 
5.2.3 Investigating the substrate scope 
In order to evaluate the substrate scope and the functional group tolerance of the new catalytic 
system, substrates of type 104 were synthesized (in collaboration with Dr. J. Carreras) in a 
two-step sequence from the appropriate aryl-(pseudo)halides 135. This sequence included a 
Suzuki-coupling and a subsequent Seyferth-Gilbert alkynylation (Scheme 5-4, Figure 5-3).
[57]
 
Overall, 16 different biphenyl-alkynes of general structure 104 were prepared with different 
success (27-94%, Figure 5-3) over two steps.  
AuCl(PPh3) 
AuCl(P(OPh)3) 
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Scheme 5-4: General scheme for the synthesis of biphenyl-alkynes 104. a) Suzuki-coupling; b) 1.5 equiv. Ohira-
Bestmann reagent, 2.0 equiv. K2CO3, MeOH, r.t., overnight. 
 
 
Figure 5-3: List of prepared substrates. All of the reported yields are over two steps. 
[a]
: The displayed yield 
represents an isolated yield over three steps as it includes the methylation of the primary alkyne 104a. 
Submission of these compounds to the optimized cycloisomerization conditions afforded the 
desired phenanthrenes of type 107 in good to excellent yields (Figure 5-4). Filtration over a 
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short pad of Celite
® 
was enough in most of the cases to obtain the desired products in 
analytical purity.  
 
Figure 5-4: Substrate scope of the cycloisomerization under optimized conditions. Conditions: 0.02 equiv. Au-
cat. 97a, 0.02 equiv. AgSbF6, DCM, r.t.. 
It can be concluded that the developed catalyst allows the introduction of up to two groups at 
the internal positions of the phenanthrene (C-4 for R
3
, C-5 for R
4
) with good tolerance 
towards functional groups of different steric and electronic nature (H, Me, i-Pr, Ph, F, OH, 
OMe). The catalyst is active enough to enable the ring-closing of biphenyl-alkynes, whose 
reaction is hindered (i.e.: 104f: R
3
 = Me, R
4
 = Me; 104j: R
3
 = Ph, R
4
 = Ph; 107p: R
3
 = OMe, 
R
4
 = i-Pr) by steric repulsion between R
1
 and R
2
 (Figure 5-3, Figure 5-4). Furthermore, it has 
to be highlighted that it was possible to convert free phenols (104m) to the corresponding 
phenanthrenes (107m). Competitive coordination of the oxygen to the activated Au(I)-center 
does not seem to be a problem.  
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The X-Ray structures of compounds 107f and 107j (Figure 5-5) further emphasize the 
strained nature of the obtained products as well as the remarkable reactivity of the established 
catalytic system in the synthesis of such sterically strained phenanthrene derivatives. The 
clash between substituents on the C-4 and C-5 atoms generates destabilizing twists of up to 
31.6° within the phenanthrene moiety. Despite this strain the ring-closing takes place quickly 
and cleanly. 
 
 
Figure 5-5: X-Ray crystal structures of 107f (up) and 107j (down). Dihedral angles between the two terminal 
rings are defined in terms of torsion angle C4-C4a-C5a-C5. Hydrogen atoms are omitted for clarity and 
ellipsoids are shown for 50% probability. 
5.2.4 Limitations 
The steric limits of the procedure were reached when the cycloisomerization of 2-ethynyl-2'-
iso-propyl-6-methylbiphenyl 104l (R
3
 = Me, R
4
 = i-Pr) was attempted. Although, full 
consumption of the starting material was confirmed via GC-MS after 10-15 min reaction time, 
the recorded GC-chromatogramm (Figure 5-6) showed six new compounds. A careful 
analysis of the mixture via HPLC allowed the isolation of four main products (139l, 107l, 
140l, 107b), whose identity was confirmed by measurement of the 
1
H-NMR and 
13
C-NMR 
spectra as well as the 
1
H/
1
H-COESY, 
1
H/
1
H-NOESY and 
1
H/
13
C-HMBC 2D experiments.  
Compound 107l, which was isolated in 22% yield corresponds to the expected product, where 
the –Me and -i-Pr groups occupy C-4 and C-5 positions. The structures of products 139l and 
140l reveal a migration of the iso-propyl group to adjacent positions after or during the ring-
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closure, while in the case of 107b the i-Pr has been cleaved off. Therefore, it seems that a 
migration of an iso-propyl cation over the π-system is possible if enough steric strain is 
present. In addition, the formation of 139l suggests that the activated alkyne might be attacked 
by carbon C-6’ of the aryl ring that bears the i-Pr group, followed by migration of the i-Pr 
cation to the adjacent position.  
 
Figure 5-6: GC-Chromatogram of the cycloisomerization of 104b after 10 minutes.  
At this point it has been shown that the established cycloisomerization protocol tolerates 
substituents of different steric demand at the C-6 carbon (R
3
) and C-2’ carbon (R4) of the 
evaluated biphenyl alkyne up to the aforementioned limitation (104l, R
3
 = Me, R
4
 = i-Pr). 
However, there are also electronic limitations, because as soon as the C-2’ atom is bound to a 
methoxy-group the cycloisomerization may cease to work like in the case of 2-ethynyl-2',6-
dimethoxybiphenyl 104r. The methoxy group in this substrate is in meta position to the 
carbon, which has to attack the activated alkyne. Therefore, the negative inductive effect of 
this substituent, and not its positive mesomeric one, dominates the situation and reduces the 
overall reactivity. Additionally, steric repulsion between both –OMe groups raises the energy 
barrier for the cyclization of 104r further (Figure 5-7).
[51, 58]
 However, it is possible to 
compensate the presence of one –OMe at this postion through additional -OMe substituents 
on the same aryl ring, which increase the electron density at the correct carbon and facilitate 
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the 6-endo-dig cyclization as shown in the case of 2'-ethynyl-2,3,4,6'-tetramethoxybiphenyl 
104g (Figure 5-7).  
 
Figure 5-7: Carbons activated towards an electrophilic attack (highlighted in red) in substrates 104r/104g. 
5.2.5 Exchanging the solvents 
At this point the prepared Au-precatalyst 97a-b/f-i were tested in the cycloisomerization of 
biphenyl-alkynes in non-polar solvents, using 2-ethynyl-2’,6-dimethylbiphenyl 104f as a 
model substrate. Thus, we planned to determine the effect of R
2
 and the counter-ion X
-
 on the 
reactivity. 
 
Figure 5-8: General structure of applied Au(I)-precatalysts 97. 
Interestingly, precatalysts 97f (R
1
 = Ph, R
2
 = n-Bu, X = BF4
-
) and 97g (R
1
 = Ph, R
2
 = n-Hex, 
X = BF4
-
) were completely soluble at 50 °C in toluene. Note however, that the substrate 
concentration had to be raised from 0.05 M to 0.25 M in order to achieve complete conversion 
of 104f to 107f under these conditions.  
Figure 5-9 clearly depicts the effect of decorating the ancillary ligands with longer aliphatic 
chains. Because dicationic phosphines (95f, 95g), which are coordinated to the Au(I)-center of 
precatalysts 97f and 97g, are virtually identical to phosphine 95a (R
1
 = Ph, R
2
 = i-Pr, X =  
BF4
-
) from an electronic standpoint, the increased conversion and rate can be ascribed to a 
better solubility of the respective Au-complexes with longer chains lengths in toluene. This 
observation is supported by the fact, that precatalyst 97a (R
1
 = Ph, R
2
 = i-Pr,  
X = BF4
-
) is completely insoluble in toluene.  
Furthermore, ion-exchange from BF4
-
 to the less coordinating SbF6
-
 also leads to a clear 
improvement of the reaction rate. Probably, the SbF6
-
 counter-ion increases additionally the 
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solubility of the corresponding active Au(I)-catalysts. Moreover, the less coordinating SbF6
-
 
surely minimizes a possible competition for the vacant site of the Au(I)-catalyst between the 
substrate and the counter-ion. This explains the increased conversion and rate obtained for 
precatalyst 97h (R
1
 = Ph, R
2 
= n-Hex, X = SbF6
-
) in comparison to those obtained for 97g. 
When 97h was utilized, full conversion was achieved after 15 minutes without any significant 
loss of catalytic activity throughout this time frame.  
 
 
Figure 5-9: Cycloisomerization of 2-ethynyl-2’,6-dimethylbiphenyl 104f in the presence of different Au(I) 
precatalysts. Conditions: 0.02 equiv. Au-cat.; 0.02 equiv. AgSbF6, toluene (c(104b) = 0.25 M), 50 °C. 
5.2.6 Theoretical studies on the catalytic system 
In order to get more insight into the actual catalyst 97a-Cl (Figure 5-10), its electronic 
structure was evaluated by a fragment molecular orbital (MO) analysis employing the 
Amsterdam Density Functional (ADF) program package (details in section 6.6, calculations 
were performed at our department of theoretical chemistry).
[59] 
In 97a-Cl, the LUMO 
corresponds to a low-lying antibonding σ*-orbital (P−Au), which exhibits a strong 
contribution from the Au 6s-orbital (46%) (Figure 5-10, left). Comparison of this MO with 
the LUMO of [(MeO)3PAu]
+ 
141-Cl shows that the shapes of the respective LUMOs (σ* 
P−Au) are similar. However, the LUMO of 97-Cl lies much lower in energy (-11.89 eV) than 
the corresponding one of 141-Cl (-8.03 eV). This probably explains the enhanced reactivity of 
97a-Cl
 
 since the energy of these orbitals dictates the π-acidity of both catalysts.[41a] 
97h: R
1
 = Ph, R
2
 = n-Hex, X =  SbF
6
-
/AgSbF
6
 
97g R
1
 = Ph, R
2
 = n-Hex, X =  BF
4
-
/AgSbF
6
 
97f: R
1
 = Ph, R
2
 = n-Bu, X =  BF
4
-
/AgSbF
6
 
97a: R
1
 = Ph, R
2
 = i-Pr, X =  BF
4
-
/AgSbF
6
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Figure 5-10: Calculated LUMOs of active tricationic Au(I)-catalyst 97a-Cl and active monocationic Au(I)-
catalyst 141-Cl (ADF approach). 
The possible reaction pathways for the cycloisomerization of 2-ethynyl-2’,6-dimethylbiphenyl 
104f in the presence of either tricationic Au(I)-catalyst 98a-Cl (green) or the monocationic 
Au(I)-catalyst 142-Cl (red) in DCM were investigated by DFT calculations at our department 
of theoretical chemistry (Figure 5-11, exact conditions for these calculations are given in 
section 6.6). 
 
Figure 5-11: Free energy profiles (kcal/mol) for the cycloisomerization 2-ethynyl-2’,6-dimethylbiphenyl 104f to 
4,5-dimethylphenanthrene 107f in DCM. The green line represents the calculated profile for catalyst 97a-Cl. The 
red line represents the calculated profile for catalyst 142-Cl. Both diastereomeric protons were considered in the 
calculations of TS4a and TS4b. 
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In both cases the catalytic cycle starts with coordination of alkyne to the Au(I)-center 
generating the catalyst-substrate complex Int1, which is more exergonic when the dicationic 
phosphine is used (catalyst 97a-Cl), Int1a. The increased thermodynamic stability of Int1a is 
a direct result of the very low lying LUMO of the Au(I)-catalyst 97a-Cl. The subsequent step 
of this reaction involves the nucleophilic attack of the aryl-system on the activated alkyne for 
both catalytic species (97a-Cl and 142-Cl) forming the cyclopropyl intermediates Int2a/b. 
According to the calculated relative free energies this intermediate is generated more easily 
when the strongly activating catalyst 97a-Cl is employed, since the free energy of activation 
(relative to the preceding intermediate) is only 7.6 kcal/mol compared with 20.9 kcal/mol 
when using the catalyst 142-Cl derived from PPh3. Cyclopropane ring-opening and 
subsequent 1,2-H shift to Int4a/b occur in both cases readily as they have free energy barriers 
of less than 10 kcal/mol. Therefore, these steps are not strongly influenced by the nature of 
the ancillary ligand. Both intermediates Int4a/b are more stable than intermediates Int3a/b by 
14.8 and 21.3 kcal/mol respectively. Furthermore, the energies of the subsequent transition 
states TS4a (−59.1 kcal/mol) and TS4b (−29.7 kcal/mol) leading to protodemetalation are 
much lower in energy than those determined for TS3a (−48.7 kcal/mol) and TS3b (−15.8 
kcal/mol), respectively. Due to this, the formation of the Au-carbenes Int4a/b is probably 
irreversible. Then, a 1,2-hydrogen shift occurs, which involves one of the diastereomeric H 
atoms, affording the phenanthrene-Au(I) complexes Prod-cplxa/Prod-cplxb. As might be 
expected, this step is more difficult when dicationic phosphines are employed as ligands. 
Finally, dissociation of the Au(I)-olefin complexes liberates the product and regenerates the 
catalyst. It should be noted, that the calculated interaction between the tricationic catalytic 
species 97a-Cl and the phenanthrene 142-Cl is very strong (92.4 kcal/mol). This might 
explain why the catalyst deactivation is observed at high substrate conversion once the 
phenanthrene product accumulates (in DCM as a solvent).
[41a]
  
5.2.7 Synthesis of Calanquinone C 
5.2.7.1 Introduction 
There are many natural products like Bulbophylatrin 143
[60]
, Calanquinone C 144
[61]
, 
Orcholide 145
[62]
, Angustatin A 146
[63]
 or epimedoicarisoside A 147
[64]
, which are derived 
from phenanthrenes with at least one oxygenated group in C-4 or C-5 position (Figure 5-12). 
Therefore, these natural products could be ideal candidates to test the synthetic potential of 
the new catalyst prepared.  
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Figure 5-12: Examples for phenanthrene derived natural products with at least one internal methoxy group. 
In this regard, Calanquinone C 144 was chosen as a synthetic target. Calanquinone C 144 is a 
phenanthrenequinone, which was isolated alongside Calanquinone B 148 from Calanthe 
Arisanensis, a plant belonging to the Orchidaceae family, (Figure 5-13) by C.-L. Lee et al. in 
2009. Moreover, Calanquinone C 144 shows significant cytotoxic activity (EC50<4μg/mL) 
against certain breast cancer cell lines.[61] This work was performed in cooperation with Dr. A. 
Zanardi and Dr. J. Carreras. 
 
Figure 5-13: Left: Structures of Calanquinone B 148 and Calanquinone C 144. Right: Calanthe arisanensis.  
5.2.7.2 Optimization Studies 
Our synthetic approach towards Calanquinone C included the cyclization of alkyne 149 to 
phenanthrene derivative 150 as the key-step (section 5.2.7.3). It was decided to optimize the 
reaction conditions of this transformation by using the 2'-ethynyl-2,3,4,6'-
tetramethoxybiphenyl 104g as a test substrate, due to its similar substitution pattern to 149 
(Scheme 5-5). This investigation was first initialized with 2 mol% Au(I)-precatalyst 97a and 
2 mol% AgSbF6, before the catalyst amount was reduced to the smallest amount possible to 
afford complete conversion. 
 
Calanthe arisanensis 
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Scheme 5-5: Left Key-step in the Synthesis of calanquinone C. Right: Model System for the screening of 
possible precatalysts. Conditions: 0.02 equiv. Au-cat. 97a/97c-e, 0.02 equiv. AgSbF6, DCM, r.t.. 
 
 
Figure 5-14: Effect of the catalyst amount on the cycloisomerization of 2'-ethynyl-2,3,4,6'-tetramethoxybiphenyl 
104g to 2,3,4,5-tetramethoxyphenanthrene 107g. Conditions: amount of 97a and AgSbF6 shown in the figure 
above, DCM (c(104g) = 0.05 M), r.t.. 
Figure 5-14 illustrates the conversion vs. time profile for the cycloisomerization of 2'-ethynyl-
2,3,4,6'-tetramethoxybiphenyl 104g. As it can be seen, it proceeds much faster under standard 
conditions than the cycloisomerization of 2-ethynyl-2’,6-dimethylbiphenyl 104f. The reaction 
was finished within 60 seconds (for 104f: full coversion after 10-15 min, Figure 5-2). This 
high reactivity can be rationalized by the presence of three –OMe groups on the upper aryl 
system, which increase the electron density in C-6 position through a strong mesomeric effect 
(Scheme 5-3, Figure 5-2). As a consequence of this high reactivity, full conversion was still 
achieved with a catalyst loading of 0.5 mol% within 45 minutes. A further decrease of the 
catalyst amount to 0.25 mol% leads to a maximum conversion of 60% after 20 minutes before 
the reaction stops, likely due to catalyst decomposition.  
In order to determine the most effective precatalyst for the desired cycloisomerization, the 
different precatalysts 97a/c-e were tested in the cyclization of 104g in DCM at a catalyst 
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loading of 0.25 mol%. As the substrate was shown to be highly reactive, the reduced catalyst 
loading was essential to illustrate the activity difference of the Au(I)-catalysts (Figure 5-15). 
 
 
Figure 5-15: Effect of R on the cycloisomerization of 2'-ethynyl-2,3,4,6'-tetramethoxybiphenyl 104g to 2,3,4,5-
tetramethoxyphenanthrene 107g. Conditions: 0.025 equiv. 97a/97c-e, 0.025 eqiv. AgSbF6, DCM 
(c(104g) = 0.05 M), r.t.. 
Comparison of the different precatalysts shows that the conversion and rate both increase with 
rising π-acidity of the Au(I)-catalysts (Figure 5-15): 97a (R1= Ph) >97c (R1 = o-biPh) >97d 
(R
1
 = Cy) > 97e (R
1
 = Ad). This is in agreement with the results discussed in section 5.2.2. 
Precatalyst 97a (R
1
 = Ph) provided the highest conversion and rate upon activation, affording 
approximately 63% product within 20 min before the catalyst was decomposed. While 
precatalyst 97c (R
1
 = o-biPh) provided the second best results with 74% conversion after 
3 hours, the active species derived from 97c was stable for 60 minutes before decomposition 
became an issue. The enhanced stability of the active species derived from 97c can be 
probably attributed to the secondary phenyl group in ortho position, which could stabilize the 
Au(I)-center via π-coordination. In light of these results, it was decided to investigate, if the 
utilization of toluene as a solvent in this reaction led to a similar stabilizing effect.  
At this point it was known that full conversion of 104g to the desired product 107g can be 
achieved with 0.5 mol% catalyst loading as long as R
1
 = Ph. Furthermore, it was also known 
that full solution of dicationic Au(I)–precatalyst 97h in toluene at 50 °C is possible, if R2 = n-
Hex and X = SbF6
-
 (section 5.2.5). Under those conditions 97h (2 mol%) provided a similar 
catalytic activity for the cyclization of 104f to 107f to the one of 97a (2 mol%) in DCM.  
With this information in hand, it was possible to establish optimal reaction conditions for the 
cycloisomerization of 104g. These cyclizations were performed at 0.5 mol% catalyst loading 
97a: R
1
 = Ph/ AgSbF
6
 
97d: R
1
 = Cy/ AgSbF
6
 
97e: R
1
 = Ad/ AgSbF
6
 
97c: R
1
 = o-biPh/ AgSbF
6
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in toluene at 0.25 M substrate concentration and 50 °C using precatalyst 97h (R
1
 = Ph, R
2
 = n-
Hex, X = SbF6
-
). Full conversion of 104g to 107g was achieved within 120 seconds under 
these optimized conditions. This is comparable with the results obtained at  
2 mol% catalyst loading (97a) in DCM. Due to the lowered loading, the TON for this reaction 
increased from 50 (for 2 mol%) to 200 (for 0.5 mol%). A slight delay of the reaction was also 
observed, which probably can be attributed to the time needed for the activation of the Au(I)-
catalyst via halide-abstraction. Furthermore, an exchange of the solvent for anisole resulted in 
a slight decrease of the rate as the reaction time was extended to 180 seconds to achieve full 
conversion. Because anisole is more electron rich than toluene, this observation might 
indicate π-coordination of the activated Au(I)-catalyst by the solvent molecules. 
In order to check, if the utilized precatalyst 97h was applicable for less reactive substrates like 
2-ethynyl-2’,6-dimethylbiphenyl 104f under the same conditions, the reaction was repeated 
for this substrate. 
 
Figure 5-16: Cycloisomerization of 2-ethynyl-2’,6-dimethylbiphenyl 104f under optimized conditions in the 
presence of precatalyst 97h (R
1
 = Ph, R
2 
= n-Hex, X = SbF6
-
). Conditions: 0.005 equiv. 97h, 0.005 equiv. 
AgSbF6, toluene, 50 °C, (c(104f) = 0.25 M). 
To our delight, full conversion to the desired 6-endo-dig 107f product was detected after 60 
minutes under optimized conditions. Throughout the duration of the reaction, the activated 
Au(I)-catalyst remained stable without any significant decrease of activity, which might 
support the formation of a π-complex with toluene (Figure 5-16).  
These conditions were then applied in the synthesis of Calanquinone C 144.  
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5.2.7.1 Synthesis 
Our synthetic route towards Calanquinone C 144 commences with the Suzuki-coupling of 
153c
[65]
 and the aryl bromide 154
[66]
 (Scheme 5-6). This reaction was facilitated by utilizing 
5 mol% Pd2(dba)3 as precatalyst to afford 3,3',6-tris(benzyloxy)-2',4'-dimethoxybiphenyl-2-
carbaldehyde 155 in 84% yield. 
 
 
Scheme 5-6: Synthetic sequence for the preparation of Calanquinone C 144. a) Suzuki-coupling, b) Seyferth-
Gilbert homologation, c) Au(I)-catalyzed cycloisomerization, d) Pd-catalyzed reduction/deprotection, e) 
oxidation. 
According to our expectations the exposure of the carbaldeyde 155 to Seyferth-Gilbert 
alkynylation conditions afforded 3,3',6'-tris(benzyloxy)-2'-ethynyl-2,4-dimethoxybiphenyl 
149 in 67% yield as the main product. However, 5-(benzyloxy)-4-(3-(benzyloxy)-2,4-
dimethoxyphenyl)benzofuran 157 was also obtained as a side-product of this reaction in 23% 
yield. The formation of 157 can be explained by a nucleophilic attack of the oxygen-lone pair 
of the benzyloxy group adjacent to the C-2 atom on the carbene-C-atom of the transcent 
vinylidencarbene 158, which is formed as an intermediate during the alkynylation reaction 
(Scheme 5-7).
[67] 
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Scheme 5-7: Established mechanism for the formation of the Alkyne 149 via Seyferth-Gilbert reaction (Path 1) 
and proposed mechanism for the formation of side-product 191(Path 2). 
The successful cycloisomerization of 149 into 150 was achieved by utilizing 0.5 mol% of 
precatalyst 97h (Figure 5-17) and 0.5 mol% AgSbF6 under the already optimized conditions. 
After purification by column chromatography 1,4,6-tris(benzyloxy)-5,7-dimethoxy-
phenanthrene 150 was isolated in 89% yield. The identity of the product was confirmed by 
full NMR analysis (including the measurements of the following spectra: 
1
H-NMR, 
13
C{
1
H}-
NMR,
1
H/
1
H-COSY, 
1
H/
1
H-NOESY, 
1
H/
13
C{
1
H}-HMQC, 
1
H/
13
C{
1
H}-HMBC), HRMS 
spectrometry and IR-spectroscopy.  
 
Figure 5-17: Successful precatalysts 97h  in the formation of 1,4,6-tris(benzyloxy)-5,7-dimethoxyphenanthrene 
150. 
Subsequently, compound 150 was deprotected to Calanhydroquinone A 156 in 89% yield by 
hydrogenation (20 bar) using Pd/C as catalyst. The structure of 156 was also proven by XRD-
analysis confirming the expected connectivity (Figure 5-18). 
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Finally, the oxidation of Calanhydroquinone A 156 to Calanquinone C 144 was performed 
using (NH4)2Ce(NO3)6 as oxidant in THF at room temperature (69% yield). The connectivity 
of 144 was again confirmed by XRD analysis. The decrease of the C4-O4 and C1-O5 bond 
lengths from 1.375(1)-1.388(1) Å in 156 to 1.288(3)-1.239(4) Å in 144 supports the formation 
of the quinone moiety (d(R2C=O) = 1.20 Å).
 
This is in agreement with the two new signals in 
the 
13
C-NMR spectrum with chemical shifts of 185.3 ppm and 185.6 ppm, as well as the 
presence of a CO-band at 1664 cm
-1
.  
 
Figure 5-18: X-Ray structures of Calanhydroquinone A 156 and Calanquinone C 144. Hydrogen atoms are 
omitted (exceptions are Hydrogens on –OH groups and C9/C10 atoms) for clarity and ellipsoids are shown for 
50% probability. 
5.2.8 Summary 
After an initial optimization it was possible to establish a cycloisomerization protocol for 
biphenyl-alkynes with (two) substituents in C-6 (R
3
) and C-2’ (R4) positions using the 
prepared Au(I)-precatalyst 97a (R
1
 = Ph, R
2
 = i-Pr, X = BF4
-
) and AgSbF6. Kinetic studies of 
the cyclization of 2-ethynyl-2’,6-dimethylbiphenyl 104f revealed that rate and conversion 
increase with rising π-acceptor properties of the employed ligand. This indicated that the 
nucleophilic attack of the activated alkyne is the rate-determing step.  
Subsequently, this methodology was used for the cyclization of 16 different biphenyl-alkynes, 
which were prepared in a two-step procedure. The utilized conditions gave access to 15 
different phenanthrene derivatives with substituents of varying steric and electronic properties 
(R
3
 = H, Me, OMe, Ph, F; R
4 
= Me, i-Pr, OMe, Ph, OH).  
156 
144 
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While this method is powerful, there are limits how much steric strain can be tolerated during 
the cyclization as a migration of a i-Pr group was detected for the ring-closing of 104l (R
3 
= 
Me, R
4
 = i-Pr). Furthermore, no reaction at all was observed for 104r (R
3 
= OMe, R
4
 = OMe). 
The exchange of the aliphatic residues R
2
 for more lipophilic groups like n-Hexyl and the 
counter-ion for SbF6
- 
on the Au-precatalysts 97 (i.e.: 97h: R
1
 = Ph, R
2
 = n-Hex, X = SbF6
-
) 
facilitated the cycloisomerization of 2-ethynyl-2’,6-dimethylbiphenyl 104f in toluene 
avoiding the use of chlorinated solvents.  
Finally, the synthesis of Calanquinone C 144 proved the scope of our catalysts. After 
optimization, Calanquinone C 144 was accessed in a sequence of 10 steps from 2,6-
dimethoxyphenol 151 and gentisaldehyde 152 in 18% overall yield for the longest linear 
sequence. The key step of this sequence involved a late stage Au(I)-catalyzed 
cycloisomerization utilizing precatalyst 97h with a catalyst loading of 0.5 mol%.  
5.3 Synthesis of naphto-furans 
5.3.1 Initial Evaluations 
At this point, it was decided to extend the substrate scope of our methodology to the synthesis 
of heterocycles such as, for example, naphto-furans. This is of interest, because the naphto-
furan architecture is often present in nature. Balsaminone A 162
[68]
, Furomullugin 163
[69]
 and 
Senarguine B 164
[70]
 are examples for such natural products (Figure 5-19).  
 
Figure 5-19: Examples for naphto-furan derived natural products (162, 163, 164) and model substrate 165 
prepared for the evaluation of the cycloisomerization of 2-(ethynylaryl)furans. 
Thus, we started to investigate whether the cycloisomerization of 2-(2-ethynylphenyl)furan 
165a into the corresponding naphtofuran 166a could be possible in the presence of precatalyst 
97a. After some optimization, full conversion of 165a into the desired product 166a was 
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achieved after 10-15 minutes employing 2 mol% precatalyst 97c (or 97a alternatively) and 
2 mol% AgSbF6 in 1,2-DCE at 50 °C (Scheme 5-8).  
 
Scheme 5-8: Cycloisomerization of 2-(2-ethynylphenyl)furan 165a to naphtha[1,2-b]furan 166a. a) 0.02 equiv. 
Au-cat. 97c, 0.02 equiv. AgSbF6, DCE, 50 °C. 
5.3.2 Ligand Effect 
5.3.2.1 Comparison with commercial phosphines 
After determing the necessary reaction conditions, the performance of precatalysts 97a (R
1
 = 
Ph, R
2
 = i-Pr, X = BF4
-
) and 97c (R
1
 = o-biPh, R
2
 = i-Pr, X = BF4
-
) in the cycloisomerization 
of 2-(2-ethynylphenyl)furan 165a was compared with other Au(I)-catalysts derived from 
commercial P-centered compounds ((PhO)3PAuCl, Ph3PAuCl, Ph2(C6F5)PAuCl; Figure 5-20). 
 
 
 
Figure 5-20: Ligand effect for the cycloisomerization of 2-(2-ethynylphenyl)furan 165a to naphtha[1,2-b]furan 
166a. Conditions: 0.02 equiv. Au-cat. 97a, 0.02 equiv. AgSbF6, DCE, 50 °C. 
 
It can be concluded that the reaction rate of the cycloisomerization of 165a is directly related 
to the π-acidity of the catalyst. Like in the case of biphenyl-alkyne 104f it becomes evident 
 
AuCl(PPh2(C6F5)) 
AuCl(P(OPh)3) 
AuCl(PPh3) 
5. Applications in catalysis                                                                                   ………………  
 
68 
that an increased reaction rate can be observed with increasing π-acceptor properties of the 
phosphine bound to the Au(I)-center (Figure 5-20). While no notable difference between the 
results for precatalyst 97a and 97c was detected at this catalyst loading, the general trend 
remains the same and results in the following activity hierarchy: 
Ph3PAuCl < Ph2(C6F5)PAuCl < (PhO)3PAuCl <97c = 97a. These results are also in agreement 
with the known TEP-values of the employed ligands. 
5.3.2.2 Comparison with other dicationic phosphines 
Again it is clear, that the catalyst derived from Au(I)-complexes 97a/97c are superior to other 
Au(I)-catalysts derived from the typical neutral P-centered compounds. Subsequently, the 
influence of different residues R
1
 attached to the P-center of those dicationic phosphines on 
the reactivity of their corresponding Au(I)-catalysts was evaluated (Scheme 5-9, Figure 5-21).  
 
Scheme 5-9: Effect of R on the cycloisomerization of 2-(2-ethynylphenyl)furan 165a to naphtha[1,2-b]furan 
166a. a) 0.02 equiv. [Au]-cat. 97a/1c-e, 0.02 equiv. AgSbF6, 1,2-DCE, 50 °C. 
 
 
Figure 5-21: Effect of R on the cycloisomerization of 2-(2-ethynylphenyl)furan 165a to naphtha[1,2-b]furan 
166a. 
97c (R
1 
= o-biPh)/ AgSbF6 
97a (R
1
 =Ph)/ AgSbF6 
97d (R
1
 = Cy)/ AgSbF6 
97e (R
1 
= Ad)/ AgSbF6 
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From Figure 5-21 it becomes evident that the reactivity of the catalyst decreases when the  
π-acidity of ligands diminishes (97d, 97e), resulting in the following order of activity 
(Scheme 5-16, Figure 5-21): 97a (R
1
 = Ph) = 97c (R
1
 = o-biPh) > 97d (R
1
 = Cy) > 97e 
(R
1
 = Ad).  
This observation, which is in agreement with the determined TEP and the oxidation potentials 
of the free dicationic phosphines, makes us think that the rate determing step in this reaction is 
again the attack of the furan ring on the activated alkyne.  
5.3.3 Substrate scope  
After the initial evaluations of the cycloisomerization of 165a to 166a the substrate scope of 
this reaction was evaluated. Hence, 2-(ethynylaryl)furans of general structure 165 were 
prepared in a two-step sequence (Scheme 5-10, Figure 5-22). This sequence included a 
Suzuki-reaction, which converted the corresponding aryl-halide 135 to the desired 
carbaldehyde 167 in moderate to good yield (51-81%) while a subsequent Seyferth-Gilbert 
homologation yielded the desired products of type 165 in moderate to good yield (47-92%). 
Once prepared, these furans were submitted to the cycloisomerization conditions (precatalyst 
97c, Scheme 5-9).  
 
 
 
Scheme 5-10: General scheme for the synthesis of 2-(ethynylaryl)furans 165. a) Suzuki-coupling; b) 1.5 equiv. 
Ohira-Bestmann reagent, 2.0 equiv. K2CO3, MeOH, r.t., overnight. 
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Figure 5-22: List of prepared furan-phenyl/cyclohexene-alkynes 200b. All reported yields are over two steps.
[a]
: 
modified Seyferth-Gilbert conditions: 1.5 equiv. Ohira-Bestmann reagent, 2.0 equiv. K2CO3, MeOH, -40 °C, 1.0 
equiv. aldehyde 206a, -40 °C to 0 °C, 40  min, 0 °C, overnight. 
As can be seen from figure 5-23, products containing -OMe, -F, -COOMe and methyl 
substituents on the aryl residue were formed. Moreover, derivatization of the 2-furan group by 
introduction of methyl substituents and benzannulation is possible. The structure of the 
isolated naphto-furans was confirmed not only by spectroscopic techniques, but also by an 
exemplary XRD-analysis of methyl naphtho[1,2-b]furan-9-carboxylate 166c (Figure 5-24). 
 
Figure 5-23: Substrate scope for cycloisomerization 2-(ethynylaryl)furans  of type 165 to naphto-furans of type 
166. Conditions: 0.02 equiv. Au-cat. 97c, 0.02 equiv. AgSbF6, 1,2-DCE (c(substrate) =0.05M), 50 °C. 
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Figure 5-24: X-Ray crystal structure of 166c. Dihedral angles between the two terminal rings are defined in 
terms of torsion angle 01-C9a-C9b-C9. Hydrogen atoms are omitted for clarity and ellipsoids are shown for 50% 
probability. 
5.3.4 Limitations 
The procedure reached its limit when the aromatic ring was exchanged by a partially 
hydrogenated one. In the cases of 165g and 165h (Figure 5-25) either no reaction (165g) or 
polymerization (165h) was observed. Indicative for the polymerization of 165h was the signal 
broadening in the aromatic region of the 
1
H-NMR spectrum, which was measured from the 
residue of the reaction after filtration and solvent removal.  
 
Figure 5-25: Substrates, which failed to cyclize. 
[a]
: Prepared and attempted to cyclize by G. Mehler. 
Further difficulties were encountered, when the phenyl-residue was exchanged for a furan 
(165i, 165j, Figure 5-25). In these cases the cycloisomerization does not proceed at all. 
Probably, the longer distance d between the activated alkyne and the C3-atom of the upper 
furan ring, which is a consequence of the geometry of the furan ring, exceeds the capabilities 
of the employed catalyst (Figure 5-26).   
5. Applications in catalysis                                                                                   ………………  
 
72 
 
Figure 5-26: Distances between the activated alkyne and the C6-carbon of 104b or the C3-carbon of 165i. 
5.3.5 Summary 
In the initial optimization of the cyclization of 2-(2-ethynylphenyl)furan 165a to naphto-furan 
166a, full conversion to the desired product was afforded employing 2 mol% precatalyst (97a 
or 97c) and 2 mol% AgSbF6 in 1,2-DCE at 50 °C. Furthermore it was demonstrated, that the 
the conversion and rate of this reaction improve with increasing π-acceptor properties of the 
employed ligands, which leads to the conclusion that the rate-determing step is the 
nucleophilic attack of the furan on the alkyne.  
8 alkynes of type 165 were prepared in the same two step sequence as the biphenyl-alkynes. 
The applied cycloisomerization protocol tolerated the presence of -OMe, -F, -COOMe and 
methyl substituents on the aryl rings as well as the derivatization of the furan group by methyl 
substituents. The exchange of the 2-furan for a benzofuran/3-furan residue was also tolerated. 
Despite this promising behavior under the same conditions substrates 165g and 165h (as well 
as 165i and 165j) did not yield the desired products. 
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6 Experimental Part 
6.1 General remarks 
Working techniques 
All moisture- and oxidation-sensitive reactions were performed in dried glassware under an 
argon atmosphere. Argon was obtained from Air Liquide with higher than 99.5% purity. 
 
Solvents and reagents 
All solvents were purified by distillation before use following standard procedures. Dry 
solvents were obtained by distillation over the appropriate drying agent and then kept under 
an atmosphere of argon: diethyl ether, tetrahydrofuran, toluene and pentane (sodium, 
benzophenone as indicator); N,N'-dimethylformamide (dried over molecular sieves 4 Å); 
dichloromethane, 1,2-dichloroethane, acetone, acetonitrile, triethylamine (calcium hydride); 
anisole (calcium chloride and molecular sieves 4 Å), methanol (magnesium) and 1,1,2,2-
tetrachloroethane (potassium carbonate and molecular sieves 4 Å). Ohira-Bestmann reagent 
was prepared according to literature procedure.
[57b]
 Unless specified commercial reagents 
were used as received from commercial sources. 
 
Chromatographic methods 
Reactions were monitored by thin layer chromatography (TLC) using silica gel  
pre-coated polyester sheets (40 × 80 mm, Polygram
®
 SIL G/UV254 from Macherey-Nagel). 
The spots were visualized with UV-light (λ = 254 nm) and/or by staining with 
phosphomolybdic acid or potassium permanganate stains.  
 
Flash column chromatography  
Column chromatography was performed using silica gel 60 (Merck, 60 Å, 230-400 mesh 
0.040-0.063 mm) and separations were conducted at slight overpressure in a glass column. 
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6.2 Analytical methods 
Nuclear magnetic resonance spectroscopy (NMR) 
Spectra were recorded on a Bruker AV400, AV500, AV600 or a DPX 300; 
1
H and 
13
C chemical 
shifts (δ) are given in ppm relative to TMS and coupling constants (J) in Hz. All spectra were 
measured at room temperature unless stated otherwise. The solvent signals were used as 
reference and the chemical shifts converted to the TMS scale. Multiplicities are assigned as 
follows: singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin), sextet (sext), septet 
(sept), octet (oct), multiplet (m), pseudo (p) and broad (br). The signals have been assigned 
using 1D and 2D experiments. 
 
Infrared spectroscopy 
IR spectra were recorded using ATR-techniques (attenuated total reflection) on a Nicolet FT-
7199 and a Bruker Alpha Platinum ATR spectrometer at room temperature. The characteristic 
absorption bands are given in wavenumbers [cm
-1
]. 
 
Analytical gas chromatography 
GC-MS couplings were performed on an Agilent Technology GC 6890 Series and MSD 5973 
(carrier gas: helium) with HP6890 Series Injector, employing an MN Optima
®
5 column (30 m 
x 0.25 mm x 0.25 mm). Mass spectra were recorded with an Agilent Technology 5973 
Network MSD spectrometer. Qualitative evaluation of the integration was based on the 
substance peaks without considering response factors, unless stated otherwise. 
 
Mass spectrometry (MS) 
Mass spectra were measured on a Finnigan MAT 8200 (70 eV) or MAT 8400 (70 eV) 
spectrometer by electron ionization, chemical ionization, or fast atom/ion bombardment 
techniques. For electron-spray ionization a Finnigan MAT 95 was used. High resolution 
masses were determined on a Bruker APEX III FT-MS spectrometer (7 T magnet). All masses 
are given in atomic units per elementary charge (m/z) and reported in percentage relative to 
the basic peak. 
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X-ray crystal structure analysis 
The crystal structures were measured in the X-ray department of the “Max Planck Institut für 
Kohleforschung” in Mülheim an der Ruhr, under the direction of Prof. C. W. Lehmann. The 
measurements were made using a Bruker-AXS Kappa CCD diffractometer. 
6.3 Provided Chemicals 
The following chemicals were provided by co-workers of our work-group (Figure 6-1): 
- Chloro cyclopropenium salt 111/112 (provided by G. Mehler), 
- tertiary biscyclopropenium phosphines 95c, 95d, 95e and 95f (provided by G. 
Mehler), 
- Aryl ester 135i (provided by T. Deden). [71] 
 
Figure 6-1: Structures of of provided chemicals. 
The experimental results of the provided chemicals and their respective precursors are shown 
in section 6.5 in order to provide a comprehensive overview over the relevant data as the 
provided dicationic phosphines were utilized for coordination purposes (section 4) and 
catalysis (section 5).  
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6.4 Literature known compounds 
The following chemicals were prepared according to known literature procedures (Figure 6-
2):
 [25, 37b, 41b, 65, 66,72, 73, 74, 75, 76,77, 78, 79, 80, 81]
 
 
Figure 6-2: Compounds prepared according to literature procedures. 
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6.5 Synthesis 
6.5.1 Synthesis of Cyclopropenium salts 
Chlorocyclopropenium salt 63 
Compound 63 was prepared in 82% yield according to literature 
procedure.
[25] 
1
H-NMR (400 MHz, CDCl3): δ = 1.42 (d, J = 1.5 Hz, 12H), 1.43 (d, 
J = 1.6 Hz, 12H), 3.87 (sept, J = 6.8 Hz, 2H), 4.16 ppm (sept, J = 6.7 Hz, 2H). 
The measured spectral data were in agreement with those found in the literature.
[25] 
Triaminocyclopropenium salt 114 
Pentachlorocyclopropane 113 (10.0 g, 47.7 mmol) was dissolved in 
DCM (150 mL) and the resulting solution was cooled down to -78 °C. 
Then HN(n-Bu)2 (48.3 g, 373 mmol) was added over 1 hour and the 
solution stirred at 0 °C for 4 additional hours. Subsequently, the reaction 
mixture was allowed to warm to room temperature during 18 hours. Afterwards this mixture 
was refluxed for 5 hours, which resulted in the formation of a light brown liquid. The DCM 
was removed in vacuo and acetone was added to precipitate the secondary ammonium salt, 
which was filtered from the solution comprising the triaminocyclopropenium salt 114. Once 
the aqueous phase was extracted with DCM (3x), the organic phases were combined and the 
solvent removed in vacuo. Then the crude was washed with pentane (4x) to remove residual 
amine and the residue was redissolved in DCM. HBF4 (50 mL, 48%) in water (50 mL) was 
added. Extraction of the product with DCM yielded an organic phase, which was washed with 
HBF4 (20 mL, 35%) and with water (until the pH was neutral). The combined extracts were 
dried over Na2SO4 before the solvent was removed in vacuo in affording 114 as an orange 
liquid (19.0 g, 80.2%).
[40] 
1
H-NMR (400 MHz, CDCl3): δ = 0.91 (t, J = 7.32 Hz, 18H), 1.23-1.33 (m, 12H), 1.52-1.60 
(m, 12H), 3.22-3.26 ppm (m, 12H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 13.4, 19.5, 30.5, 52.4, 116.4 ppm. 
HRMS calcd. for C27H54N3
+
: 420.431220 [M-BF4]
+
; found: 420.431380. 
IR: ῦ = 519, 654, 763, 891,1048, 1194, 1375, 1528, 1853, 2958, 2973 cm-1. 
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The measured spectral data were in agreement with those found in the literature.
[40] 
Triaminocyclopropenium salt 115
 
Tetrachlorocyclopropene 68 (5.0g, 28.1 mmol) was dissolved in DCM 
(100 mL) and the resulting solution was cooled down to -78 °C. Then 
HN(n-Hex)2 (20.85 g, 112.5 mmol) was added over 1 hour and the 
solution stirred at 0 °C for 4 additional hours. Subsequently, the 
reaction mixture was allowed to warm to room temperature during 18 hours. Then it was 
cooled to 0 °C and HBF4 (50 mL, 48%) in water (50 mL) was added. The mixture thus 
obtained was extracted with DCM (3x) and the combined organic phases were washed with 
HBF4 (20 mL, 48%) and water (until the pH was neutral) before being dried over sodium 
sulfate. Removal of the solvents in vacuo yielded an orange liquid, which was resolved in dry 
DCM. From this solution the product 115 was precipitated with n-pentane (13.4 g). Small 
impurities of dihexylammonium salt could not be removed. The mixture was used for the next 
step in this state. 
1
H-NMR(400 MHz, CDCl3): δ = 0.82 (t, J = 6.7 Hz, 18H), 1.24 (mbr, 36H), 1.55 (mbr, 12H), 
3.21 (pt, J = 7.9 Hz, 12H) ppm. 
HRMS calcd. for C39H78N3
+
: 588.619021 [M-BF4]
+
; found: 588.619280. 
Ketone 116 
To an aqueous KOH solution (19.64 g, 350 mmol, in 68.5 mL water) 
cyclopropenium salt 114 (17.76 g, 35.0 mmol) was added dissolved in MeOH 
(30.0 mL). The reaction mixture was heated to 60
o
C for 16 hours and then 
cooled to room temperature. Then the obtained reaction crude was extracted 
with DCM (4x), the combined organic phases dried over sodium sulfate and the solvent 
evaporated. Finally, the obtained residue was purified by column chromatography on silica 
gel (DCM/Acetone, 9/1) affording 116 as a transparent oil (5.63 g, 52.1%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.87 (t, J = 7.26 Hz, 12H), 1.22-1.31 (m, 8H), 1.48-1.56 
(m, 8H), 3.08 ppm (pt, J = 7.5 Hz, 8H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ =13.5, 19.6, 30.5, 52.3, 119.1, 133.3 ppm. 
HRMS calcd. for C19H37N2O
+
: 309.290036 [M+H]
+
; found: 309.290250. 
IR: ῦ= 518, 643, 747, 1052, 1192, 1347, 1454, 1590, 1899, 2872, 2957 cm-1.
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Ketone 117 
To an aqueous KOH solution (15.6 g, 277 mmol, in 100 mL water) 
cyclopropenium salt 115 (18.75 g, 27.7 mmol) was added dissolved in 
MeOH (15.0 mL). The reaction mixture was heated to 60
o
C for 16 hours and 
then cooled to room temperature. Then the obtained reaction crude was 
extracted with DCM (4x), the combined organic phases dried over sodium sulfate and the 
solvent evaporated. Finally, the obtained residue was purified by column chromatography on 
silica gel (DCM/Acetone, 15/1) affording 117 as a transparent oil (11.1 g, 95.0%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.81 (t, J = 6.88 Hz, 12H), 1.22 (psbr, 24H), 1.52 (mbr, 8H), 
3.06-3.09 ppm (m, 8H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 13.2, 21.8, 25.7, 27.9,31.0, 51.1, 118.7, 132.8 ppm. 
HRMS calcd. for C27H53N2O
+
: 421.415237 [M+H]
+
; found: 421.415390. 
IR: ῦ = 726, 1105, 1261, 1375, 1420, 1463, 1597, 1893, 2856, 2925, 2955 cm-1. 
Chlorocyclopropenium salt 111 
Oxalyl chloride (5.0 mL, 58.2 mmol) was added dropwise to ketone 116 (5.6 
g, 18.2 mmol) at 0 
o
C. Strong gas evolution was observed. After the addition 
was finished, the reaction mixture was stirred at room temperature for an 
additional hour and then the excess of oxalyl chloride was removed in vacuo. 
The residue obtained was dissolved in DCM and the solution washed with a saturated solution 
of NaBF4(aq) (3x). Finally, the organic phase was dried over sodium sulfate, the solvent 
removed in vacuo and the crude obtained was purified by column chromatography on silica 
gel (DCM/acetone, 9/1) to afford 111 as a red liquid (6.27 g, 83.1%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.89 (t, J = 7.26 Hz, 6H), 0.91 (t, J = 7.40 Hz, 6H), 1.23-
1.30 (m, 4H), 1.30-1.38 (m, 4H), 1.56-1.62 (m, 4H), 1.64-1.69 (m, 4H), 3.39 (t, J = 7.7 Hz, 
4H), 3.42 ppm (t, J = 7.8 Hz, 4H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 13.2, 13.3, 19.3, 19.6, 29.6, 30.2, 52.3, 53.6, 92.1,  
133.4 ppm. 
HRMS calcd. for C19H36N2Cl
+
: 327.256151 [M-BF4]
+
; found: 327.256220. 
IR: ῦ= 519, 647, 734, 1048, 1239, 1376, 1455, 1605, 1903, 2875, 2960 cm-1. 
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Chloro cyclopropenium salt 112 
Oxalyl chloride (3.5 mL, 41.1 mmol) was added dropwise to ketone 117 (5.4 
g, 12.8 mmol) at 0 
o
C. Strong gas evolution was observed. After the addition 
was finished, the reaction mixture was stirred at room temperature for an 
additional hour and then the excess of oxalyl chloride was removed in vacuo. 
The residue obtained was dissolved in DCM and the solution washed with a saturated solution 
of NaBF4(aq) (3x). Finally, the organic phase was dried over sodium sulfate, the solvent 
removed in vacuo and the crude obtained was purified by column chromatography on silica 
gel (DCM/acetone, 15/1) to afford 112 as a red liquid (4.57 g, 67.6%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.86-0.89 (m, 12H), 1.28-1.36 (m, 24H), 1.63 (mbr, 4H), 
1.78-1.74 (m, 4H), 3.41-3.45 (m, 4H), 3.46-3.49 (m 4H) ppm. 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 14.0, 14.1, 22.5, 22.6, 26.3, 26.5, 28.0, 28.7, 31.3, 
31.6, 53.1, 54.4, 92.5, 133.9 ppm. 
HRMS calcd. for C27H52N2Cl
+
: 439.381351 [M-BF4]
+
; found: 439.380970. 
IR: ῦ = 520, 731, 1048, 1269, 1377, 1414, 1604, 1933, 2858, 2927, 2955 cm-1. 
6.5.2 Synthesis secondary phosphines bearing one cyclopropenium 
substituent 
General procedure A 
 
A dry Schlenk-flask was charged with a primary phosphine (2.0-3.0 equiv.), chloro 
cyclopropenium salt 63 (1.0 equiv.) and THF (or diglyme) and the resulting mixture was 
heated overnight (in THF: 60 °C; in diglyme: 100 °C). After cooling the reaction mixture to 
room temperature, the solvent was removed in vacuo, the residue dissolved in DCM and the 
organic phase thus obtained was washed with a saturated aqueous solution of NaBF4. Once 
the combined organic phases were dried over sodium sulfate, removal of the solvent in vacuo 
afforded a residue that was further purified by column chromatography on silica gel 
(DCM/Acetone, 9/1) affording the desired product as a white solid.  
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Monocationic phosphine 96a 
A dry Schlenk-flask was charged with a solution of phenylphosphine 
(7.4 mL, 5.3 mmol, 10% in hexane) and the solvent was concentrated in 
vacuo to approximately 1/3 of its starting volume. Then, chloro 
cyclopropenium salt 63 (630.0 mg, 1.8 mmol) and THF (6.0 mL) were added 
and the resulting mixture heated to 60 °C overnight. After cooling the reaction mixture to 
room temperature, the solvent was removed in vacuo, the residue dissolved in DCM and the 
organic phase thus obtained was washed with a saturated aqueous solution of NaBF4. Once 
the combined organic phases were dried over sodium sulfate, removal of the solvent in vacuo 
afforded a residue that was further purified by column chromatography on silica gel 
(DCM/Acetone, 9/1). Thus the desired compound 96a was obtained as a white solid (575 mg, 
76%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.10 (d, J = 6.8 Hz, 6H), 1.32 (d, J = 6.9 Hz, 6H), 1.37 (d, 
J = 6.8 Hz, 6H), 1.40 (d, J = 6.8 Hz, 6H), 3.71 (sept d, J = 6.8, 2.0 Hz, 2H), 4.13 (sept, 
J =6.8 Hz, 2H), 5.63 (d, J =233.3 Hz, 1H), 7.45-7.47 (m, 3H), 7.64-7.69 ppm (m, 2H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.0, 21.1, 21.3, 21.4, 22.4, 22.5, 49.6, 56.5, 103.4 
(d, JP-C = 56.4 Hz), 125.4 (d, JP-C = 6.3 Hz), 129.7 (d, JP-C = 8.5 Hz), 131.3 (d, JP-C = 0.9 Hz), 
136.2 (d, JP-C = 20.5 Hz), 138.5 (d, JP-C = 3.9 Hz) ppm.  
31
P{
1
H}-NMR (162 MHz, CDCl3): δ = -70.2 ppm. 
HRMS calcd. for C21H34N2P
+
: 345.245415 [M-BF4]
+
; found: 345.245568. 
IR: ῦ = 729, 1032, 1349, 1558, 1872, 2984 cm-1. 
The measured spectral data were in agreement with those found in the literature.
[41] 
Secondary monocationic phosphine 96b 
Compound 96b was prepared according to general procedure A from 1,1'-
(biphenyl-2-yl)-phosphine 168 (2.24 g, 12.0 mmol) and chloro 
cyclopropenium salt 63 (2.15 g, 6.0 mmol) in diglyme (20.0 mL). White 
solid (1.86 g, 61.0%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.08 (d, J = 6.8 Hz, 6H), 1.16 (d, J = 6.8 Hz, 6H), 1.34 (d, 
J = 6.8 Hz, 6H), 1.37 (d, J = 6.8 Hz, 6H), 3.65 (sept d, J = 6.8, 1.8 Hz, 2H), 4.12 (sept, J = 6.9 
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Hz, 2H), 5.39 (d, J = 233.3 Hz, 1H), 7.22-7.23 (m, 1H), 7.26 (m, 1H, overlaps with solvent) 
7.31-7.51 (m, 6H), 7.69-7.75 (m, 1H) ppm. 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.0, 21.0, 21.5, 21.5, 22.1, 22.2, 49.4, 56.5, 103.4 
(d, JP-C = 58.4 Hz), 124.9 (d, JP-C= 8.1 Hz), 128.2, 128.7, 128.9 (d, JP-C = 4.4 Hz), 129.1 (d, 
JP-C = 3.0 Hz), 130.6 (d, JP-C = 4.0 Hz), 131.0, 136.8 (d, JP-C = 9.3 Hz), 138.9 (d, JP-
C = 2.0 Hz), 141.0 (d, JP-C = 4.0 Hz), 147.9 (d, JP-C = 20.2 Hz) ppm. 
31
P{
1
H}-NMR (161 MHz, CDCl3): δ = -79.1 ppm. 
HRMS calcd. for C27H38N2P
+
: 421.276711 [M-BF4]
+
; found: 421.276383. 
IR: ῦ = 702, 762, 861, 884, 1029, 1152, 1340, 1458, 1562, 1874, 2297, 2984 cm-1. 
Secondary monocationic phosphine 96c 
 Compound 96b was prepared according to general procedure A from 
mesitylphsophine (2.44 g, 17.7 mmol) and chloro cyclopropenium salt 63 
(3.1g, 8.64 mmol) in diglyme (20.0 mL). White solid (2.9 g, 70.7%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.08 (d, J = 6.9 Hz, 6H), 1.19 (d, J = 
6.9 Hz, 6H), 1.35 (d, J = 6.9 Hz, 6H), 1.37 (d, J = 6.9 Hz, 6H), 2.30 (s, 3H), 2.48 (s, 6H), 3.58 
(sept., J = 6.4 Hz, 2H), 4.08 (sept., J = 6.4 Hz, 2H), 5.44 (d, J = 240 Hz, 1H), 7.00 ppm (d, J = 
2.6 Hz, 2H). 
13
C{
1
H}-NMR (101 MHz, CD2Cl2): δ = 21.0, 21.1, 21.4 (d, JP-C = 5.6 Hz), 22.3, 23.4, 23.5, 
49.9, 54.7, 105.4 (d, JP-C = 62.5 Hz), 120.5 (d, J = 9.6 Hz), 129.7 (d, JP-C = 5.0 Hz), 137.9, 
142.2, 144.7 ppm (d, JP-C = 8.1 Hz). 
31
P{
1
H}-NMR (161 MHz, CDCl3): δ = -94.4 ppm. 
HRMS calcd. for C24H40N2P
+
: 387.292359[M-BF4]
+
; found: 387.292161. 
IR: ῦ = 520, 562, 658, 803, 1050, 1093, 1155, 1345, 1538, 1868, 2982 cm-1. 
Secondary monocationic phosphine 96d 
Compound 96d was prepared according to general procedure A from 
cyclohexylphosphine (2.44 g, 21.0 mmol) and chloro cyclopropenium 
salt 63 (2.5 g, 7.0 mmol) in THF (30.0 mL). White solid (2.0 g, 65%). 
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1
H-NMR (400 MHz, CDCl3): δ = 1.07-1.23, (m, 4H), 1.30 (d, J = 6.6 Hz, 6H), 1.33 (d, J = 
6.6 Hz, 12H), 1.38 (d, J = 6.6 Hz, 6H), 1.65-1.90 (7H), 3.85 (sept, J = 6.4 Hz, 2H), 4.07 (dd, J 
= 220 Hz, J = 9.5 Hz, 1H),4.09 (sept, J = 6.4 Hz, 2H) ppm. 
13
C{
1
H}-NMR (101 MHz, CD2Cl2): δ = 20.6 (d, JP-C = 2.9 Hz), 21.0 (d, JP-C = 1.7 Hz), 22.2 
(d, JP-C = 3.7 Hz), 25.2, 26.5, 26.6 (d, J = 1.7 Hz), 31.0 (d, JP-C = 19.8 Hz), 32.3 (d, JP-C = 
10.8 Hz), 35.1, 49.2, 56.1, 103.0 (d, JP-C = 62.2 Hz), 138.9 (d, JP-C = 3.4 Hz) ppm. 
31
P{
1
H}-NMR (161 MHz, CDCl3): δ = -59.4 ppm. 
HRMS calcd. for C21H40N2P
+
: 351.292360 [M-BF4]
+
; found: 351.292146. 
IR: ῦ = 732, 891, 1033, 1142, 1348, 1542, 1859, 2933 cm-1. 
Secondary monocationic phosphine 96e
[82] 
Compound 96e was prepared in 87% yield according to a literature 
procedure.
[41b] 
1
H-NMR (400 MHz, CDCl3): δ = 1.35 (d, J = 6.8 Hz, 18H), 1.41 (d, J = 
6.8 Hz, 6H), 1.67 (m, 6H), 1.81-1.82 (m, 6H), 1.97 (m, 3H), 3.96 (sept, J = 
6.8 Hz, 2H), 3.99 (d, J = 221.3 Hz, 1H), 4.13 (sept, J = 6.8 Hz, 2H) ppm. 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 20.6, 20.9, 21.0, 21.4, 28.4 (d, JP-C = 8.6 Hz), 35.5, 
36.7 (d, JP-C = 11.2 Hz), 42.7 (d, JP-C = 9.5 Hz), 51.4, 53.6, 101.9 (d, JP-C = 67.7 Hz), 140.3 
ppm.  
31
P{
1
H}-NMR (162 MHz, CDCl3): δ = -44.5 ppm.  
HRMS calcd. for C25H44N2P
+
: 403.323658 [M-BF4]
+
; found: 403.323727. 
IR: ῦ = 607, 1045, 1153, 1376, 1543, 1863, 2903 cm-1.  
The measured spectral data were in agreement with those found in the literature.
[41b] 
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6.5.3 Synthesis of biscyclopropenium phosphines 
General procedure B 
 
Dry THF was added to a cooled (-40
o
C) solid mixture of KHMDS (1.0 equiv.) and 
phosphines 96a-e (1.0 equiv.) and the resulting suspension was stirred at this temperature for 
2 hours. Then, the desired chloro cyclopropenium salt 63/111/112 (1.0 equiv.) was added, and 
the reaction warmed to room temperature overnight. Removal of the solvent in vacuo afforded 
a residue that was redissolved in DCM and washed with an aqueous saturated solution of 
NaBF4 (3x). Once dried over sodium sulfate, the organic phase was concentrated and the 
obtained residue (oil or solid) washed with THF to afford the desired compounds 95a-g as a 
solid. 
Biscyclopropenium phosphine 95a 
Compound 95a was prepared according to general procedure B, 
employing KHMDS (230.1 mg, 1.16 mmol), phosphine 96a (500 mg, 
1.16 mmol) and chloro cyclopropenium salt 63 (414.8 mg, 1.16 mmol) in 
dry THF (7 mL). White solid (598.2 mg, 68.2%).  
1
H-NMR (400 MHz, CDCl3): δ = 1.21 (d, J = 6.9 Hz, 12H), 1.25 (d, J = 6.9 Hz, 12H), 1.38 
(d, J = 6.9 Hz, 12H), 1.44 (d, J = 6.9 Hz, 12H), 3.64 (sept, J = 6.9 Hz, 4H), 4.17 (sept d, J = 
6.8, 1.4 Hz, 4H), 7.62-7.68 (m, 3H), 7.73-7.80 ppm (m, 2H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.2, 21.5, 21.6, 21.7, 53.4, 54.8, 98.2 (d, JP-C = 59.5 
Hz), 125.0 (d, JP-C = 4.6 Hz), 131.1 (d, JP-C = 8.9 Hz), 133.0, 134.8 (d, JP-C = 22.9 Hz), 140.0 
ppm. 
31
P{
1
H}-NMR (400 MHz, CDCl3): δ = -47.2 ppm. 
19
F-NMR (282 MHz, CDCl3): δ = -152.2 ppm. 
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HRMS calcd. for C36H61BF4N4P
+
: 667.467509 [M-BF4]
+
; found: 667.467401. 
IR: ῦ = 694, 1029, 1151, 1357, 1555, 1858, 2974 cm-1. 
The measured spectral data were in agreement with those found in the literature.
[41]
 
Biscyclopropenium phosphine 95b 
Compound 95b was prepared according to general procedure B, 
employing KHMDS (325 mg, 1.63 mmol), phosphine 96b (830 mg, 
1.63 mmol) and chloro cyclopropenium salt 63 (580 mg, 1.63 mmol) 
in dry THF (20 mL). White solid (660 mg, 48.7%). 
1
H-NMR (400 MHz, CD3CN): δ = 0.97 (d, J = 6.8 Hz, 12H), 1.16 (d, J = 6.8 Hz, 12H), 1.32 
(d, J = 6.8 Hz, 12H), 1.35 (d, J = 6.8 Hz, 12H), 3.68-3.71 (mbr, 4H), 4.13 (sept, J = 6.8 Hz, 
4H), 7.17-7.19 (m, 2H), 7.44-7.50 (m, 3H), 7.52-7.56 (m, 1H), 7.60-7.64 (m, 1H) 7.67-7.70 
(m, 1H), 7.73 ppm (td, J = 7.5 Hz, 1.3 Hz, 1H).  
13
C{
1
H}-NMR (101 MHz, CD3CN): δ = 21.1, 21.2, 21.5, 21.6, 21.6, 21.7, 53.2, 56.0, 98.7 (d, 
JP-C = 60.6 Hz), 125.7, 129.7, 129.8, 129.9 (d, JP-C = 4.0 Hz), 130.2, 132.4 (d, JP-C = 6.5 Hz), 
134.0, 136.2(d, JP-C = 3.1 Hz), 140.6 (d, JP-C = 2.0 Hz), 140.7, 150.0 ppm (d, JP-C = 36.1 Hz).  
31
P{
1
H}-NMR (162 MHz, CD3CN): δ = -54.7 ppm. 
HRMS calcd. for C42H65BF4N4P
+
: 743.497053 [M-BF4]
+
; found: 743.498110. 
IR: ῦ = 440, 519, 549, 578, 616, 640, 666, 688, 705, 740, 761, 891, 1028, 1048, 1150, 1182, 
1204, 1283, 1353, 1376, 1457, 1552, 1852, 2879, 2939, 2976 cm
-1
. 
Biscyclopropenium phosphine 95c 
Compound 95c was prepared according to general procedure B, 
employing KHMDS (69.0 mg, 0.35 mmol), phosphine 96c (164.0 
mg, 0.35 mmol) and chloro cyclopropenium salt 63 (125.5 mg, 
0.35 mmol) in dry THF (10 mL). White solid (88.0 mg, 31.6%). 
1
H-NMR (400 MHz, CD2Cl2): δ = 1.08 (d, J = 6.6 Hz, 12H), 1.26 (d, J = 6.8 Hz, 12H), 1.32 
(d, J = 6.8 Hz, 12H), 1.33 (d, J = 6.8 Hz, 12H), 2.26 (s, 3H), 2.40 (s, 6H),3.71 (sept, J = 6.6 
Hz, 4H), 4.13 (sept, J = 6.6 Hz, 4H), 7.03 ppm (d, J = 3.9 Hz, 2H). 
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13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.2, 21.4, 21.4, 21.5, 21.5, 21.6, 21.8, 53.7, 54.3, 
99.1 (d, JP-C = 58.0 Hz), 118.9 (d, JP-C = 9.6 Hz), 131.1, 131.2, 139.2, 144.2 ppm. 
31
P{
1
H}-NMR (161 MHz, CD2Cl2): δ = -64.7 ppm. 
HRMS calcd. for C39H67BF4N4P
+
: 709.512703 [M-BF4]
+
; found: 709.513703. 
IR: ῦ= 520, 579, 645, 689, 893, 1034, 1051, 1151, 1362, 1455, 1551, 1852, 2974 cm-1. 
Biscyclopropenium phosphine 95d 
Compound 95d was prepared according to general procedure B, 
employing KHMDS (49.9 mg, 0.25 mmol), phosphine 96d (109.6 mg, 
0.25 mmol) and chloro cyclopropenium salt 63 (89.7 mg, 0.25 mmol) 
in dry THF (6 mL). White solid (80.0 mg, 42%). 
1
H-NMR (400 MHz, CD2Cl2): δ = 1.26-1.37 (m, 4H), 1.28 (d, J = 6.9 Hz, 12H), 1.30 (d, J = 
6.9 Hz, 12H), 1.35 (d, J = 6.9 Hz, 12H), 1.37 (d, J = 6.9 Hz, 12H), 1.71-1.84 (m, 6H), 2.59 
(m, 1H), 3.90 (sept, J = 6.9 Hz, 4H), 4.13 (sept, J = 6.9 Hz, 4H) ppm. 
13
C{
1
H}-NMR (101 MHz, CD2Cl2): δ = 21.2, 21.4, 21.4, 21.6, 21.6, 21.8, 25.3, 26.6 (d, JP-C 
= 13.0 Hz), 30.5 (d, JP-C = 16.1 Hz), 36.6 (d, JP-C = 10.5 Hz), 53.0, 54.1, 98.5 (d, JP-C = 70.1 
Hz), 140.4 ppm. 
31
P{
1
H}-NMR (161 MHz, CD2Cl2): δ = -43.7 ppm. 
HRMS calcd. for C36H67 BF4N4P
+
: 673.512703 [M-BF4]
+
; found: 673.512360. 
IR: ῦ= 519, 576, 684, 892, 1030, 1049, 1151, 1355, 1455, 1547, 1851, 2937 cm-1. 
Biscyclopropenium phosphine 95e 
Compound 95e was prepared according to general procedure B, employing 
KHMDS (49.9 mg, 0.25 mmol), phosphine 96e (122.6 mg, 0.25 mmol) 
and chloro cyclopropenium salt 63 (89.7 mg, 0.25 mmol) in dry THF (6.0 
mL). White solid (102.0 mg, 50%). 
1
H-NMR (400 MHz, CD2Cl2): δ = 1.32 (d, J = 6.8 Hz, 12H), 1.30 (d, J = 6.9 Hz, 12H), 1.46 
(dd, J = 6.8, 4.0 Hz, 24H), 1.76-1.85 (m, 6H), 2.04 (m, 6H), 2.17 (m, 3H), 4.15-4.28 ppm (m, 
8H). 
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13
C{
1
H}-NMR (101 MHz, CD2Cl2): δ = 21.4, 21.7, 21.8, 28.6 (d, JP-C = 10.3 Hz), 35.8, 39.4 
(d, JP-C = 16.5 Hz), 40.0 (d, JP-C = 11.2 Hz), 53.0-55.0 (broad CHi-Prsignal covered by 
CD2Cl2), 98.2 (d, JP-C = 76.1 Hz), 140.5 ppm. 
31
P{
1
H}-NMR (161 MHz, CD2Cl2): δ = -21.8 ppm. 
HRMS calcd. for C40H71BF4N4P
+
: 725.544003 [M-BF4]
+
; found: 725.544080. 
IR: ῦ = 520, 575, 685, 893, 1033, 1051, 1151, 1358, 1458, 1555, 1845, 2910,  
2978 cm
-1
. 
Biscyclopropenium phosphine 95f  
Compound 95f was prepared according to general procedure B, 
employing KHMDS (115.6 mg, 0.78 mmol), phosphine 96a (338.0 mg, 
0.78 mmol) and chloro cyclopropenium salt 111 (414.8 mg, 0.78 mmol) 
in dry THF (20 mL). After the reaction was finished the work-up was 
performed as described and the obtained crude product was washed with pentane (4x, instead 
of THF), affording the desired compound 95f as a dark red oil of high viscosity (353.0g, 
56%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.82 (t, J = 7.4 Hz, 6H), 0.93 (t, J = 7.4 Hz, 6H), 0.99-1.09 
(m, 4H), 1.20 (d, J = 6.8 Hz, 6H), 1.28-1.33 (m, 4H), 1.37(d, J = 6.8 Hz, 6H), 1.40 (d, 
J = 6.8 Hz, 6H), 1.42 (d, J = 6.8 Hz, 6H), 1.46-1.54 (m, 4H), 1.56-1.65 (m, 4H), 3.16-3.20 (m, 
4H), 3.46-3.50 (m, 4H), 3.84 (sept d, J = 6.8 Hz, 1.5 Hz, 2H), 4.18 (sept, J = 6.8 Hz, 2H), 
7.50-7.59 (m, 3H), 7.7.70-7.75 ppm (m, 2H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 13.3, 19.4, 19.6, 20.6, 20.7, 20.8, 20.8, 29.5, 30.2, 
51.6, 53.4, 53.5, 55.1, 96.6 (d, JP-C = 55.6 Hz), 98.4 (d, JP-C = 61.8 Hz), 126.0 (d, JP-
C = 4.2 Hz), 130.0 (d, JP-C = 8.7 Hz), 131.7, 133.5 (d, JP-C = 22.4Hz), 139.3 (d, JP-C = 3.7 Hz), 
141.1 ppm (d, J P-C = 1.8 Hz). 
31
P{
1
H}-NMR (162 MHz, CDCl3): δ = -51.5 ppm. 
HRMS calcd. for C40H69BF4N4P
+
: 723.528353 [M-BF4]
+
; found: 723.528140. 
IR: ῦ = 519, 696, 753, 892, 1031, 1046, 1152, 1377, 1437, 1460, 1563, 1862, 1897, 2874, 
2936, 2961 cm
-1
. 
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Biscyclopropenium phosphine 95g  
Compound 95g was prepared according to general procedure B, 
employing KHMDS (521 mg, 2.61 mmol), phosphine 96a (1.11 g, 
2.56 mmol) and chloro cyclopropenium salt 112 (1.35 g, 2.56 mmol) in 
dry THF (15.5 mL). After the reaction was finished the work-up was 
performed as described and the obtained crude product purified by column chromatography 
on silica gel (DCM/Acetone, 2/1) to afford 95g as a dark red solid (1.53 g, 65%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.84-0.91 (m, 12H), 0.99-1.06 (m, 4H), 1.23 (d, 
J = 6.8 Hz, 10H), 1.26-1.30 (m, 15H), 1.37-1.46 (m, 19H), 1.51-1.56 (m, 4H), 1.60-1.68 (mbr, 
4H), 3.17-3.22 (m, 4H), 3.46-3.51 (m, 4H), 3.85 (sept, J = 6.8 Hz, 2H), 4.19 (sept, J = 6.8 Hz, 
2H), 7.49-7.62 (m, 3H), 7.73-74 (m, 1H), 7.76-7.77 ppm (m, 1H). 
13
C{
1
H}-MR (101 MHz, CDCl3): δ = 14.1, 14.1, 21.1, 21.1, 21.2, 21.3, 21.3, 22.6, 22.7, 26.3, 
26.5, 27.9, 28.7, 31.4, 31.5, 51.9, 54.0, 54.2, 55.6, 96.8 (d, JP-C = 57.4 Hz), 98.1 (d, JP-
C = 54.9 Hz), 126.5 (d, JP-C = 4.1 Hz), 130.5 (d, JP-C = 8.2 Hz), 132.1, 133.9 (d, JP-
C= 22.2Hz), 139.7 (d, JP-C = 2.9 Hz), 141.5 ppm (d, JP-C = 2.02 Hz). 
31
P{
1
H}-NMR (122 MHz, CDCl3): δ = -52.6 ppm. 
19
F{
1
H}-NMR (282 MHz, CDCl3): δ = -152.4 ppm. 
HRMS calcd. for C48H85BF4N4P
+
: 835.653553 [M-BF4]
+
; found: 835.654050. 
IR: ῦ = 411, 441, 583, 646, 695, 725, 751, 892, 1031, 1041, 1153, 1182, 1207, 1282, 1315, 
1351, 1377, 1437, 1460, 1563, 1864, 1897, 2859, 2930, 2956 cm
-1
. 
General procedure C: Anion exchange of the BF4
-
 counter ion for SbF6
-
 
 
A suspension of the desired dicationic phosphine 95a/g (1.0 equiv.) and sodium 
hexafluoroantimonate (7.0 equiv.) in acetonitrile (c(phosphine) = 0.1M) was stirred overnight 
at room temperature. After filtration the solvent was removed in vacuo and the remaining 
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residue dissolved in DCM causing the precipitation of inorganic salts, which were discarded 
by filtration. Removal of the solvent in vacuo afforded the desired product 95h/i. 
Biscyclopropenium phosphine 95h 
Compound 95h was prepared according to general procedure C 
employing dicationic phosphine 95a (110 mg, 0.14 mmol) and sodium 
hexafluoroantimonate (264 mg, 1.0 mmol) in acetonitrile (1.4 mL). 
However, in this case the inorganic salts had to be separated from the 
product by precipitation via addition of DCM to a solution of crude 95h in CH3CN. Removal 
of the solvents in vacuo afforded compound 95h as a white solid (114 mg, 74%). 
1
H-NMR (300 MHz, CD3CN): δ = 1.14 (d, J = 6.8 Hz, 12H), 1.21 (d, J = 6.8 Hz, 12H), 1.38 
(pt, J = 7.2 Hz, 24H), 3.67 (septbr, J = 6.8 Hz, 4H), 4.18 (sept, J = 6.9 Hz, 4H), 7.68-7.70 ppm 
(m, 5H). 
13
C{
1
H}-NMR (101 MHz, CD3CN): δ = 21.3, 21.4, 21.6, 21.7, 21.8, 21.9, 53.6(sbr), 55.6(sbr), 
98.2 (d, JP-C = 57.2 Hz), 126.1 (d, JP-C = 4.0 Hz), 131.5 (d, JP-C = 8.8 Hz), 133.8, 135.2 (d, JP-
C = 23.0 Hz), 140.6 ppm. 
31
P{
1
H}-NMR (122 MHz, CD3CN): δ = -48.7 ppm. 
19
F{
1
H}-NMR (282 MHz, CD3CN): δ = -124.0 ppm (sext, JF-Sb(l=5/2) = 1930.5 Hz, oct, JF-
Sb(l=7/2) =  1054.7 Hz). 
ESI-MS (negative): m/z = 234.9 [SbF6
-
]. 
HRMS calcd. for C36H61F6N4PSb
+
: 815.357003 [M-SbF6]
+
; found: 815.357470. 
IR: ῦ = 499, 549, 579, 653, 752, 892, 1012, 1038, 1148, 1182, 1204, 1352, 1377, 1438, 1458, 
1552, 1854, 2883, 2939 cm
-1
. 
Biscyclopropenium phosphine 95i 
Compound 95i was prepared according to general procedure C 
employing dicationic phosphine 95g (194 mg, 0.21 mmol) and sodium 
hexafluoroantimonate (381 mg, 1.47 mmol) in acetonitrile (2.1 mL). 
Clean 95i was obtained by precipitation from 1,2-DCE/ diethyl ether. 
White solid (127 mg, 49%). 
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1
H-NMR (400 MHz, CDCl3): δ = 0.83-0.89 (m, 12H), 0.98-1.02 (m, 4H), 1.17 (d, 
J = 6.8 Hz, 6H), 1.19-1.24 (m, 7H), 1.28 (m, 13H), 1.34 (d, J = 6.8 Hz, 6H), 1.41 (d, 
J = 3.2 Hz, 6H), 1.42 (d, J = 3.2 Hz, 6H), 1.48-1.54 (m, 4H), 1.61 (mbr, 4H), 3.11-3.23 (m, 
4H), 3.43 (d, J = 6.8 Hz, 2H), 3.45 (d, J =6.8 Hz, 2H), 3.77-3.84 (m, 2H), 4.14 (sept., 
J = 6.8 Hz, 2H), 7.51-7.55 (m, 1H), 7.58-7.65 (m, 4H) ppm.  
13
C{
1
H}-NMR (126 MHz, CDCl3): δ =14.0, 14.1, 21.1, 21.1, 21.3, 21.3, 22.6, 22.7, 26.4, 
26.6, 27.9, 28.6, 31.4, 31.5, 52.1 (sbr), 54.0, 54.1, 55.8 (sbr), 97.4 (d, JP-C = 62.3 Hz), 98.0 (d, 
JP-C = 58.0 Hz), 126.3 (d, JP-C = 4.2 Hz), 130.8 (d, JP-C = 8.4 Hz), 132.3, 133.6 (d, JP-
C = 22.6 Hz), 139.6 (d, JP-C = 2.7 Hz), 141.5 (d, JP-C =1.1 Hz) ppm. 
31
P{
1
H}-NMR (162 MHz, CDCl3): δ = -52.3 ppm. 
ESI-MS (negative): m/z = 234.9 [SbF6
-
]. 
HRMS calcd. for C48H85F6N4PSb: 983.544803 [M-SbF6]
+
; found: 983.545350. 
IR: ῦ = 583, 652, 694, 721, 750, 891, 1015, 1098, 1151, 1180, 1207, 1268, 1314, 1349, 1377, 
1436, 1463, 1565, 1586, 1865, 1893, 2859, 2930, 2956 cm
-1
. 
6.5.4 Coordination chemistry of dicationic phosphines  
6.5.4.1 Coordination to Au(I)  
General Procedure D: Synthesis of Au(I)-complexes 
 
[AuCl(Me2S)] (1.0 equiv.) was added to a precooled (-20
o
C) solution of biscyclopropenium 
phosphine 95a-i (1.0 equiv.) in dry DCM (c = 0.033 M). The reaction mixture was stirred at 
this temperature for 30 minutes, warmed to room temperature and stirred for an additional 
hour at this temperature. Removal of the solvent in vacuo afforded the desired products 97a-i 
as white solids. 
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Au(I)-complex 97a 
Synthesized according to general procedure D from [AuCl(Me2S)] 
(17.9 mg, 0.061 mmol) and biscyclopropenium phosphine 95a (45.8 mg, 
0.061 mmol) in DCM (1.8 mL). White solid (54 mg, 90%).  
1
H-NMR (400 MHz, CD2Cl2): δ = 1.25 (d, J = 7.0 Hz, 12H), 1.34 (d, J = 
7.0 Hz, 12H), 1.45 (d, J = 7.0 Hz, 24H), 3.86 (sept, J = 7.0 Hz, 4H), 4.24 (sept, J = 7.0 Hz, 
4H), 7.72-7.78 (m, 3H), 8.08-8.17 ppm (m, 2H). 
13
C{
1
H}-NMR (101 MHz, CD2Cl2): δ = 21.5, 21.7, 21.9, 55.5, 56.0, 90.9 (d, JP-C = 53.2 Hz), 
121.9 (d, JP-C = 69.4 Hz), 131.5 (d, JP-C = 14.2 Hz), 135.4, 135.4 (d, JP-C =17.9 Hz), 138.9 (d, 
JP-C = 6.3 Hz) ppm. 
31
P{
1
H}-NMR (161 MHz, CD2Cl2): δ = -9.9 ppm. 
HRMS calcd. for C36H61AuBClF4N4P
+
: 899.401161 [M-BF4]
+
; found 899.401924. 
IR: ῦ = 694, 1030, 1151, 1358, 1556, 1858, 2973 cm-1. 
The found spectral data are in agreement with those previously reported by our workgroup.
[41] 
Au(I)-complex 97b (SbF6) 
Synthesized according to general procedure D from [AuCl(Me2S)] 
(11.2 mg, 0.038 mmol) and biscyclopropenium phosphine 95h (40 mg, 
0.038 mmol). Acetonitrile was employed as a solvent (1.2 mL, since the 
ligand is NOT soluble in DCM). White solid (43 mg, 88%).  
1
H-NMR (400 MHz, CD3CN): δ = 1.21 (d, J = 6.6 Hz, 12H), 1.26 (d, J = 6.6 Hz, 12H), 1.37-
1.39 (dd, J = 6.9, 2.3 Hz, 24 H), 3.81 (mbr, 4H), 4.21-4.25 (mbr, 4H), 7.75-7.80 (m, 2H), 7.84-
7.88 (m, 1H), 7.92-7.95 (m, 1H), 7.97-7.99 ppm (m, 1H). 
13
C{
1
H}-NMR (101 MHz, CD3CN): δ = 21.4, 21.8, 22.0, 55.9 (sbr), 90.5 (d, JP-C = 57.2 Hz), 
122.4 (d, JP-C = 69.7 Hz), 131.9 (d, JP-C = 14.0 Hz), 135.8 (d, JP-C = 17.5 Hz), 136.6 (d, JP-
C = 2.7 Hz), 139.3 ppm.  
31
P{
1
H}-NMR (162 MHz, CD3CN): δ = -8.8 ppm. 
19
F{
1
H}-NMR (282 MHz, CD3CN): δ = -123.9 ppm (sext, JF-Sb(l=5/2) = 1936.3 Hz, oct, 
JF-Sb(l=7/2) = 1096.4 Hz). 
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HRMS calcd. for C36H61AuClF6N4PSb
+
: 1047.292408 [M-SbF6]
+
; found: 1047.292180. 
IR: ῦ = 447, 522, 582, 654, 759, 870, 893, 1008, 1035, 1098, 1146, 1179, 1201, 1319, 1350, 
1377, 1441, 1456, 1568, 1855, 2881, 2944, 2988, 3063 cm
-1
. 
Au(I)-complex 97c 
Synthesized according to general procedure D from [AuCl(Me2S)] 
(17.7 mg, 0.06 mmol) and biscyclopropenium phosphine 95b (50 mg, 
0.06 mmol) in DCM (1.8 mL). White solid (58 mg, 91%). 
1
H-NMR (400 MHz, CD3CN): δ = 1.12 (d, J = 6.8 Hz, 12H), 1.22 (d, 
J = 7.4 Hz, 12H), 1.41 (d, J = 6.9 Hz, 24H), 3.91 (sept, J = 6.8 Hz, 
4H), 4.25 (sept, J = 6.8 Hz, 4H), 7.24-7.25 (m, 2H), 7.51-7.56 (m, 3H), 7.63 (t, J = 7.4 Hz, 
1H), 7.78-7.81 (m, 1H), 7.89 (td, J = 7.7, 0.9 Hz, 1H), 7.94-8.00 ppm (m, 1H). 
13
C{
1
H}-NMR (101 MHz, CD3CN): δ = 21.5, 21.6, 22.2, 56.2(sbr), 92.0 (d, JP-C = 54.1 Hz), 
121.5 (d, JP-C = 71.7 Hz), 130.2, 130.6, 130.7, 130.8, 134.4 (d, JP-C = 9.4 Hz), 135.9, 136.1 
(d, JP-C = 2.0 Hz), 139.1, 140.3 (d, JP-C = 10.1 Hz), 149.3 ppm (d, JP-C = 21.2 Hz). 
31
P{
1
H}-NMR (162 MHz, CD3CN): δ = -17.9 ppm. 
HRMS calcd. for C42H65AuBClF4N4P
+
: 975.432459 [M-BF4]
+
; found: 975.432440. 
IR: ῦ = 447, 498, 519, 552, 582, 617, 644, 685, 704, 737, 760, 891, 1029, 1048, 1147, 1180, 
1201, 1355, 1377, 1459, 1565, 1848, 2878, 2941, 2977 cm
-1
. 
Au(I)-complex 97d 
 Synthesized according to general procedure D from [AuCl(Me2S)] 
(31 mg, 0.11 mmol) and biscyclopropenium phosphine 95d (80 mg, 
0.11 mmol) in DCM (3.2 mL). White solid (82.0 mg, 79%). 
1
H-NMR (400 MHz, CD2Cl2): δ = 1.34-1.39 (m, 2H), 1.47 (dd, 
J = 7.0 Hz, 2.0 Hz, 24H), 1.55 (pt, J= 7.0 Hz, 24H), 1.61-1.67 (m, 3H), 
1.81-1.84 (mbr, 1H), 1.98-2.00 (mbr, 4H), 2.93 (m, 1H), 4.13-4.20 ppm (m, 8H). 
13
C{
1
H}-NMR (101 MHz, CD2Cl2): δ = 21.9, 22.0, 22.5, 25.2 (d, JP-C = 2.0 Hz), 25.7 (d, JP-
C = 18.2 Hz), 30.6 (d, JP-C = 6.1 Hz), 38.5 (d, JP-C = 37.0 Hz), 57.8 (sbr), 89.9 (d, JP-
C = 42.2Hz), 139.7 ppm (d, JP-C = 8.6 Hz). 
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31
P{
1
H}-NMR (162 MHz, CD2Cl2): δ = -9.92 ppm. 
HRMS calcd. for C36H67AuBClF4N4P
+
: 905.448109 [M-BF4]
+
; found: 905.449040.  
IR: ῦ = 457, 519, 557, 581, 645, 664, 684, 892, 1026, 1047, 1148, 1180, 1358, 1377, 1453, 
1561, 1848, 2858, 2936, 2978 cm
-1
. 
Au(I)-complex 97e 
Synthesized according to general procedure D from [AuCl(Me2S)] 
(22.1 mg, 0.075 mmol) and biscyclopropenium phosphine 95e (61.0 mg, 
0.075 mmol) in DCM (2.0 mL). White solid (66.2 mg, 84%). 
1
H-NMR (400 MHz, CD3CN): δ = 1.37-1.41(m, 21H), 1.43 (d, J = 
7.0 Hz, 12H), 1.48 (d, J = 6.5 Hz, 12H), 1.76-1.86 (m, 6H), 2.12-2.14 (m, 6H), 2.18 (s, 3H), 
2.22 (s, 3H) 4.21 (sept, J = 6.8 Hz, 4H), 4.30 ppm (mbr, 4H). 
13
C{
1
H}-NMR (101 MHz, CD3CN): δ = 21.3, 22.0, 22.3 (sbr, overlaps with former signal), 
28.9 (d, JP-C = 12.5 Hz), 35.7, 39.6 (d, JP-C = 3.4 Hz), 56.4 (sbr), 139.9 ppm (Cq signals for 
CAd-P and CCpr-P are missing due to signal broadening even if extended measurements were 
done (amount of scans increased from 800 to 60000)).
 
31
P{
1
H}-NMR (162 MHz, CD3CN): δ = 12.2 (sbr) ppm. 
HRMS calcd. for C40H71AuBClF4N4P
+
: 957.479409 [M-BF4]
+
; found: 957.479480.  
IR: ῦ = 453, 520, 557, 586, 641, 684, 801, 893, 1029, 1051, 1149, 1182, 1357, 1377, 1454, 
1556, 1846, 2858, 2915, 2972 cm
-1
. 
Au(I)-complex 97f 
Synthesized according to general procedure D from [AuCl(Me2S)] 
(39.2 mg, 0.13 mmol) and biscyclopropenium phosphine 95f (107 mg, 
0.13 mmol) in DCM (3.9 mL). Red solid (121 mg, 87%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.87 (t, J = 7.3 Hz, 6H), 0.93 (t, 
J = 7.3 Hz, 6H), 0.98-1.06 (mbr, 2H), 1.12-1.20 (mbr, 2H), 1.26-1.32 (m, 4H), 1.34-1.36 (m, 
8H), 1.41 (d, J = 6.5 Hz, 6H), 1.46 (dd, J = 6.9 Hz, J =1.7 Hz, 12H), 1.61-1.70 (m, 6H), 3.20-
3.28 (m, 2H), 3.46-3.52 (m, 6H), 3.84 (sept, J = 6.6 Hz, 2H), 4.22 (mbr, 2H), 7.57-7.61 (m, 
2H), 7.65-7.69 (m 1H), 7.86-7.88 (m, 1H), 7.92 ppm (m, 1H). 
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13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 13.7, 13.9, 19.8, 20.0, 21.2, 21.3, 21.4, 21.8, 29.6, 
30.2, 53.7, 54.9, 55.0(sbr), 88.5 (d, JP-C = 60.6 Hz), 88.5 (d, JP-C = 59.6 Hz), 121.8 (d, JP-
C = 72.8 Hz), 130.9 (d, JP-C = 13.8 Hz), 132.3 (d, JP-C = 15.5 Hz), 134.7, 139.0 (d, JP-
C = 5.4 Hz), 140.5 ppm (d, JP-C = 7.1 Hz). 
31
P{
1
H}-NMR (162 MHz, CDCl3): δ = -20.51 ppm. 
19
F{
1
H}-NMR (470 MHz, CDCl3): δ = -151.1 ppm. 
HRMS calcd. for C40H69AuBClF4N4P
+
: 955.463759 [M-BF4]
+
; found: 955.46400. 
IR: ῦ = 454, 520, 554, 586, 652, 690, 727, 754, 798, 893, 1031, 1042, 1148, 1316, 1355, 
1377, 1439, 1458, 1573, 1607, 1863, 1898, 2874, 2934, 2961cm
-1
. 
Au(I)-complex 97g 
Synthesized according to general procedure D from [AuCl(Me2S)] 
(58.4 mg, 0.2 mmol) and biscyclopropenium phosphine 95g 
(183.0  mg, 0.2 mmol) in DCM (6.0 mL). Orange solid (177.8 mg, 
86%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.81-0.85 (m, 12H), 0.96 (mbr, 2H), 1.10 (mbr, 2H), 1.21-
1.26 (m, 19H), 1.32-1.35 (m, 7H), 1.39 (d, J = 6.7 Hz, 6H), 1.44 (dd, J = 6.8 Hz, 2.0 Hz, 
12H), 1.51-1.58 (mbr, 2H), 1.65-1.74 (m, 6H), 3.20-3.27 (m, 2H), 3.41-3.53 (m, 6H), 3.80-
3.83 (mbr, 2H), 4.19 (mbr, 2H), 7.53-7.57 (m, 2H), 7.62-7-65 (m, 1H), 7.84 (d, J = 7.6 Hz, 
1H), 7.88 ppm (d, J = 7.6 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 14.1, 14.2, 21.3, 21.4, 21.6, 22.1, 22.7, 22.7, 26.3, 
26.6, 27.7, 28.4, 31.4, 31.5, 54.0, 55.2, 55.3 (sbr), 88.5 (d, JP-C = 58.0 Hz), 88.7 (d, JP-
C = 60.4 Hz), 121.8 (d, JP-C = 71.8 Hz), 131.0 (d, JP-C = 13.5 Hz), 132.2 (d, JP-C = 15.5 Hz), 
134.8 (d, JP-C = 2.0 Hz), 139.1 (d, JP-C = 6.3 Hz), 140.5 ppm (d, JP-C = 7.1 Hz). 
31
P{
1
H}-NMR (162 MHz, CDCl3): δ = -23.3 ppm. 
IR: ῦ = 448, 520, 586, 652, 690, 726, 752, 797, 863, 1049, 1149, 1377, 1463, 1573, 1607, 
1863, 1898, 2859, 2930 cm
-1
. 
HRMS calcd. for: C48H85N4AuBClF4P
+
: 1067.588959 [M-BF4]
+
; found: 1067.588230. 
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Au(I)-complex 97h 
Synthesized according to general procedure D from [AuCl(Me2S)] 
(7.3 mg, 0.025 mmol) and biscyclopropenium phosphine 95i (30 mg, 
0.025 mol) in DCM (0.75 mL). White solid (28 mg, 78%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.85-0.90 (m, 12H), 0.95 (mbr, 2H), 
1.13 (mbr, 2H), 1.26-1.29 (m, 21H), 1.37-1.39 (m, 11H), 1.46 (d, J = 6.8 Hz, 12H), 1.51-1.56 
(m, 2H), 1.68-1.71 (mbr, 6H), 3.26-3.30 (m, 2H), 3.42-3.60 (m, 6H), 3.84 (mbr, 2H), 4.20 (mbr, 
2H), 7.58-7.64 (m, 3H), 7.72 (d, J = 7.8 Hz, 1H), 7.76 ppm (d, J = 7.3 Hz, 1H). 
13
C{
1
H}-NMR (150 MHz, CDCl3):δ = 14.0, 14.1, 21.2, 21.3, 21.6, 22.3, 22.6, 22.7, 26.4, 
26.6, 27.5, 28.2, 31.4, 31.5, 54.2, 55.1, 55.6, 87.9, (d, JP-C =55.6 Hz), 88.4 (d, JP-C =56.9 Hz), 
121.8 (d, JP-C = 71.8 Hz), 131.3 (d, JP-C = 13.6 Hz), 132.0 (J = 15.9 Hz), 135.0, 138.8 (d, JP-
C = 6.2 Hz), 140.6 ppm (d, JP-C = 6.7 Hz). 
31
P{
1
H}-NMR (162 MHz, CDCl3): δ = -23.8 ppm. 
HRMS calcd. for C48H85AuClF6N4PSb
+
: 1215.480208 [M-SbF6]
+
; found: 1215.480400. 
IR: ῦ = 453, 525, 587, 652, 691, 726, 751, 892, 1009, 1036, 1098, 1148, 1180, 1202, 1269, 
1315, 1354, 1378, 1439, 1457, 1573, 1606, 1859, 1894, 2859, 2930, 2956 cm
-1
. 
Au(I)-complex 97i 
Au(I)-complex 97f (40.9 mg, 0.039 mmol) and sodium 
hexafluoroantimonate (101.4 mg, 0.39 mmol) were stirred in acetonitrile 
(0.39 mL) overnight at room temperature. After this time, the solvent 
was removed in vacuo, the residue washed with DCM (3x) and the 
combined organic phases were concentrated to 1/3 of their original 
volume. Addition of diethyl ether caused a separation of an oily phase that was solidified 
at -78 °C. The crude product thus obtained was dried in vacuo affording product 97i as a 
yellow solid (21 mg, 40%). 
1
H-NMR (400 MHz, CD2Cl2): δ = 0.89 (t, J = 7.2 Hz, 6H), 0.99 (t, J = 7.3 Hz, 6H), 1.09-
1.21 (m, 4H), 1.31 (d, J = 6.5 Hz, 6H), 1.34 (d, J = 6.9 Hz, 6H), 1.36-1.40 (m, 6H), 1.46 (d, 
J = 6.9 Hz, 6H), 1.49 (d, J = 6.6 Hz, 6H) 1.58-1.71 (m, 6H), 3.33-3.43 (m, 2H), 3.48-3.57 (m, 
6H), 3.90 (sept, J = 6.7 Hz, 2H), 4.24 (sept, J = 6.7 Hz, 2H), 7.80 (mbr, 3H), 7.91-7.93 (m, 
1H), 7.97-7.99 ppm (m, 1H). 
6. Experimental Part                                                                                                                   .  
 
96 
13
C{
1
H}-NMR (101 MHz, CD2Cl2): δ = 13.7, 13.8, 20.0, 20.2, 21.0, 21.3, 21.4, 21.6, 29.9, 
30.8, 54.4, 55.3, 55.9(sbr), 88.5 (d, JP-C = 53.6 Hz), 90.1 (d, 57.6 Hz), 121.8 (d, JP-
C = 69.8 Hz), 131.7 (d, JP-C = 14.7 Hz), 134.0 (d, JP-C = 16.5 Hz), 135.6, 137.8, 140.4 ppm (d, 
JP-C = 6.1 Hz). 
31
P{
1
H}-NMR (162 MHz, CD2Cl2): δ = -14.7 ppm. 
ESI-MS (negative): m/z = 234.9 [SbF6
-
]. 
HRMS calcd. for C40H69AuClF6N4PSb
+
: 1103.355009 [M-SbF6]
+
; found: 1103.355960. 
IR: ῦ = 524, 587, 652, 726, 754, 799, 892, 935, 1012, 1035, 1097, 1147, 1181, 1201, 1242, 
1261, 1315, 1354, 1378, 1459, 1573, 1607, 1860, 1895, 2875, 2936, 2963 cm
-1
. 
(Pentafluorophenyl)diphenylphosphine gold chloride 171 
 Synthesized according to general procedure D from [AuCl(Me2S)] 
(21.2 mg, 0.072 mmol) and pentafluorophenyl diphenyl-phosphine 
(25.5 mg, 0.072 mmol) in DCM (2.1 mL). White solid (34.7 mg, 88%). 
1
H-NMR (400 MHz, CDCl3): δ = 7.46-7.51 (m, 4H), 7.55-7.60 (m, 
2H), 7.62-7.70 (m 4H) ppm. 
13
C{
1
H}-NMR(101 MHz, CDCl3): δ = 104.9 (m), 126.4 (d, JP-C= 64.4 Hz), 129.7 (d, JP-
C = 13.0 Hz), 133.0 (d, JP-C = 2.8 Hz), 133.8 (d, JP-C = 15.7 Hz), 138.2 (m), 144.3 (m), 147.5 
ppm (m). 
31
P{
1
H}-NMR (122 MHz, CDCl3): δ = 15.4 ppm (m). 
19
F{
1
H}-NMR (282 MHz, CDCl3): δ = -157.9-(-157.7) (m), -144.8-(-144.6) (m), -125.6-(-
125.4) ppm (m). 
HRMS calcd. for C36H20Au2ClF10P2
+
: 1132.989472 [M2-Cl]
+
; found: 1132.991070. 
IR: ῦ = 419, 429, 478, 519, 534, 631, 688, 709, 724, 744, 799, 848, 979, 998, 1024, 1093, 
1260, 1295, 1390, 1436, 1477, 1518, 1644, 2852, 2920, 3055, 3074 cm
-1
. 
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6.5.4.2 Coordination to Pt(II) 
Pt(II)-complex 98 
Biscyclopropenium phosphine 95a (40 mg, 0.053 mmol), K2PtCl4 
(24.2 mg, 0.058 mmol) and acetonitrile (1 mL) were stirred overnight at 
room temperature. After that, the solvent was removed in vacuo and the 
residue obtained redissolved in dry DMSO (3 mL). Slow addition of DCM 
(6 mL) caused the precipitation of the inorganic salts, which were 
subsequently discarded after filtration. Removal of the solvents in vacuo afforded product 98 
as a yellow solid (47 mg, 91%). 
1
H-NMR (400 MHz, CD3CN): δ = 1.12 (d, J = 6.7 Hz, 12H), 1.22 (d, J = 6.7 Hz, 12H), 1.39 
(d, J = 6.8 Hz, 24H), 4.24 (sept, J = 6.9 Hz, 4H), 4.41 (mbr, 4H), 7.65-7.78 (m, 3H), 8.31 (d, 
J = 7.7 Hz, 1H), 8.36 (d, J = 7.7 Hz, 1H) ppm. 
13
C{
1
H}-NMR (100 MHz, CD2Cl2): δ = 17.5, 18.1, 18.5, 53.4, 90.6 (d, JP-C = 51.5 Hz), 118.9 
(d, JP-C = 70.8 Hz), 126.8 (d, JP-C = 12.9 Hz), 130.9 (d, JP-C = 2.3 Hz), 133.5 (d, JP-C = 13.5 
Hz), 134.7 ppm (d, JP-C = 8.6 Hz). 
31
P{
1
H}-NMR (162 MHz, CD3CN): δ = -23.6 (JPt-P=3997.8 Hz). 
19
F{
1
H}-NMR (282 MHz, CD3CN): δ = -152.1 ppm. 
HRMS calcd. for C36H61Cl3N4PPt
+
: 880.333066 [M-BF4]
+
; found 880.333903. 
IR: ῦ= 679, 1050, 1148, 1376, 1557, 1850, 2977 cm-1. 
The found spectral data are in agreement with those previously reported by our 
workgroup.
[41b] 
Pt(II)-complex 126 
Pt(II)-complex 98 (48 mg, 0.050 mmol, 1.0 equiv.) and sodium 
hexafluoroantimonate (44.8 mg, 0.173 mmol, 3.5 equiv.) were stirred in 
acetonitrile (5 ml) overnight at room temperature. Then, the solvents were 
removed in vacuo and the resulting solid extracted with DCM. The 
combined organic phases thus obtained were dried over sodium sulfate and 
after solvent removal the afforded crude material was redissolved in acetonitrile (3 mL). Slow 
addition of diethyl ether (5 mL) caused the separation of an oily phase which solidified 
at -30 °C. Yellow solid (38 mg, 69%). 
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1
H-NMR (400 MHz, CD3CN): δ = 1.11 (d, J = 6.8 Hz, 12H), 1.21 (d, J = 6.8 Hz, 12H), 1.39 
(dd, J = 7.0 Hz, 24H), 4.24 (sept, J = 7.0 Hz, 4H), 4.41 (mbr, 4H), 7.65-7.79 (m, 3H), 8.29-
8.32 (m, 1H), 8.34-8.37 ppm (m, 1H). 
13
C{
1
H}-NMR (101 MHz, CD3CN): δ = 21.3, 21.4, 22.0, 22.1, 54.4 (sbr), 57.4 (sbr), 94.2 (d, 
JP-C = 51.5 Hz), 123.7 (d, JP-C = 71.1 Hz), 130.9 (d, JP-C = 12.6 Hz), 135.4 (d, JP-C = 2.9 Hz), 
137.4 (d, JP-C = 14.8 Hz), 139.1 ppm. 
31
P{
1
H}-NMR (122 MHz, CD3CN): δ = -23.4 (JPt-P = 3995.9 Hz) ppm. 
19
F{
1
H}-NMR (282 MHz, CD3CN): δ = -124.1 (sext, JF-Sb(l=5/2) = 1939.8 Hz, oct,  
JF-Sb(l=7/2) = 1045.5 Hz) ppm. 
ESI-MS (negative): m/z = 234.9 [SbF6
-
]. 
HRMS calcd. for C36H61Cl3N4Pt
+
: 880.334520 [M-SbF6]
+
; found: 880.334206. 
IR: ῦ = 449, 496, 578, 655, 894, 1036, 1112, 1146, 1180, 1354, 1377, 1454, 1555, 1848, 
2886, 2941, 2980 cm
-1
. 
6.5.4.3 Coordination to Ag(I) 
Ag(I)-complex 127a/b (proposed structures) 
Biscyclopropenium phosphine 95a (49.2 mg, 0.065 mmol) and silver 
tetrafluoroborate (12.7 mg, 0.065 mmol) were stirred in dry DCM 
(1.3 mL) for 30 minutes at -25 °C. Then, the reaction mixture was 
warmed to room temperature and stirred for additional 1.5 hours. 
Subsequently, the yellow solution was filtered over a glass fiber filter 
and the solvent was removed in vacuo affording a yellow solid 127a/b (52 mg). 
As previously mentioned in section 4.3, a definitive structure assignment of the isolated 
species is difficult without XRD-analysis. Structures 127a and 127b represent just two 
possible structures.  
1
H-NMR (400 MHz, CD2Cl2): δ = 1.25 (d, J = 6.8 Hz, 12H), 1.28 (d, J = 6.9 Hz, 12H), 1.42 
(d, J = 7.0 Hz, 12H), 1.45 (d, J = 7.0 Hz, 12H), 3.73 (sept, J = 6.6 Hz, 4H), 4.21 (sept, 
J = 6.7 Hz, 4H), 7.72-7.75 (m, 3H), 8.03-8.05 (m, 1H), 8.06-8.09 ppm (m, 1H). 
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13
C{
1
H}-NMR (101 MHz, CD2Cl2): δ = 21.4, 21.5, 21.6, 21.7, 54.5 (sbr), 55.6 (sbr), 93.0 (d, 
JP-C = 7.6 Hz), 121.3 (d, JP-C = 37.7 Hz), 131.4 (d, JP-C = 12.7 Hz), 134.9, 135.7 (d, JP-
C = 21.1 Hz) 139.0 ppm (d, JP-C = 5.0 Hz). 
31
P{
1
H}-NMR (162 MHz, CD2Cl2): δ = -32.6 ppm. 
HRMS calcd. for. C36H61AgB2F8N4P: 861.373640 [M-BF4]
+
; found: 861.373040. 
IR: ῦ = 427, 442, 483, 519, 553, 580, 644, 689, 733, 754, 892, 1025, 1148, 1182, 1202, 1285, 
1355, 1378, 1440, 1455, 1561, 1628, 1855, 2884, 2941, 2988, 3078, 3527 cm
-1
. 
6.5.4.4 Coordination to Ir(I) 
Ir(I)-complex 134 
Biscyclopropenium phosphine 95a (45 mg, 0.06 mmol) and 
[IrCl(COD)]2 (20 mg, 0.03 mmol) were stirred in DCM (1.5 mL) 
at -25 °C for 1 hour. Removal of solvent in vacuo at this 
temperature afforded a residue, which was washed with pentane 
(3x) and dried in vacuo at -25 °C overnight. Yellow solid (83%, 
54 mg). The compound slowly decomposes over time already at 
0 °C. 
1
H-NMR (500 MHz, CDCl3, 0 °C): δ = 1.20-1.49 (mbr, 48H), 1.80 (mbr, 2H), 1.96 (mbr, 2H), 
2.21 (mbr, 4H), 2.29-5.12 (mbr, 10H), 5.39 (mbr, 2H), 7.50-7.53 (mbr, 1H), 7.70 (mbr, 1H), 
7.78-7.81 (mbr, 3H) ppm. 
13
C{
1
H}-NMR (125 MHz, CDCl3, -20 °C): δ = 21.8 (sbr), 29.0 (sbr), 33.6 (sbr), 54.4-63.0 (sbr), 
102.6 (mbr), 130.9 (mbr), 131.0, 131.8-132.4 (mbr), 133.0 (mbr), 140.2 ppm (mbr) (Cq signal for 
CPh-P is missing due to signal broadening).
 
31
P{
1
H}-NMR (202 MHz, CDCl3, -20 °C): δ = -18.8 (sbr) ppm. 
31
P{
1
H}-NMR (202 MHz, CDCl3, 0 °C): δ = -18.7 (sbr) ppm. 
HRMS calcd. for C44H73BClF4IrN4P
+
: 1003.491794 [M-BF4]
+
; found: 1003.492010. 
IR: ῦ = 427, 519, 578, 646, 675, 753, 871, 895, 1032, 1044, 1149, 1181, 1376, 1454, 1551, 
1849, 2840, 2881, 2975 cm
-1
. 
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6.5.5 Preparation and cycloisomerization of biphenyl-alkynes 
6.5.5.1 Synthesis of precursors 
2-Chloro-3-formylphenyl trifluoromethanesulfonate 135b 
2-Chloro-3-hydroxybenzaldehyde (522 mg, 3.33 mmol) and an aqueous 
potassium phosphate solution (1.93 g, 9.1 mmol, in 6.5 mL water) were 
stirred at room temperature until a clear solution was formed. Then toluene 
was added (6.5 mL) and the mixture was cooled down to 0 °C. Subsequently, 
trifluoromethanesulfonic anhydride (0.67 mL, 1.1 g, 4.00 mmol) was added slowly over 10 
minutes while keeping the reaction temperature below 6 °C. After the addition was complete, 
the reaction mixture was allowed to warm to room temperature and then stirred for additional 
40 minutes. The organic phase was separated and the remaining aqueous phase extracted with 
toluene (2x). The combined organic phases were washed with brine (2x) and dried over 
sodium sulfate. Removal of the solvents in vacuo afforded the desired product 135b as a 
colorless oil (904 mg, 94%). 
1
H-NMR (300 MHz, CDCl3): δ = 7.48 - 7.52 (m, 1H), 7.61 (dd, J = 8.2 Hz, 1.6 Hz, 1H), 7.97 
(dd, J = 7.8 Hz,1.6 Hz, 1H), 10.48 ppm (s, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 118.8 (d, JF-C = 320.6 Hz, CF3), 128.2, 128.4, 131.1, 
129.1, 134.7, 146.4, 188.0 ppm. 
19
F{
1
H}-NMR (282 MHz, CDCl3): δ = -73.2 ppm. 
HRMS calcd. for C8H4Cl1F3O4S
+
: 287.947094 [M]
+
; found: 287.947140. 
IR: ῦ = 708, 745, 774, 798, 826, 949, 1052, 1134, 1165, 1209, 1388, 1427, 1460, 
1568, 1594, 1702, 1777, 2877, 3091 cm
-1
. 
2-Chlorobiphenyl-3-carbaldehyde 135c 
A two neck-flask equipped with a reflux condenser was charged with 2-
Chloro-3-formylphenyl trifluoromethanesulfonate 135b (400 mg, 
1.39 mmol), phenylboronic acid (169 mg, 1.39 mmol), potassium 
phosphate (588 mg, 2.72 mmol) and palladium(II) acetate as catalyst 
(15. 6 mg, 0.069 mmol). A THF/water solution (9 mL/6.2 μL) was subsequently added. Then, 
the mixture was heated to 80 °C for 20 hours. After this time, the crude reaction was filtered 
over a short pad of silica and rinsed with ethyl acetate. Removal of the solvents and 
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purification of the crude material by column chromatography on silica gel (gradient hexane to 
hexane/ethyl acetate (15/1)) afforded 135c as a white solid (75 mg, 25 %). 
1
H-NMR (300 MHz, CDCl3): δ = 7.42-7.50 (m, 6H), 7.57 (dd, J = 7.5 Hz, 1.8 Hz, 1H), 7.94 
(dd, J = 7.7 Hz,1.8 Hz, 1H), 10.60 ppm (s, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 127.1, 128.3, 128.4, 128.6 , 129.6, 133.4 , 136.4, 
136.8, 138.4, 142.5, 190.6 ppm. 
HRMS calcd. for C13H9ClO
+
: 216.034192 [M]
+
; found: 216.033995. 
IR: ῦ = 698, 726, 757, 768, 800, 918, 972, 1028, 1042, 1072, 1109, 1159, 1173, 1239, 1268, 
1301, 1336, 1380, 1421, 1447, 1457, 1479, 1569, 1603, 1682, 1710, 1728, 1813, 1979, 2884, 
3015, 3056 cm
-1
. 
6.5.5.2 Synthesis of Biphenyl-carbaldehydes  
 
General procedure E: A suspension of the aldehyde 135, boronic acid 172 (1.1 equiv.), 
palladium acetate (0.02 equiv.) and potassium carbonate (2.5 equiv.) was prepared in a 
THF/water mixture (9/1, c(aldehyde) = 0.16 M) and was stirred overnight at room 
temperature. After that, the mixture was diluted with water and ethyl acetate was added to 
extract (3x) the aqueous phase. The combined organic phases were washed with brine (1x) 
and dried over sodium sulfate. Removal of the solvents in vacuo yielded a residue, which was 
purified by column chromatography on silica gel affording the desired product 136. 
General procedure F: A two neck flask equipped with a reflux condenser was charged with 
the corresponding aldehyde 135 (1.0 equiv.), boronic acid 172 (1.5 equiv.), 
tris(dibenzylideneaceton)dipalladium (0.032 equiv.), tricyclohexylphosphine (0.074 equiv.), 
cesium carbonate (1.7 equiv.) and a toluene/1,4-dioxane mixture (3/2, c(aldehyde) = 0.5 M). 
The suspension thus obtained was heated to 85°C for 24 hours and after that time it was 
filtered through a pad of Celite
®
. Removal of the solvents in vacuo afforded a crude material 
that was purified by column chromatography.  
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2'-Methylbiphenyl-2-carbaldehyde 136b 
Compound 136b was prepared according to general procedure E from 2-bromo-
benzaldehyde 135g (0.31 mL, 2.65 mmol) and o-tolylboronic (400 mg, 2.94 
mmol. The crude material thus obtained was purified by column chromatography 
on silica gel (hexanes/EtOAc, 9/1) affording 136b as a yellow oil (327 mg, 63%). 
1
H-NMR (400 MHz, CDCl3): δ = 2.10 (s, 3H), 7.19 (dd, J = 7.5, 1.2 Hz, 1H), 
7.25 (dd, J = 7.1, 1.4 Hz, 1H), 7.28-7.36 (m, 3H), 7.470-7.52 (m, 1H), 7.64 (td, J = 7.5, 
1.5 Hz, 1H), 8.03 (dd, J = 7.7, 1.2 Hz, 1H), 9.74 ppm (d, J = 0.8 Hz, 1H). 
The found spectral data were in agreement with those reported in the literature.
[79] 
 
2'-Phenyl-biphenyl-2-carbaldehyde 136c 
Compound 136c was prepared according to general procedure E from 2-
bromo-benzaldehyde 135g (0.19 mL, 300 mg, 1.62 mmol) and 2-biphenyl 
boronic acid (353 mg, 1.78 mmol). In this case a N,N-DMF/water solvent 
mixture (5/1, 10 mL) was employed. The crude material thus obtained was 
purified by column chromatography on silica gel (hexanes/ethyl acetate, 95/5) 
affording 136c as a pale yellow solid (370 mg, 88%). 
1H-NMR (300 MHz, CD2Cl2): δ = 7.04-7.12 (m, 2H), 7.15-7.23 (m, 3H), 7.29-7.59 (m, 7H), 
7.73-7.80 (m, 1H), 9.76 ppm (d, J= 0.9 Hz, 1H). 
The found spectral data were in agreement with those reported in the literature.
[80] 
2'-Isopropyl-[1,1'-biphenyl]-2-carbaldehyde 136h 
Compound 136h was prepared according to general procedure E from 2-
bromo-benzaldehyde 135g (222 mg, 1.2 mmol) and (2-iso-
propylphenyl)boronic acid (216 mg, 1.32 mmol). The crude material thus 
obtained was purified by column chromatography on silica gel (hexanes) 
affording 136h as a colorless oil (254 mg, 94%). 
1
H-NMR (300 MHz, CDCl3):δ = 1.02 (d, J = 6.9 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H), 2.67 
(hept, J = 6.9 Hz, 1H), 7.07 (dt, J = 7.4, 0.9 Hz, 1H), 7.12 - 7.20 (m, 1H), 7.24 (dd, J = 7.6, 
0.8 Hz, 1H), 7.31 - 7.38 (m, 2H), 7.43 (tt, J = 7.5, 1.1 Hz, 1H), 7.55 (td, J = 7.5, 1.5 Hz, 1H), 
7.95 (dd, J = 7.8, 1.2 Hz, 1H), 9.69 (d, J = 0.7 Hz, 1H) ppm.  
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13
C{
1
H}-NMR (75 MHz, CDCl3):δ = 23.5, 24.5, 30.2, 125.4, 125.7, 127.1, 127.9, 128.8, 
130.4, 131.1, 133.6, 134.3, 136.3, 145.8, 147.2, 192.4 ppm.  
HRMS calcd. for C17H16NaO
+
: 247.108915 [M+Na]
+
; found: 247.109335. 
IR: ῦ = 715, 755, 825, 1004, 1033, 1193, 1251, 1389, 1442, 1473, 1596, 1692, 2747, 2868, 
2927, 2961, 3023, 3060 cm
-1
. 
2',6-Dimethylbiphenyl-2-carbaldehyde 136f 
A microwave vial was charged with 2-bromo-3-methylbenzaldehyde 135a 
(250 mg, 1.26 mmol), 2-tolyl boronic acid (187.9 mg, 1.39 mmol), 
tetrakis(triphenylphosphine)palladium (14.6 mg, 1.26 µmol), sodium carbonate 
(267.1 mg, 2.52 mmol) and a 1,4-dioxane/water mixture (3/2, 1.4 mL). The 
vessel was sealed with a Teflon crimp top and the suspension was heated to 
120 °C under microwave irradiation for 25 minutes. After this time the mixture was diluted 
with water and ethyl acetate was added to extract (4x) the aqueous phase. Then, the combined 
organic phases were washed with brine (1x), dried over sodium sulfate and the solvent 
removed in vacuo. The crude material thus obtained was purified by column chromatography 
on silica gel (pentane/MTBE, 30/1) affording 136f as a colorless oil (97%, 257.3 mg). 
1
H-NMR (300 MHz, CDCl3): δ = 1.93 (s, 3H), 1.98 (s, 3H), 7.04 (d, J = 7.2 Hz, 1H), 7.18 - 
7.28 (m, 3H), 7.34 (t, J = 7.6 Hz, 1H), 7.45 - 7.58 (m, 1H), 7.80 (dd, J = 7.7, 0.7 Hz, 1H), 
9.55 ppm (d, J = 0.8 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 19.6, 20.0, 124.8, 126.1, 127.8, 128.3, 129.8, 130.2, 
134.2, 135.7, 136.3, 136.5, 137.4, 145.2, 192.8 ppm.  
HRMS calcd. for C15H14O
+
: 210.104454 [M]
+
; found: 210.104462. 
IR: ῦ = 730, 759, 781, 918, 1006, 1120, 1214, 1235, 1381, 1458, 1491, 1591, 1684, 1739, 
2856, 2921, 3017 cm
-1
. 
6-Methyl-2'-phenyl-biphenyl-2-carbaldehyde 136i 
A microwave vial was charged with 2-bromo-3-methylbenzaldehyde 135a 
(200 mg, 1.0 mmol), 2-biphenylboronic acid (218.9 mg, 1.1 mmol), 
tetrakis(triphenyl-phosphine)palladium (11.6 mg, 0.01 mmol), sodium 
carbonate (212 mg, 2.0 mmol) and a 1,4-dioxane/water mixture (3/2, 1.1 mL) 
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was added. The vessel was sealed with a Teflon crimp top and the suspension was heated to 
120 °C under microwave irradiation for 25 minutes. After this time, the mixture was diluted 
with water and ethyl acetate was added (4x) to extract the aqueous phase. The combined 
organic phases were then washed with brine (1x), dried over sodium sulfate and the solvents 
removed in vacuo. The crude material thus obtained was purified by column chromatography 
on silica gel (hexanes) affording 136i as a colorless oil (204 mg, 75%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.90 (s, 3H), 6.86-6.93 (m, 2H), 6.96-7.02 (m, 3H), 7.09-
7.16 (m, 2H), 7.21 (dd, J = 7.5, 0.7 Hz, 1H), 7.26-7.33 (m, 1H), 7.34-7.38 (m, 2H), 7.59 (dd, J 
= 7.7, 0.8 Hz, 1H), 9.63 ppm (d, J = 0.7 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 20.0, 124.8, 126.9, 127.3, 127.6, 128.0, 128.6, 129.0, 
130.2, 131.0, 134.3, 135.0, 135.4, 137.4, 140.6, 141.8, 144.6, 192.4 ppm. 
HRMS calcd. for C20H16O
+
: 272.119921 [M]
+
; found: 272.120111. 
IR: ῦ = 699, 715, 747, 781, 921, 1008, 1074, 1116, 1162, 1239, 1448, 1459, 1480, 1591, 
1686, 2744, 2852, 3058 cm
-1
. 
6-Phenyl-2'-phenyl-biphenyl-2-carbaldehyde 136j 
Compound 136j was prepared according to general procedure F from 2-
chlorobiphenyl-3-carbaldehyde 135c (190 mg, 0.87 mmol) and 2-
biphenylboronic acid (260.5 mg, 1.31 mmol). The crude material thus obtained 
was purified by column chromatography on silica gel (hexanes/ethyl acetate, 
15/1) affording 136j as a white solid (179 mg, 61%). 
1
H-NMR (300 MHz, CDCl3): δ = 6.60 - 6.65 (m, 4H), 7.01-7.16 (m, 6H), 7.24-7.27 (m, 1H), 
7.31 - 7.50 (m, 5H), 7.98 (dd, J = 7.3, 1.8 Hz, 1H), 9.97 ppm (s, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 126.5, 126.7, 126.8, 127.7, 127.7, 128.1, 128.7, 129.4, 
129.6, 130.4, 133.3, 134.3, 135.2, 135.7, 139.9, 140.3, 142.1, 142.5, 143.5, 192.9 ppm. 
HRMS calcd. for C25H18O
+
: 334.135767 [M]
+
; found: 334.135729. 
IR: ῦ = 696, 715, 745, 764, 807, 866, 910, 951, 982, 1008, 1026, 1075, 1117, 1158, 1181, 
1231, 1263, 1294, 1329, 1386, 1425, 1434, 1448, 1456, 1480, 1497, 1570, 1584, 1687, 1731, 
1805, 1903, 1954, 2746, 2803, 2852, 3029, 3057 cm
-1
. 
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6-Fluoro-2'-methylbiphenyl-2-carbaldehyde 136k 
A microwave vial was charged with 2-bromo-3-fluorobenzaldehyde (150 mg, 
0.72 mmol), 2-methyl-phenyl boronic acid (126.8 mg, 0.93 mmol), 
tetrakis(triphenylphosphine)palladium(0) (49.7 mg, 0.043 mmol) as catalyst, 
potassium carbonate (240.8 mg, 1.8 mmol) and a 1,4-dioxan/water mixture 
(4/1, 3.0 mL). The vessel was sealed with a Teflon crimp top and the 
suspension heated to 110 °C under microwave irradiation for 2.5 hours. After this time, the 
suspension was filtered over a short pad of silica gel and rinsed with DCM. Removal of the 
solvents in vacuo gave a crude residue which was purified by column chromatography on 
silica gel (hexanes) affording 136k as a yellow oil (113 mg, 71%). 
1
H-NMR (300 MHz, CDCl3): δ = 2.13 (s, 3H), 7.19 (dd, J = 7.4 Hz, 1.1 Hz, 1H), 7.29 (td, 
J = 7.3 Hz, 7.3, 1.6 Hz, 1H), 7.33-7.38 (m, 2H), 7.40-7.42 (m, 1H), 7.47-7.53 (m, 1H), 7.84 
(dd, J = 7.7 Hz, 1.1 Hz, 1H), 9.68 ppm (dd, J = 0.92 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 20.3, 121.1 (d, JF-C = 22.6 Hz), 123.2 (d, JF-
C = 3.0 Hz), 125.9, 129.1, 129.4 (d, JF-C = 8.2 Hz), 130.4, 130.4, 132.7 (d, JF-C = 21.6 Hz), 
131.0, 135.9 (d, JF-C = 2.0 Hz), 137.4, 159.9 (d, JF-C = 247.6 Hz), 191.2 ppm (d, JF-C = 3.9 
Hz).  
19
F{
1
H}-NMR(282 MHz, CDCl3): δ = -14.3 ppm.
HRMS calcd. for C14H11FO
+
: 214.079396 [M]
+
; found: 214.079586. 
IR: ῦ = 695, 729, 739, 761, 782, 796, 870, 907, 942, 959, 1007, 1036, 1073, 1120, 1158, 
1240, 1258, 1288, 1389, 1458, 1496, 1569, 1609, 1693, 2750, 2858, 2928, 3012, 3064 cm
-1
. 
2'-Iso-propyl-6-methylbiphenyl-2-carbaldehyde 136l 
Compound 136l was prepared according to general procedure E from 2-
bromo-3-methylbenzaldehyde 135a (100 mg, 0.5 mmol) and 2-iso-propyl-
phenyl boronic acid (90.2 mg, 0.55 mmol). The crude material thus obtained 
was purified by column chromatography on silica gel (hexanes) affording 136l 
as a white solid (98 mg, 66%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.92 (d, J = 6.9 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H), 1.97 (s, 
3H), 2.44 (hept, J = 6.9 Hz, 1H), 6.96 (dd, J = 7.7, 0.9 Hz, 1H), 7.16 (ddd, J = 7.6, 6.7, 2.0 
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Hz, 1H), 7.26 - 7.39 (m, 3H), 7.43 (dd, J = 7.5, 0.4 Hz,1H), 7.78 (dd, J = 7.7, 0.4 Hz, 1H), 
9.56 ppm (d, J = 0.6 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 20.0, 23.6, 24.1, 30.3, 124.7, 125.9, 127.7, 128.7, 
129.8, 134.6, 135.0, 135.5, 137.7, 145.1, 147.1, 192.8, 192.8 ppm.  
HRMS calcd. for C17H18O
+
: 238.135875 [M]
+
; found: 238.135768. 
IR: ῦ = 716, 756, 787, 920, 1004, 1034, 1127, 1216, 1234, 1362, 1382, 1443, 1460, 1591, 
1687, 1740, 2867, 2960 cm
-1
. 
4-Hydroxy-2'-methoxybiphenyl-2-carbaldehyde 136m 
Compound 136m was prepared according to general procedure E from 2-
bromo-5-hydroxybenzaldehyde (387 mg, 1.92 mmol) and 2-
methoxyphenylboronic acid (380 mg, 2.50 mmol). In this case a DMF/water 
solvent mixture (5/1, 12.0 mL) was employed instead. Heating to 50 °C was 
necessary to achieve full conversion. The crude material thus obtained was 
purified by column chromatography on silica gel (hexanes/ethyl acetate, 7/3) 
affording 136m as a pale yellow solid (328 mg, 75%). 
1
H-NMR (400 MHz, CDCl3): δ = 3.74 (s, 3H), 5.88 (s, J = 2.8 Hz, 1H), 6.97 (d, J = 8.2 Hz, 
1H), 7.07 (td, J = 7.73, 0.3 Hz, 1H), 7.18 (dd, J = 9.7, 1.4 Hz, 1H), 7.26 (1xCHAr under 
solvent signal), 7.28 (s, 1H), 7.38-7.42 (m, 1H), 7.52 (d, J = 2.8 Hz, 1H), 9.70 ppm (s, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 55.5, 110.7, 112.5, 121.1, 121.6, 126.4, 129.9, 131.7, 
132.9, 134.6, 134.8, 155.6, 156.6, 193.2 ppm. 
HRMS calcd. for C14H12NaO3
+
: 251.067864 [M+Na]
+
; found: 251.067890. 
IR: ῦ = 441, 458, 503, 529, 544, 574, 586, 615, 703, 719, 772, 798, 828, 859, 875, 928, 955, 
977, 1020, 1052, 1091, 1124, 1162, 1178, 1225, 1272, 1311, 1347, 1413, 1430, 1446, 1469, 
1486, 1504, 1600, 1674, 2848, 2921, 2951, 3010, 3057, 3343 cm
-1
. 
6-Methoxy-2'-methylbiphenyl-2-carbaldehyde 136n 
Compound 136n was prepared according to general procedure F from 2-
chloro-3-methoxy-benzaldehyde (200 mg, 1.17 mmol) and 2-methyl-
phenylboronic acid (239 mg, 1.76 mmol. The crude material thus obtained 
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was purified by column chromatography on silica gel (hexanes/ethyl acetate 15/1) affording 
136n as a yellow solid (182 mg, 69%). 
1
H-NMR (300 MHz, CDCl3): δ= 2.06 (s, 3H), 3.78 (s, 3H), 7.11-7.14 (m, 1H), 7.20 (dd, 
J = 8.1 Hz, 0.8 Hz, 1H), 7.23 - 7.36 (m, 3H), 7.47 (td, J = 8.0 Hz, 8.0 Hz, 0.6 Hz, 1H), 7.63 
(dd, J = 7.8 Hz, 1H), 9.62 ppm (d, J = 0.7 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 20.2, 56.4, 116.3, 119.1, 125.7, 128.4, 128.9, 130.0, 
131.0, 133.3, 134.9, 135.4, 137.5, 157.5, 192.6 ppm. 
HRMS calcd. for C15H14NaO2
+
: 249.088595 [M+Na]
+
; found: 249.088542. 
IR: ῦ =729, 744, 762, 794, 911, 943, 983, 1003, 1067, 1119, 1185, 1240,  1262, 1298, 1389, 
1467, 1494, 1575, 1592, 1682, 1697, 2341, 2742, 2837, 2948, 3011, 3067 cm
-1
. 
6-Methoxy-2'-phenyl-biphenyl-2-carbaldehyde 136o 
Compound 136o was prepared according to general procedure F from 2-
chloro-3-methoxy-benzaldehyde (713 mg, 4.18 mmol) and 2-
biphenylboronic acid (1.2 g, 6.27 mmol). The crude material thus obtained 
was purified by column chromatography on silica gel (hexanes/ethyl 
acetate 7/1) affording 136o as a yellow solid (1.18 g, 98%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.60 (s, 3H), 6.99-7.15 (m, 6H), 7.15-7.27 (m, 2H), 7.41-
7.49 (m, 4H), 9.74 ppm (m, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 55.8, 115.9, 119.2, 126.9, 127.1, 127.9, 128.6, 128.9, 
129.0, 129.9, 132.0, 132.1, 134.7, 135.2, 141.3, 143.0, 157.2, 192.2 ppm. 
HRMS calcd. for C20H16NaO2
+
: 311.104249 [M+Na]
+
; found: 311.103990. 
IR: ῦ = 699, 715, 748, 778, 798, 880, 912, 1000, 1009, 1066, 1114, 1156, 1185, 1239, 1260, 
1301, 1387, 1437, 1463, 1483, 1574, 1592, 1684, 1947, 2750, 2837, 2857, 2938, 2960, 3011, 
3055 cm
-1
. 
2'-Isopropyl-6-methoxybiphenyl-2-carbaldehyde 136p 
Compound 136p was prepared according to general procedure F from 2-
chloro-3-methoxy-benzaldehyde (200 mg, 1.17 mmol) and 2-iso-propyl-
phenyl boronic acid (288 mg, 1.76 mmol. The crude material thus obtained 
6. Experimental Part                                                                                                                   .  
 
108 
was purified by column chromatography on silica gel (hexanes/ethyl acetate 15/1) affording 
136p as a yellow solid (208 mg, 70%). 
1
H-NMR (300 MHz, CDCl3): δ = 1.01 (d, J = 6.9 Hz, 3H), 1.17 (d, J = 6.9, 3H), 2.61 (hept., 
J = 6.9 Hz, 1H), 3.76 (s, 3H), 7.05-7.08 (m, 1H), 7.18 (dd, J = 8.1 Hz, 1.0 Hz, 1H), 7.19-7.26 
(m, 1H), 7.40-7.41 (m, 1H), 7.41(d, J = 1.0 Hz, 1H), 7.46 (td, J = 8.0 Hz, 0.8 Hz, 1H), 7.62 
(dd, J = 7.9 Hz, 1.2 Hz, 1H), 9.64 ppm (d, J = 0.8 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 23.6, 24.1, 30.7, 56.0, 115.8, 119.0, 125.5, 125.6, 
128.8, 130.9, 131.9, 134.9, 135.7, 148.2, 157.4, 192.5 ppm. 
HRMS calcd. for C17H18O2
+
: 254.130677 [M]
+
; found: 254.130555. 
IR: ῦ = 666, 716, 744, 755, 784, 794, 872, 912, 949, 1002, 1035, 1066, 1098, 1168, 1186, 
1201, 1240, 1259, 1301, 1345, 1362, 1389, 1436, 1467, 1492, 1576, 1592, 1688, 1925, 1948, 
1979, 2837, 2867, 2961, 3018, 3064 cm
-1
. 
2',3',4',6-Tetramethoxybiphenyl-2-carbaldehyde 136g 
Compound 136g was prepared according to general procedure F from 2-
chloro-3-methoxy-benzaldehyde (226 mg, 1.32 mmol) and 2,3,4-tri-
methoxy-phenyl boronic acid (421 mg, 1.98 mmol). The crude material was 
purified by column chromatography on silica gel (hexanes/ethyl acetate, 
2/1) affording 136g as a yellow solid (386 mg, 97%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.64 (s, 3H), 3.80 (s, 3H), 3.91 (s, 3H), 3.92 (s, 3H), 6.76 
(d, J = 8.7 Hz, 1H), 6.88 (d, J = 8.7 Hz, 1H), 7.20 (dd, J = 8.3 Hz, 0.9 Hz, 1H) 7.44 (td, 
J = 8.0, 0.7 Hz, 1H), 7.61 (dd, J = 7.8 Hz, 1.1 Hz, 1H), 9.70 ppm (d, J = 0.8 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 56.1, 56.1, 60.7, 61.0, 107.1, 115.9, 119.0, 119.8, 
126.5, 128.7, 131.2, 135.6, 142.3, 152.1, 154.0, 157.6, 192.6 ppm. 
HRMS calcd. for C17H18NaO4
+
: 325.104643 [M+Na]
+
; found: 325.104246. 
IR: ῦ = 667, 689, 719, 744, 771, 788, 795, 815, 867, 916, 1001, 1012, 1071, 1091, 1111, 
1167, 1181, 1203, 1242, 1257,1289, 1395, 1409,1428, 1462, 1501, 1578, 1592, 1681, 1693, 
1874, 1977, 2163, 2761, 2838, 2868, 2939, 2977 cm
-1
. 
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6-Fluoro-2',3',4'-trimethoxybiphenyl-2-carbaldehyde 136q 
A microwave vial was charged with 2-bromo-3-fluorobenzaldehyde (150 mg, 
0.72 mmol), 2,3,4-tri-methoxy-phenylboronic acid (197.8 mg, 0.93 mmol), 
tetrakis(triphenylphosphine)palladium (49.7 mg, 0.043 mmol), potassium 
carbonate (240.8 mg, 1.8 mmol) and a 1,4-dioxan/water mixture (4/1, 
3.0 mL). The vessel was sealed with a Teflon crimp top and the suspension 
was heated to 110 °C under microwave irradiation for 2.5 hours. After this 
time, the suspension was filtered over a short pad of silica gel and rinsed with DCM. Removal 
of the solvent in vacuo afforded a crude residue, which was purified by column 
chromatography on silica gel (pentane/MTBE, 6/1) affording 136q as a yellow oil (200 mg, 
95%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.67 (s, 3H), 3.91 (s, 3H), 3.92 (s, 3H), 6.78 (d, J = 8.6 Hz, 
1H), 6.95 (dd, J = 8.5, 1.0 Hz, 1H), 7.34-7.49 (m, 2H), 7.81 (ddd, J = 7.7, 1.3, 0.3 Hz, 1H), 
9.77 ppm (d, J = 0.8 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ =56.3, 61.0, 61.2, 107.4, 117.0, 120.8 (d, JF-C = 23.4 Hz), 
123.0 (d, JF-C = 3.6 Hz), 126.5 (d, JF-C = 1.5 Hz), 129.2 (d, JF-C = 8.3 Hz), 130.2, 136.2 (d, JF-
C = 2.3 Hz), 142.6, 152.2, 154.6, 160.3 (d, JF-C = 242.3 Hz), 191.3 ppm (d, JF-C = 4.2 Hz). 
19
F{
1
H}-NMR(282 MHz, CDCl3): δ = -14.6 ppm. 
HRMS calcd. for C16H15FNaO4
+
: 313.0084461 [M+Na]
+
; found: 313.084409. 
2’,6-Di-methoxy-biphenyl-2-carbaldehyde 136r 
Compound 136r was prepared according to general procedure F from  
2-chloro-3-methoxy-benzaldehyde (713 mg, 4.18 mmol) and 2-
methoxyphenylboronic acid (952.8 mg,  6.27 mmol). The crude material thus 
obtained was purified by column chromatography on silica gel (hexanes/ethyl 
acetate 10/1) affording 136r as a yellow solid (890 mg, 88%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.73 (s, 3H), 3.78 (s, 3H), 7.00 (d, J = 8.6 Hz, 1H), 7.05 
(td, J = 7.6, 0.9 Hz, 1H), 7.20-7.25 (m, 2H), 7.39-7.44 (m, 1H), 7.46 (dd, J = 7.8, 0.4 Hz, 1H), 
7.63 (dd, J = 7.8, 1.1 Hz, 1H), 9.70 ppm (d, J = 0.8 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 55.6, 56.2, 111.0, 116.4, 118.9, 120.5, 122.1, 128.8, 
129.9, 131.4, 132.6, 135.4, 157.3, 157.4, 192.9 ppm. 
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HRMS calcd. for C15H14NaO3
+
: 265.083511 [M+Na]
+
; found: 265.083381. 
IR: ῦ = 725, 756, 793, 852, 908, 939, 975, 1000, 1023, 1050, 1061, 1093, 1122, 1162, 1178, 
1230, 1248, 1260, 1290, 1395, 1432, 1460, 1495, 1574, 1591, 1677, 1965, 2048, 2835, 2934, 
2958, 3005, 3023, 3083 cm
-1
. 
6.5.5.3 Peparation of the corresponding alkynes 
General procedure G: Ohira-Bestmann variant of the Seyferth-Gilbert alkynylation 
 
Dimethyl (1-diazo-2-oxopropyl)phosphonate (Ohira-Bestmann reagent) 173 (1.5 equiv.), 
potassium carbonate (2 equiv.) and the corresponding aldehyde 136 (1.0 equiv.) were 
suspended in methanol (c(aldehyde) = 0.13 M) and stirred overnight at room temperature. 
Subsequently, the solvent was removed in vacuo and the residue obtained dissolved in ethyl 
acetate and washed with brine (3x). Then, the organic phase was dried over sodium sulfate 
and the solvent was removed in vacuo yielding the crude product 104. Purification of this 
material by column chromatography on silica gel afforded 104. 
2-Ethynyl-2'-methyl-biphenyl 104b 
Compound 104b was prepared according to general procedure G from 
carbaldehyde 136b (327 mg, 1.67 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 12/1) afforded 104b as a white solid (223 mg, 94%). 
1
H -NMR (400 MHz, CDCl3): δ = 2.24 (s, 3H), 2.96 (s, 1H), 7.23-7.36 
(m, 5H), 7.38 (dd, J = 7.5, 1.6 Hz, 1H), 7.45 (td, J = 7.5, 1.5 Hz, 1H), 7.66 ppm (dd, J = 7.6, 
1.3 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 20.1, 79.9, 82.8, 121.9, 125.5, 127.1, 127.8, 128.7, 
129.7, 129.8, 129.9, 133.0, 136.3, 140.6, 145.1 ppm. 
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HRMS calcd. for C15H12
+
: 192.093896 [M]
+
; found: 192.094011. 
IR: ῦ = 725, 745, 755, 875, 950, 1005, 1042, 1101, 1122, 1159, 1264, 1378, 1438, 1456, 
1472, 1495, 1595, 3019, 3060, 3283 cm
-1
. 
2-Ethynyl-2'-phenyl-biphenyl 104c 
Compound 104c was prepared according to general procedure G from 
carbaldehyde 136c (370 mg, 1.43 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 95/5) afforded 104c as a white solid (350 mg, 96%). 
1
H-NMR (400 MHz, CDCl3): δ = 2.95 (s, 1H), 6.99-7.02 (m, 1H), 7.13-7.21 (m, 7H), 7.38-
7.49 ppm (m, 5H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 80.4, 83.1, 122.0, 126.6, 126.8, 126.9, 127.8, 128.1, 
128.3, 129.9, 130.2, 131.0, 131.1, 133.1, 139.2, 141.4, 141.4, 144.8 ppm. 
HRMS calcd. for C20H14
+
: 254.109546 [M]
+
; found: 254.109501. 
IR: ῦ = 698, 742, 756, 770, 913, 948, 1008, 1073, 1159, 1240, 1265, 1429, 1449, 1467, 1488, 
1597, 1735, 3020, 3057, 3283 cm
-1
. 
2-Ethynyl-2'-iso-propyl-biphenyl 104h 
Compound 104h was prepared according to general procedure G from 
carbaldehyde 136h (200 mg, 0.89 mmol Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 95/5) afforded 104h as a white solid (167 mg, 85%). 
1
H-NMR (300 MHz, CDCl3): δ = 1.00 (d, J = 6.9 Hz, 3H), 1.12 (d, J = 6.9 Hz, 3H), 2.73 
(hept, J = 6.9 Hz, 1H), 2.82 (s, 1H), 7.03-7.10 (m, 1H), 7.10-7.20 (m, 2H), 7.20-7.38 (m, 4H), 
7.51 (dd, J = 7.6, 1.4 Hz, 1H) ppm. 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 23.6, 24.6, 30.1, 80.3, 82.9, 122.2, 125.2, 125.3, 127.0, 
128.2, 128.5, 129.8, 130.0, 132.9, 139.6, 145.2, 146.9 ppm.  
HRMS calcd. for C17H16: 220.125307 [M]
+
; found:220.125200. 
IR: ῦ = 665, 747, 757, 1004, 1031, 1043, 1089, 1105, 1203, 1257, 1330, 1364, 1385, 1433, 
1446, 1470, 2867, 2961, 3020, 3057, 3267 cm
-1
. 
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2-Ethynyl-2',6-dimethylbiphenyl 104f 
Compound 104f was prepared according to general procedure G from 
carbaldehyde 136f (228.6 mg, 1.09 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (pentane) afforded 
104f as a colorless oil (210.7 mg, 94%). 
1
H-NMR (300 MHz, CDCl3): δ = 1.91 (s, 3H), 1.96 (s, 3H), 2.72 (s, 1H), 6.96-7.02 (m, 1H), 
7.09-7.20 (m, 5H), 7.35 ppm (dd, J = 7.3, 1.3 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 19.6, 20.4, 79.5, 82.9, 122.1, 125.8, 127.1, 127.6, 
129.1, 129.9, 130.5, 130.6, 136.0, 136.6, 139.8, 144.5 ppm. 
HRMS calcd. for C16H14
+
: 206.109326 [M]
+
; found: 206.109547. 
IR: ῦ =727, 746, 756, 785, 915, 1006, 1120, 1268, 1379, 1454, 1489, 1574, 2921, 3016, 3061, 
3286 cm
-1
. 
2-Ethynyl-6-methyl-2'-phenyl-biphenyl 104i 
Compound 104i was prepared according to general procedure G from 
carbaldehyde 136i (204 mg, 0.75 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes) affording 
104i as a white solid (158 mg, 78%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.88 (s, 3H), 2.96 (s, 1H), 7.08 (d, J = 7.6 
Hz, 1H), 7.15 (t, J = 7.6 Hz, 1H), 7.19 - 7.25 (m, 5H), 7.29-7.32 (m, 1H), 7.40-7.47 (m, 2H), 
7.49-7.51 ppm (m, 2H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 20.5, 80.3, 83.6, 122.8, 126.7, 127.0, 127.2, 127.7, 
127.9, 129.2, 130.0, 130.3, 130.4, 130.6, 136.6, 138.4, 141.4, 141.4, 144.3 ppm.  
HRMS calcd. for C21H16
+
: 268.125101 [M]
+
; found: 268.125200. 
IR: ῦ = 668, 698, 742, 749, 757, 772, 915, 952, 1008, 1074, 1105, 1159, 1262, 1428, 1449, 
1468, 1488, 1598, 1967, 3059, 3270 cm
-1
. 
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2-Ethynyl-2',6-diphenyl-biphenyl 104j 
Compound 104j was prepared according to general procedure G from 
carbaldehyde 136j (135 mg, 0.40 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 20/1) affording 104j as a white solid (115 mg, 85%). 
1
H-NMR (300 MHz, CDCl3): δ = 2.99 (s, 1H), 6.48-6.52 (m, 2H), 6.58-6.61 (m, 2H); 6.93-
7.14 (m, 8H), 7.24 (d, J = 1.6 Hz, 1H), 7.28-7.38 (m, 2H), 7.49-7.52 (m, 1H), 7.58 ppm (dd, 
J = 7.5 Hz, 1.4 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 80.9, 83.6, 123.6, 126.3, 126.4, 126.4, 127.3, 127.4, 
127.4, 128.0, 129.4, 129.6, 129.9, 130.7, 132.1, 132.7, 137.6, 140.5, 141.0, 141.5, 142.0, 
143.1 ppm. 
HRMS calcd. for C26H18
+
: 330.140849 [M]
+
; found: 330.140613. 
IR: ῦ = 654, 671, 697, 730, 741, 749, 760, 810, 854, 910, 966, 979, 1008, 1027, 1073, 1092, 
1115, 1157, 1182, 1253, 1284, 1419, 1434, 1455, 1481, 1496, 1578, 1597, 1748, 1804, 1819, 
1881, 1900, 1947, 3029, 3056, 3278 cm
-1
. 
2-Ethynyl-6-fluoro-2'-methylbiphenyl 104k 
Compound 104k was prepared according to general procedure G from 
carbaldehyde 136k (61.7 mg, 0.29 mmol). Purification of the crude product 
was performed by column chromatography on silica gel 
(hexanes/ethylacetate, 40/1) affording 104k as a white solid (33 mg, 54%). 
1
H-NMR (300 MHz, CDCl3): δ =2.10 (s, 3H), 2.86 (s, 1H), 7.06-7.25 (m, 6H), 7.35 (d, 
J = 7.5 Hz, 1H) ppm. 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ =19.8, 80.9, 81.5 (d, JF-C = 4.6 Hz), 116.4 (d, JF-
C = 23.1 Hz), 124.3 (d, JF-C = 5.0 Hz), 125.6, 128.4, 128.8 (d, JF-C = 9.0 Hz), 128.9 (d, JF-
C = 3.4 Hz), 130.0, 130.2, 132.3 (d, JF-C = 19.5 Hz), 133.7, 137.0, 159.7 (d, JF-C = 246.1 Hz) 
ppm.  
19
F{
1
H}-NMR (282 MHz, CDCl3):δ = -113.2 ppm.
HRMS calcd. for C15H11F: 210.084479 [M]
+
; found: 210.084303. 
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IR: ῦ = 724, 737, 760, 794, 940, 960, 1008, 1034, 1074, 1120, 1159, 1250, 1379, 1452, 1494, 
1564, 1601, 1608, 2861, 2928, 3019, 3063, 3293 cm
-1
. 
2-(Prop-1-ynyl)-1,1'-binaphthyl 137a 
To a solution of 2-ethynyl-1,1'-binaphthyl 104a (250 mg, 0.90 mmol) in 
THF (5.8 mL) at -10 °C, n-BuLi (1.4 mL, 2.25 mmol, c = 1.6 M in 
hexane) was added dropwise over 30 minutes. The mixture was then 
stirred for 1.5 h at this temperature and then iodomethane (0.15 mL, 
331.5 mg, 2.33 mmol) was added dropwise over 30 minutes at -20 °C. 
After 2 hours under these conditions, the solution was warmed to room temperature and 
stirred for an additional hour. Then, the solvents were removed in vacuo and the crude 
product purified by column chromatography on silica gel (hexanes) affording 136a as a 
colorless solid (185 mg, 70%).
 
1
H-NMR (400 MHz, CDCl3): δ = 1.66 (s, 3H), 7.22-7.24 (m, 2H), 7.28-7.30 (m, 2H), 7.44-
7.49 (m, 3H), 7.61-7.67 (m, 2H), 7.87-7.91 (m, 2H), 7.95-7.98 ppm (m, 2H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 4.5, 79.5, 90.2, 122.1, 125.5, 125.8, 126.0, 126.2, 
126.4, 126.5, 126.9, 127.8, 128.0, 128.0, 128.2, 128.3, 129.2, 132.7, 132.7, 133.1, 133.6, 
137.1, 140.6 ppm.  
HRMS calcd. for C23H16
+
: 292.125200 [M]
+
; found: 292.125095. 
IR: ῦ = 432, 442, 508, 536, 569, 584, 614, 633, 659, 679, 689, 747, 779, 801, 818, 866, 943, 
1017, 1032, 1049, 1079, 1132, 1144, 1157, 1205, 1260, 1332, 1366, 1427, 1501, 1559, 1592, 
1617, 1703, 1769, 1814, 1923, 2226, 2846, 2912, 2962, 3053 cm
-1
. 
2-Ethynyl-2'-isopropyl-6-methyl-1,1'-biphenyl 104l 
Compound 104l was prepared according to general procedure G from 
carbaldehyde 136l (123 mg, 0.52 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 20/1) affording 104l as a white solid (107 mg, 89%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.18 (d, J = 6.9 Hz, 3H), 1.23 (d, J = 6.8 Hz, 3H), 2.08 (s, 
3H), 2.65 (hept, J = 6.9 Hz, 1H), 2.89 (s, 1H), 7.09 (dd, J = 7.6, 0.9 Hz, 1H), 7.27-7.35 (m, 
3H), 7.40-7.48 (m, 2H), 7.50 ppm (dd, J = 7.4, 0.9 Hz, 1H). 
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13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 20.7, 23.9, 24.4, 30.4, 80.1, 83.3, 122.5, 125.4, 125.7, 
127.0, 128.0, 129.2, 130.4, 130.4, 136.9, 138.5, 144.5, 146.8 ppm. 
HRMS calcd. for C18H18
+
: 234.140849 [M]
+
; found: 234.140643. 
IR: ῦ =756, 786, 1005, 1035, 1085, 1258, 1362, 1381, 1456, 1575, 2867, 2960, 3286 cm-1. 
2-Ethynyl-2'-methoxybiphenyl-4-ol 104m 
Compound 104m was prepared according to general procedure G from 
carbaldehyde 136m (328 mg, 1.43 mmol). Purification of the crude 
product was performed by column chromatography on silica gel 
(hexanes/ethyl acetate, 7/3) affording 104m as a white solid (227 mg, 
96%). 
1
H-NMR (400 MHz, CDCl3): δ = 2.91 (s, 1H), 3.79 (s, 3H), 4.83 (s, 1H), 6.87 (dd, J = 8.4, 
2.7 Hz, 1H), 6.97 (d, J = 8.3 Hz, 1H), 7.01 (dd, J = 7.4, 1.0 Hz, 1H), 7.05 (d, J = 2.7 Hz, 1H), 
7.21 (d, J = 8.4 Hz, 1H), 7.26-7.29 (m, 1H), 7.34 ppm (ddd, J = 8.2, 7.5, 1.8 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 55.7, 79.3, 82.9, 111.3, 116.3, 119.6, 120.4, 123.2, 
129.0, 129.3, 131.6, 131.8, 134.5, 154.4, 157.0 ppm. 
HRMS (negative) calcd. for C15H11O2
-
: 223.076455 [M-H]
-
; found: 223.076432. 
IR: ῦ = 675, 700, 719, 760, 793, 829, 868, 936, 946, 1004, 1015, 1050, 1101, 1122, 1160, 
1181, 1227, 1266, 1283, 1306, 1432, 1463, 1477, 1507, 1578, 1596, 2840, 3241, 3408 cm
-1
. 
2-Ethynyl-6-methoxy-2'-methylbiphenyl 104n 
Compound 104n was prepared according to general procedure G from 
carbaldehyde 136n (140 mg, 0.62 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 20/1) affording 104n as a white solid (113 mg, 82%). 
1
H-NMR (300 MHz, CDCl3): δ= 2.04 (s, 3H), 2.79 (s, 1H), 3.67 (s, 3H), 
6.90 (dd, J = 8.1, 1.1 Hz, 1H), 7.07-7.23 ppm (m, 6H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 19.8, 56.0, 79.9, 82.5, 111.7, 123.4, 125.3, 125.4, 
127.7, 128.4, 129.7, 130.2, 133.9, 136.6, 136.9, 157.0 ppm. 
HRMS calcd. for C16H14O
+
: 222.104464 [M]
+
; found: 222.104228. 
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IR: ῦ = 667, 729, 758, 795, 810, 909, 945, 967, 1004, 1068, 1120, 1159, 1171, 1186, 1260, 
1292, 1378, 1436, 1462, 1566, 1589, 1602, 1672, 1701, 1842, 1931, 2836, 2934, 2956, 3018, 
3063, 3277 cm
-1
. 
2-Ethynyl-6-methoxy-2'-phenyl-biphenyl 104o 
Compound 104o was prepared according to general procedure G from 
carbaldehyde 136o (179 mg, 0.62 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 15/1) affording 104o as a white solid (125 mg, 71%). 
1
H-NMR (300 MHz, CDCl3): δ = 2.94 (s, 1H), 3.41 (s, 3H), 6.70 (dd, J = 7.2, 2.4 Hz, 1H), 
7.11-7.18 (m, 7H), 7.35-7.45 ppm (m, 4H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 55.5, 80.5, 83.0, 111.5, 123.7, 125.1, 126.5, 127.0, 
127.4, 128.0, 128.3, 129.0, 129.5, 131.2, 134.0, 135.3, 142.0, 142.4, 156.7 ppm. 
HRMS calcd. for C21H16O
+
: 284.120115 [M]
+
; found: 284.120047. 
IR: ῦ= 672, 698, 742, 759, 779, 794, 845, 911, 948, 1008, 1065, 1117, 1159, 1187, 1265, 
1292, 1427, 1435, 1449, 1460 , 1484, 1503, 1565, 1597, 1634, 1927, 1950, 1970, 2837, 2934, 
2967, 3014, 3051, 3262 cm
-1
. 
2-Ethynyl-2'-isopropyl-6-methoxybiphenyl 104p 
Compound 104p was prepared according to general procedure G from 
carbaldehyde 136p (158 mg, 0.62 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 10/1) affording 104p as a white solid (139 mg, 89%). 
1
H-NMR (300 MHz, CDCl3): δ = 1.04 (d, J = 3.3 Hz, 3H), 1.06 (d, J = 3.3 Hz, 3H), 2.56 
(sept, J = 6.9 Hz, 1H), 2.77 (s, 1H), 3.64 (s, 3H), 6.88 (d, J = 7.9 Hz, 1H), 7.02 (d, J = 7.1 Hz, 
1H), 7.12-7.21 (m, 3H), 7.30-7.32 ppm (m, 2H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 23.7, 24.2, 30.7, 55.7, 80.3, 82.6, 111.4, 123.8, 125.0, 
125.2, 125.4, 128.1, 128.2, 130.2, 134.1, 135.4, 147.6, 157.2 ppm. 
HRMS calcd. for C18H18O
+
: 250.135768 [M]
+
; found: 250.135996. 
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IR: ῦ = 660, 731, 739, 758, 789, 909, 948, 1004, 1034, 1069, 1098, 1169, 1187, 1201, 1253, 
1293, 1343, 1361, 1381, 1431, 1461, 1493, 1569, 1591, 2834, 2863, 2958, 3019, 3060, 3263, 
3314 cm
-1
. 
2'-Ethynyl-2,3,4,6'-tetramethoxybiphenyl 104g 
Compound 104g was prepared according to general procedure G from 
carbaldehyde 136g (187 mg, 0.62 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 3/1) affording 104g as a white solid (180 mg, 97%). 
1
H-NMR (300 MHz, CDCl3): δ= 2.90 (s,1H), 3.69 (s, 3H), 3.75 (s, 3H), 
3.90 (s, 3H), 3.91 (s, 3H), 6.73 (d, J = 8.6 Hz, 1H), 6.9 (d, J = 9.1 Hz, 1H), 6.95-6.98 (m, 1H), 
7.19-7.29 ppm (m, 2H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 56.0, 56.0, 61.0, 61.0, 80.0 , 82.9, 106.9, 111.7, 123.7, 
124.0, 125.2, 125.6, 128.3, 131.0, 142.2, 152.1, 153.5, 157.5 ppm. 
HRMS calcd. for C18H18NaO4
+
: 321.109730 [M+Na]
+
; found: 321.109738. 
IR: ῦ = 690, 746, 795, 872, 920, 1004, 1070, 1092, 1115, 1169, 1206, 1261, 1296, 1410, 
1432, 1462, 1501, 1568, 1590, 2102, 2837, 2936, 3000, 3278 cm
-1
. 
2'-Ethynyl-6'-fluoro-2,3,4-trimethoxybiphenyl 104q 
Compound 104q was prepared according to general procedure G from 
carbaldehyde 136q (132.0 mg, 0.45 mmol). Once the reaction was finished, 
the crude material was purified by column chromatography on silica gel 
(hexanes/ethyl acetate, 15/1). Additional purification HPLC (Nucleodur, 15 
cm x 4.8 cm, methanol/H2O 70/30, 50 mL/min; 91.1 mg in 6 mL methanol 
and 1 mL H2O) was necessary to afford 104q in analytical purity as a white 
solid (72.7 mg, 56%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.00 (s, 1H), 3.73 (s, 3H), 3.91 (s, 3H), 3.92 (s, 3H), 6.75 
(d, J = 8.6 Hz, 1H), 6.96 (d, J = 8.5 Hz, 1H), 7.11-7.16 (m, 1H), 7.25-7.30 (m, 1H), 7.39 ppm 
(dd, J = 7.6, 0.98 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 54.9, 59.9, 60.07, 79.6, 80.8 (d, JF-C = 5.3 Hz), 105.8, 
115.1 (d, JF-C = 23.2 Hz), 119.5, 123.5 (d, JF-C = 4.3 Hz), 124.6, 127.5 (d, JF-C = 9.1 Hz), 
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127.6 (d, JF-C = 3.5 Hz), 128.0 (d, JF-C = 19.2), 141.1, 150.9, 153.0, 159.1 ppm (d, JF-
C = 245.6).  
19
F{
1
H}-NMR (282 MHz, CDCl3): δ = -112.6 ppm.
HRMS calcd. for C17H15FNaO3
+
: 309.089746 [M+Na]
+
; found: 309.089731. 
IR: ῦ = 662, 691, 741, 797, 874, 921, 960, 1005, 1064, 1089, 1113, 1170, 1209, 1235, 1251, 
1272, 1298, 1411, 1432, 1454, 1470, 1503, 1564, 1597, 2839, 2938, 3000, 3283 cm
-1
. 
2-Ethynyl-2',6-dimethoxybiphenyl 104r 
Compound 104r was prepared according to general procedure G from 
carbaldehyde 136r (150 mg, 0.62 mmol). Purification of the crude product 
was performed by column chromatography on silica gel (hexanes/ethyl 
acetate, 15/1) affording the desired product 104r as a white solid (136 mg, 
93%). 
1
H-NMR (300 MHz, CDCl3): δ = 2.81 (s, 1H), 3.69 (s, 3H), 3.72 (s, 3H), 6.92-6.96 (m, 2H), 
6.99 (dd, J = 7.5, 1.1 Hz, 1H), 7.16 (d, J = 1.8 Hz, 1H), 7.19 (d, J = 1.5 Hz, 1H), 7.21 (d, 
J = 1.8 Hz, 1H), 7.29-7.34 ppm (m, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 56.0, 56.1, 79.4, 82.9, 111.4, 112.0, 120.4, 123.8, 
125.3, 126.0, 128.3, 129.1, 131.1, 131.7, 157.4, 157.4 ppm. 
HRMS calcd. for C16H14NaO2
+
: 261.088596 [M+Na]
+
; found: 261.088337. 
IR: ῦ= 676, 745, 754, 793, 801, 907, 935, 1001, 1022, 1049, 1067, 1119, 1159, 1182, 1232, 
1258, 1295, 1434, 1462, 1497, 1568, 1600, 1694, 1934, 2838, 2939, 3011, 3263, 3279 cm
-1
. 
6.5.5.4 Cycloisomerization 
General procedure H: Cycloisomerization of biphenyl alkynes 
 
A solution of the desired biphenyl alkyne 104 (1.0 equiv.) in DCM (c = 0.05 M) solution was 
transferred via cannula to a Schlenk-flask previously charged with Au(I)-precatalyst 97a (0.02 
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equiv) and silver hexafluoroantimonate (0.02 equiv.). The mixture was stirred at room 
temperature until full consumption of the starting material was detected via GC-MS (10-15 
minutes unless stated otherwise) and then filtered over a short pad of Celite
®
. If necessary, 
further purification of the isolated compound was performed via column chromatography on 
silica gel and/or HPLC in order to afford phenanthrene 107 in analytical purity.  
4-Methylphenanthrene 107b 
Alkyne 104b (28.0 mg, 0.15 mmol) was treated with precatalyst 97a (2.87 mg, 
2.91 µmol) and silver hexafluoroantimonate (1.0 mg, 2.91 µmol) in DCM 
(3.0 mL) according to general procedure H. The crude material thus obtained 
was purified by column chromatography on silica gel (hexanes/ethyl acetate, 
20/1) affording 107b as a white solid (24.7 mg, 88%). 
1
H-NMR (400 MHz, CDCl3): δ = 3.18 (s, 3H), 7.49 - 7.55 (m, 2H), 7.58-7.63 (m, 1H), 7.63- 
7.68 (m, 1H), 7.74 (s, 2H), 7.77-7.83 (m, 1H), 7.91-7.96 (m, 1H), 8.95 ppm (dd, J = 9.3, 8.2 
Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 27.5, 125.7, 125.9, 126.0, 127.2, 127.6, 127.7, 128.1, 
128.9, 130.2, 131.4, 131.8, 133.6, 133.9, 135.7 ppm. 
HRMS calcd. for C15H12: 192.093898 [M]
+
; found:192.093722. 
IR: ῦ = 666, 709, 735, 793, 820, 862, 895, 943, 957, 993, 1027, 1106, 1165, 1215, 1295, 
1315, 1376, 1438, 1449, 1497, 1597, 2875, 2963, 3048 cm
-1
. 
The spectral data measured were in agreement with those reported in the literature.
[83] 
4-Phenylphenanthrene 107c 
Alkyne 104c(33.3 mg, 0.13 mmol) was treated with precatalyst 97a (2.6 mg, 
2.62 µmol) and silver hexafluoroantimonate (0.9 mg, 2.62 µmol) in DCM 
(2.6 mL) according to general procedure H. Pale yellow solid (30.6 mg, 92%). 
1
H-NMR (400 MHz, CDCl3): δ = 7.12 (ddd, J = 8.6, 7.0, 1.5 Hz, 1H), 7.38-
7.54 (m, 7H), 7.60 (t, J = 7.5 Hz, 1H), 7.73 (d, J = 9.4 Hz, 1H), 7.77 (q, J = 8.6 Hz, 2H), 7.84 
(dd, J = 7.9, 1.3 Hz, 1H), 7.90 ppm (dd, J = 7.9, 1.4 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 125.0, 125.8, 126.1, 127.2, 127.5, 127.7, 128.4, 
128.5, 128.6, 128.7, 129.1, 129.2, 130.5, 130.9, 133.6, 133.8, 140.7, 145.5 ppm. 
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HRMS calcd. for C20H14
+
: 254.109551 [M]
+
; found: 254.109307. 
IR: ῦ = 673, 698, 721, 738, 765, 779, 799, 826, 872, 910, 948, 957, 1024, 1040, 1072, 1091, 
1164, 1178, 1254, 1305, 1393, 1434, 1491, 1521, 1599, 2851, 2922, 3052 cm
-1
. 
4-Iso-propylphenanthrene 107h 
Alkyne 104h (32.4 mg, 0.15 mmol) was treated with precatalyst 97a (2.9 mg, 
2.94 µmol) and silver hexafluoroantimonate (1.0 mg, 2.94µmol) in DCM 
(3.0 mL) according to general procedure H. The crude material thus obtained 
was purified by semi-preparative HPLC (YMC, 2 cm x 15 cm, CH3CN/H2O 
75/25, 15 mL/min; 32.4 mg in 1.0 mL of CH3CN) affording 107h as a colorless 
oil (22.7 mg, 70%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.54 (d, J = 6.7 Hz, 6H), 4.34 (hept, J = 6.7 Hz, 1H), 7.56-
7.63 (m, 3H), 7.68 (d, J = 1.3 Hz, 2H), 7.72 (d, J = 7.8 Hz, 2H), 7.88-7.95 (m, 1H), 8.60-8.67 
ppm (m, 1H).  
13
C{
1
H}-NMR (101 MHz, CDCl3): δ= 25.5, 31.2, 125.4, 125.7, 126.0, 126.2, 126.7, 126.8, 
128.0, 128.1, 128.6, 129.4, 130.5, 133.5, 133.7, 147.0 ppm. 
HRMS calcd. for C17H16: 220.125282 [M]
+
; found: 220.125198. 
IR: ῦ = 666, 713, 723, 740, 771, 797, 827, 865, 965, 1040, 1162, 1176, 1261, 1324, 1363, 
1384, 1436, 1452, 1495, 1594, 1714, 2866, 2961, 3048 cm
-1
. 
4,5-Dimethylphenanthrene 107f 
Alkyne 104f (20.6 mg, 0.10 mmol) was treated with precatalyst 97a (2.0 mg, 
1.99 µmol) and silver hexafluoroantimonate (0.7 mg, µmol 1.99 µmol) in DCM 
(2.0 mL) according to general procedure H. White solid (20.1 mg, 98%). 
1
H-NMR (400 MHz, CDCl3): δ = 2.62 (s, 6H), 7.43 (dd, J = 7.2, 0.6 Hz, 2H), 
7.50 (t, J = 7.4 Hz, 2H), 7.51 (s, 2H), 7.66 ppm (dd, J = 7.6, 0.8 Hz, 2H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 22.9, 124.8, 126.0, 126.6, 128.6, 130.5, 134.0, 135.9 
ppm. 
HRMS calcd. for C16H14
+
: 206.109638 [M]
+
; found: 206.109547. 
IR: ῦ = 697, 718, 748, 756, 773, 814, 887, 1160, 1234, 1372, 1436, 1457, 2853, 2924, 2951, 
3044 cm
-1
. 
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4-Methyl-5-phenylphenanthrene 107i 
Alkyne 104i (30.0 mg, 0.12 mmol) was treated with precatalyst 97a (2.2 mg, 
2.24 µmol) and silver hexafluoroantimonate (0.8 mg, 2.24 µmol) in DCM 
(2.4 mL) according to general procedure H. The crude material thus obtained 
was purified by column chromatography on silica gel (hexanes) affording 107i 
as a colorless oil (28.8 mg, 96%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.85 (s, 3H), 6.35-8.30 (m, 4H), 7.06 (d, J = 6.9 Hz, 1H), 
7.25 (t, J = 7.3 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 7.58-7.70 (m, 5H), 7.79 ppm (dd, J = 6.3, 2.8 
Hz, 1H).  
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 23.3, 125.0, 126.3, 126.4, 126.4, 126.7, 126.8, 127.5, 
128.3, 128.7 (sbr), 128.8, 129.5, 130.6, 133.9, 135.0, 136.8, 141.6, 144.9 ppm.  
HRMS calcd. for C21H16
+
: 268.125017 [M]
+
; found: 268.125200. 
IR: ῦ = 696, 722, 749, 766, 813, 826, 882, 916, 965, 1030, 1074, 1115, 1164, 1176, 1244, 
1263, 1302, 1376, 1412, 1437, 1493, 1568, 1596, 1927, 2851, 2922, 3044 cm
-1
. 
4,5-Diphenylphenanthrene 107j 
Alkyne 104j (47.9 mg, 0.14 mmol) was treated with 97a (2.9 mg, 2.90 µmol) 
and silver hexafluoroantimonate (1.0 mg, 2.90 µmol) in DCM (2.9 mL) 
according to general procedure H. White solid (43.0 mg, 90%). 
1
H-NMR (400 MHz, CDCl3): δ = 6.51-6.60 (m, 4H); 6.93-6.98 (m, 4H), 7.06 
(tt, J = 7.4, 1.2 Hz, 2H), 7.13 (dd, J = 7.3, 1.2 Hz, 2H), 7.50 (t, J = 7.44 Hz, 
2H), 7.69 (s, 2H), 7.76 ppm (dd, J = 7.8, 1.5 Hz, 2H). 
13
C{
1
H}-NMR (101MHz, CDCl3): δ = 125.6, 126.7, 126.9, 127.2, 128.0, 128.3, 129.6, 129.7, 
134.8, 142.2, 143.7 ppm. 
HRMS calcd. for C26H18
+
: 330.140852 [M]
+
; found: 330.140898. 
IR: ῦ =693, 726, 744, 771, 828, 868, 909, 943, 961, 1025, 1075, 1130, 1155, 1176, 1260, 
1278, 1307, 1410, 1437, 1491, 1596, 1666, 1799, 1871, 1934, 2849, 2923, 3027, 3047, 3075 
cm
-1
. 
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4-Fluoro-5-methylphenanthrene 107k 
Alkyne 104k (20.0 mg, 0.10 mmol) was treated with precatalyst 97a (1.9 mg, 
1.90 µmol) and silver hexafluoroantimonate (0.8 mg, 1.90 µmol) in DCM 
(1.9 mL) according to general procedure H. The crude material thus obtained 
was purified first by column chromatography on silica gel (hexanes/ethyl 
acetate, 35/1) and then by HPLC (YMC, 2 cm x 15 cm, methanol/H2O 90/10, 
10 mL/min; 18.2 mg in 1 mL methanol ) affording 107k as an orange oil (13.1 mg, 71%). 
1
H-NMR (300 MHz, CDCl3): δ = 2.73 (d, J = 12.3 Hz, 3H), 7.25-7.32 (m, 1H), 7.51-7.58 
(m, 3H), 7.60 (d, J = 1.9 Hz, 1H), 7.63-7.70 ppm (m, 3H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ =23.7 (d, JF-C = 24.1 Hz), 112.9 (d, JF-C  = 25.4 Hz), 
119.4 (d, JF-C  = 14.0 Hz), 123.4 (d, JF-C = 3.1 Hz), 125.6 (d, JF-C  = 3.1 Hz), 126.7, 127.1 (d, 
JF-C  = 9.7 Hz), 127.3 (d, JF-C  = 2.0 Hz), 128. 5 (d, JF-C  = 1.3 Hz), 128.5, 130.2, 133.5 (d, JF-
C = 0.8 Hz), 135.6 (d, JF-C  = 4.93 Hz), 137.1 (d, JF-C  = 1.0 Hz), 159.6 ppm (d, JF-C  = 252.2 
Hz).  
19
F{
1
H}-NMR (282 MHz, CDCl3): δ = -101.0 ppm.
HRMS calcd. for C15H11F
+
: 210.084482 [M]
+
; found: 210.084528. 
IR: ῦ = 696, 713, 753, 780, 797, 819, 879, 892, 936, 960, 996, 1057, 1079, 1106, 1146, 1165, 
1202, 1252, 1277, 1308, 1378, 1397, 1417, 1441, 1492, 1523, 1569, 1590, 1609, 1621, 1714, 
1776, 1840, 1917, 2876, 2934, 2981, 3050 cm
-1
. 
Pentahelicene 138a 
Alkyne 137a (35.0 mg, 0.12 mmol) was treated with precatalyst 97a 
(2.8 mg, 2.39 µmol) and silver hexafluoroantimonate (0.8 mg, 2.39 µmol) 
in DCM (2.4 mL) according to general procedure H. The crude material 
thus obtained was purified by column chromatography on silica gel 
(pentane/DCM, 80/1) affording 138a as a pale yellow oil of high viscosity 
(32 mg, 91%). 
1
H-NMR (400 MHz, CDCl3): δ = 2.84 (s, 3H), 7.22-7.28 (m, overlaps with solvent signal, 
2H), 7.46-7.54 (m, 2H), 7.72 (s, 1H), 7.82 (d, J = 8.5 Hz, 1H), 7.88-7.99 (m, 4H), 8.09 (d, 
J = 8.8 Hz, 1H), 8.39 (dd, J = 8.5, 3.8 Hz, 1H), 8.48 ppm (dd, J = 8.5, 3.8 Hz, 1H). 
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13
C{
1
H}-NMR (400 MHz, CDCl3): δ = 20.2, 122.3, 124.4, 124.5, 125.7, 125.9, 126.1, 126.3, 
127.3, 127.5, 127.7, 127.8, 128.0, 129.0, 129.1, 129.6, 130.9, 131.0, 131.8, 132.0, 132.1, 
132.3, 133.2 ppm. 
HRMS calcd. for C23H16
+
: 292.125200 [M]
+
; found: 292.125095. 
IR: ῦ = 416, 449, 478, 505, 521, 589, 630, 655, 695, 741, 803, 875, 947, 958, 1030, 1083, 
1126, 1159, 1243, 1320, 1338, 1375, 1432, 1515, 1601, 1749, 1835, 1898, 1916, 3855, 2914, 
3015, 3052 cm
-1
. 
4-Iso-propyl-5-methylphenanthrene 107l, 3-iso-propyl-5-methylphenanthrene 140l, 1-
iso-propyl-5-methylphenanthrene 139l 
 
Alkyne 104l (95.7 mg, 0.41 mmol) was treated with precatalyst 97a (8.1 mg, 8.17 µmol) and 
silver hexafluoroantimonate (2.8 mg, 8.17 µmol) in DCM (8.2 mL) according to general 
procedure H. The crude material thus obtained was purified by semi-preparative HPLC 
(YMC, 2 cm x 15 cm, CH3CN/H2O 75/20, 10 mL/min; 19.5 mg in 1.4 mL of CH3CN and 0.1 
mL of H2O) obtaining four different products (three isomers). 
1-Iso-propyl-5-methylphenanthrene 139l 
White solid (52.6 mg, 55%). 
1
H-NMR (400 MHz, CDCl3): δ = 1.50 (dd, J = 6.9, 2.2 Hz, 6H), 3.19 (s, 
3H), 3.90 (sept, J = 6.7 Hz, 1H), 7.50-7.54 (m, 2H), 7.62-7.66 (m, 2H), 7.78 
-7.82 (m, 2H), 8.13 (d, J = 9.2, 1.3 Hz, 1H), 8.80-8.82 ppm (m, 1H). 
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13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 24.0, 27.6, 29.2, 121.9, 122.2, 125.0, 125.7, 125.9, 
127.2, 127.8, 131.0, 131.1, 131.4, 132.0, 133.2, 135.6, 144.9 ppm.  
HRMS calcd. for C18H18
+
: 234.140849 [M]
+
; found: 234.140628. 
IR: ῦ = 721, 747, 774, 819, 829, 893, 960, 1054, 1102, 1164, 1190, 1216, 1275, 1310, 1359, 
1377, 1410, 1434, 1448, 1594, 1784, 1922, 2867, 2923, 2959, 3047 cm
-1
. 
4-Iso-propyl-5-methylphenanthrene 107l 
White solid (21.0 mg, 22%). 
1
H-NMR (400 MHz, CDCl3): δ = 0.57 (d, J = 6.6 Hz, 3H), 1.69 (d, J = 6.8 Hz, 
3H), 2.68 (s, 3H), 3.78 (sept, J = 6.7 Hz, 1H), 7.37-7.39 (m, 1H), 7.46 (d, 
J = 7.6 Hz, 1H), 7.49 (m, 2H), 7.52-7.57 (m, 2H), 7.61-7.66 ppm (m, 2H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.2, 23.2, 28.3, 32.1, 123.0, 124.9, 125.1, 125.8, 
126.5, 126.6, 126.8, 128.1, 128.2, 130.2, 134.0, 134.2, 135.8, 147.9 ppm. 
HRMS calcd. for C18H18
+
: 234.140848 [M]
+
; found: 234.140779. 
IR: ῦ = 699, 725, 751, 768, 792, 813, 824, 862, 891, 925, 961, 979, 995, 1037, 1044, 1090, 
1114, 1172, 1216, 1230, 1265, 1300, 1361, 1383, 1418, 1438, 1459, 1565, 1594, 1716, 1772, 
2865, 2924, 2952, 3044 cm
-1
. 
3-Iso-propyl-5-methylphenanthrene 140l 
White solid (2.9 mg, 3%). 
1
H-NMR (300 MHz, CDCl3): δ = 1.41 (d, J = 6.8 Hz, 6H), 3.17-3.22 (m, 4H), 
7.47-7.52 (m, 3H), 7.65-7.70 (m, 2H), 7.75-7.77 (m, 1H), 7.85 (d, J = 8.2 Hz, 
1H), 8.78 ppm (s, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 24.3, 27.5, 34.8, 125.0, 125.2, 125.8, 127.0, 127.3, 
127.6, 128.7, 130.3, 131.2, 131.9, 131.9, 134.0, 135.5, 146.2 ppm. 
HRMS calcd. for C18H18
+
: 234.140848 [M]
+
; found: 234.140779. 
IR: ῦ = 716, 757, 791, 812, 838, 893, 957, 1018, 1032, 1052, 1078, 1104, 1133, 1149, 1193, 
1216, 1234, 1292, 1312, 1359, 1378, 1407, 1431, 1450, 1459, 1500, 1522, 1569, 1595, 1615, 
2869, 2928, 2957, 3047 cm
-1
. 
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5-Methoxyphenanthren-2-ol 107m 
Alkyne 104m (32.6 mg, 0.15 mmol) was treated with precatalyst 97a (2.9 mg, 
2.90 µmol) and silver hexafluoroantimonate (1.0 mg, 2.90 µmol) in DCM 
(2.9 mL) according to general procedure H. The crude material thus obtained 
was purified by column chromatography on silica gel (hexanes/ethyl acetate, 
7/3) affording 107m as a white solid (30.2 mg, 93%). 
1
H-NMR (400 MHz, CDCl3): δ = 4.12 (s, 3H), 5.10 (s, 1H), 7.14 (dd, J = 6.9, 2.2 Hz, 1H), 
7.20 (dd, J = 9.2, 2.9 Hz, 1H), 7.23 (d, J = 2.8 Hz, 1H), 7.45-7.54 (m, 2H), 7.60 (d, J = 8.8 
Hz, 1H), 7.69 (d, J = 8.8 Hz, 1H), 9.59 ppm (d, J = 9.2 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 55.8, 108.5, 111.8, 116.2, 121.1, 121.8, 124.9, 125.7, 
127.2, 128.0, 130.8, 133.7, 134.7, 153.4, 158.3 ppm. 
HRMS calcd. for C15H12O2
+
: 224.083727 [M]
+
; found: 224.083483. 
IR: ῦ = 708, 752, 788, 805, 827, 859, 877, 943, 966, 994, 1073, 1098, 1139, 1154, 1220, 
1256, 1266, 1312, 1336, 1352, 1429, 1449, 1529, 1573, 1614, 2833, 2934, 3192 cm
-1
. 
4-Methoxy-5-methylphenanthrene 107n 
Alkyne 104n (32.2 mg, 0.14 mmol) was treated with precatalyst 97a (2.9 mg, 
2.89 µmol) and silver hexafluoroantimonate (1.0 mg, 2.89 µmol) in DCM 
(2.9 mL) according to general procedure H. White solid (29.0 mg, 91%). 
1
H-NMR (300 MHz, CDCl3): δ = 2.61 (s, 3H), 3.97 (s, 3H), 7.06 (d, 
J = 7.7 Hz, 1H), 7.46-7.67 ppm (m, 7 H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 24.2, 55.0, 107.5, 120.0, 120.9, 124.9, 125.8, 125.9, 
127.0, 127.9, 128.8, 129.3, 133.5, 135.2, 137.4, 157.0 ppm. 
HRMS calcd. for C16H14O
+
: 222.104467 [M]
+
; found: 222.104643. 
IR: ῦ =698, 716, 750, 793, 817, 860, 888, 921, 977, 994, 1020, 1096, 1145, 1164, 1185, 1240, 
1261, 1311, 1332, 1374, 1414, 1432, 1450, 1491, 1522, 1568, 1600, 1777, 1907, 2832, 2926, 
2956, 2992, 3048 cm
-1
. 
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4-Methoxy-5-phenylphenanthrene 107o 
Alkyne 104o (42.6 mg, 0.15 mmol) was treated with precatalyst 97a (3.0 mg, 
2.99 µmol) and silver hexafluoroantimonate (1.0 mg, 2.99 µmol) in DCM 
(3.0 mL) according to general procedure H. White solid (40.0 mg, 93%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.06 (s, 3H), 6.67 (quin, J = 4.5 Hz, 1H), 
7.16-7.22 (m, 1H), 7.30-7.31 (m, 4H), 7.45 (d, J = 4.6 Hz, 2H), 7.59 (d, J = 4.9 Hz, 2H) 7.64 
(d, J = 8.7 Hz, 1H), 7.69 (d, J = 8.7 Hz, 1H), 7.76-7.81 ppm (m, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 53.4, 107.0, 119.8, 120.8, 125.9, 126.1, 126.1, 126.3, 
126.7, 126.8, 127.3, 127.6, 128.4, 129.9, 134.3, 135.1, 141.8, 146.8, 156.0 ppm. 
HRMS calcd. for C21H16O: 284.120116 [M]
+
; found: 284.120169. 
IR: ῦ = 667, 689, 719, 744, 771, 788, 815, 867, 916, 1001, 1062, 1091, 1111, 1167, 1181, 
1203, 1242, 1257, 1289, 1395, 1409, 1428, 1462, 1501, 1578, 1592, 1681, 1693, 2761, 2869, 
2939, 2977 cm
-1
. 
4-Iso-propyl-5-methoxyphenanthrene 107p 
Alkyne 104p (36.2 mg, 0.15 mmol) was treated with precatalyst 97a (2.9 mg, 
2.91 µmol) and silver hexafluoroantimonate (1.0 mg, 2.91 µmol) in DCM 
(2.9 mL) according to general procedure H. White solid (32.9 mg, 91%) 
1
H-NMR (300 MHz, CDCl3): δ = 1.23 (sbr, 6H), 3.59 (sept, J = 6.7 Hz, 1H), 
3.91 (s, 3H), 7.01 (dd, J = 7.6, 1.5 Hz, 1H), 7.45 (dd, J = 7.9, 1.5 Hz, 1H), 7.48-7.63 ppm (m, 
6H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 33.2, 38.2, 55.4, 107.2, 120.0, 120.7, 124.0, 124.9, 
125.9, 126.4, 126.5, 126.7, 127.8, 133.4, 135.3, 149.2, 156.7 ppm. 
HRMS calcd. for C18H18O
+
: 250.135764 [M]
+
; found: 250.135535. 
IR: ῦ= 699, 723, 757, 815, 824, 860, 891, 920, 988, 1043, 1085, 1151, 1171, 1221, 1235, 
1259, 1302, 1328, 1359, 1379, 1416, 1431, 1451, 1491, 1521, 1567, 1601, 1613, 1726, 1777, 
1912, 2867, 2932, 2951, 2984, 3047 cm
-1
. 
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2,3,4,5-Tetramethoxyphenanthrene 107g 
Alkyne 104g (44.7 mg, 0.15 mmol) was treated with precatalyst 97a (3.0 mg, 
3.00 µmol) and silver hexafluoroantimonate (1.0 mg, 3.00 µmol) in DCM 
(3.0 mL) according to general procedure H. White solid (44.0 mg, 98%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.75 (s, 3H), 4.01 (s, 6H), 4.02 (s, 3H), 
7.00 (s, 1H), 7.06 (dd, J = 7.6, 1.2 Hz, 1H), 7.40 (dd, J = 7.8, 1.3 Hz, 1H), 
7.45 (d, J = 7.6 Hz, 1H), 7.49-7.53 ppm (m, 2H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 56.1, 56.2, 60.9, 61.4, 103.6, 108.1, 117.1, 119.7, 
119.9, 126.2, 126.3, 126.7, 130.5, 133.9, 142.5, 152.5, 152.8, 157.6 ppm. 
HRMS calcd. for C18H18NaO4
+
: 321.109729 [M+Na
+
]
+
; found: 321.109738. 
IR: ῦ =688, 728, 766, 782, 814, 835, 908, 925, 953, 1003, 1048, 1079, 1096, 1111, 1138, 
1197, 1229, 1342, 1386, 1423, 1465, 1496, 1510, 1560, 1602, 2249, 2832, 2853, 2932, 2996, 
3047 cm
-1
. 
5-Fluoro-2,3,4-trimethoxyphenanthrene 107q 
 Alkyne 104q (40.0 mg, 0.14 mmol) was treated with precatalyst 97a (2.8 mg, 
2.79 µmol) and silver hexafluoroantimonate (1.0 mg, 2.79 µmol) in DCM 
(1.9 mL) according to general procedure H. The crude material thus obtained 
was purified by column chromatography on silica gel (pentane/MTBE, 5/1) 
affording 171 as a yellow oil (35 mg, 88%). 
1
H-NMR (300 MHz, CDCl3): δ = 4.16 (d, J = 0.9 Hz, 3H), 4.24 (d, J = 1.2 Hz, 6H), 7.26 
(CHAr hidden under solvent signal), 7.46-7.53 (m, 1H), 7.65-7.73 (m, 1H), 7.76-7.77 (m, 2H), 
7.81 ppm (dd, J = 8.4, 0.8 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ =56.1, 61.3, 60.4 (d, JF-C = 4.8 Hz), 104.2, 113.3 (d, JF-
C = 25.9 Hz) 116.2 (d,JF-C = 4.3 Hz), 117.8 (d, JF-C = 14.9 Hz), 123.5 (d, JF-C = 3.2 Hz), 126.2, 
126.2 (d, JF-C = 7.3 Hz), 127.2 (d, JF-C = 1.2 Hz), 130.5, 134.5 (d, JF-C = 4.9 Hz), 143.1, 152.2, 
153.5, 159.9 ppm (d, JF-C = 255.7 Hz).  
19
F{
1
H}-NMR(282 MHz, CDCl3): δ = -97.9 ppm.
HRMS calcd. for C17H15FNaO3
+
: 309.089743 [M+Na]
+
; found: 309.089110. 
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IR: ῦ = 679, 738, 748, 783, 816. 838, 882, 910, 927, 968, 999, 1069, 1104, 1139, 1169, 1192, 
1206, 1231, 1243, 1275, 1345, 1388, 1425, 1444, 1466, 1496, 1514, 1561, 1595, 1608, 2834, 
2857, 2936, 2988, 3055 cm
-1
. 
6.5.5.5 Synthesis of Calanquinone C 
2-(Benzyloxy)-4-bromo-1,3-dimethoxybenzene 153b 
To a suspension of 3-bromo-2,6-dimethoxyphenol 153a (1.8 g, 
7.72 mmol) and potassium carbonate (1.6 g 11.59 mmol) in acetone 
(40 mL), benzyl bromide (0.96 mL, 1.38 g, 8.07 mmol) was added and the 
reaction mixture stirred overnight at room temperature. Removal of the 
solvents in vacuo afforded a crude material, which was purified by column chromatography 
on silica gel (hexane/ethyl acetate, 9/1) affording 153b as a colorless oil (2.2 g, 88%). 
1
H-NMR (400 MHz, CDCl3): δ = 3.82 (s, 3H), 3.90 (s, 3H), 5.03 (s, 2H), 6.59 (d, J = 9.0 Hz, 
1H), 7.22 (d, J = 8.9 Hz, 1H), 7.32-7.39 (m, 3H), 7.48-7.53 ppm (m, 2H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 56.3, 61.3, 75.6, 108.6, 108.9, 127.1, 128.2, 128.5, 
137.5, 142.7, 151.5, 153.8 ppm. 
HRMS calcd. for C15H15BrNaO3
+
: 345.009358 [M+Na]
+
; found: 345.009358. 
IR: ῦ = 694, 734, 791, 876, 915, 980, 1008, 1088, 1179, 1214, 1226, 1271, 1293, 1371, 1413, 
1438, 1460, 1473, 1574, 2837, 2937 cm
-1
. 
3-(Benzyloxy)-2,4-dimethoxyphenylboronic acid 153c 
2-(Benzyloxy)-4-bromo-1,3-dimethoxybenzene 153b (1.6 g, 4.95 mmol) 
was dissolved in diethyl ether (40 mL) and cooled to -78 °C. n-Butyl 
lithium (1.98 mL, 4.95 mmol, c = 2.5 M in hexanes) was then added 
dropwise over 30 minutes and the resulting solution was stirred for 
1 hour at -78 °C. Then trimethylborate (1.69 mL, 14.85 mmol) was added and the mixture 
allowed to warm to room temperature overnight. After quenching the reaction with HCl(aq) 
(20 mL, c =  3 M), the aqueous phase was extracted with MTBE (3x) and dried over sodium 
sulfate. Removal of the solvent in vacuo afforded crude 153c, which was purified by column 
chromatography on silica gel (hexane/ethyl acetate, 6/4). White solid (935 mg, 66%). The 
compound should be stored at -20 °C under argon as it decomposes slowly over time at room 
temperature. 
                                                                                                                     6. Experimental Part 
 
 
129 
1
H-NMR (300 MHz, CD3CN): δ = 3.86 (s, 3H), 3.94 (s, 3H), 4.99 (s, 2H), 6.32 (s, 2H), 6.82 
(d, J = 8.4 Hz, 1H), 7.33-7.42 (m, 3H), 7.46 (d, J = 8.4, 1H),7.48-7.51 ppm (m, 2H). 
13
C{
1
H}-NMR (75 MHz, CD3CN): δ = 56.7, 62.5, 75.7, 109.3, 129.0, 129.3, 129.3, 132.1, 
138.9, 141.0, 157.7, 160.2 ppm. 
11
B{
1
H}-NMR (96 MHz, CD3CN): δ = 28.7 ppm. 
HRMS calcd. for C15H17BNaO5
+
: 311.107456 [M+Na]
+
; found: 311.107270. 
IR: ῦ = 693, 725, 751, 805, 896, 981, 1004, 1063, 1089, 1185, 1225, 1278, 1342, 1377, 1434, 
1457, 1498, 1596, 2838, 2929, 3000, 3358 cm
-1
. 
3,3',6-Tris(benzyloxy)-2',4'-dimethoxybiphenyl-2-carbaldehyde 155 
Compound 155 was prepared according to general procedure F from 3,6-
dibenzyloxy-2-bromobenzaldehyde 154 (110 mg, 0.28 mmol) and 3-(benzyl-
oxy)-2,4-dimethoxyphenylboronic acid 153c (120 mg, 0.42 mmol) 
employing 5 mol% of tris(dibenzylidenaceton)dipalladium and 10 mol% of 
tricyclohexylphosphine as a catalytic mixture. Once the reaction was finished 
the work-up was performed as described and the crude material purified by 
column chromatography on silica gel (hexane/ethyl acetate, 4/1) affording 155 as a pale 
yellow solid (130 mg, 84%). 
1
H-NMR (400 MHz, CDCl3): δ = 3.61 (s, 3H), 3.81 (s, 3H), 4.86 (d, J = 12.2 Hz, 1H), 4.90 
(d, J = 12.2 Hz, 1H), 4.99 (s, 2H), 5.11 (s, 2H), 6.67 (d, J = 8.5 Hz, 1H), 6.78 (d, J = 8.5 Hz, 
1H), 6.93 (d, J = 9.1 Hz, 1H), 7.07- 7.11 (m, 3H), 7.16- 7.22 (m, 3H), 7.24- 7.36 (m, 6H), 
7.43- 7.45 (m, 4H), 10.11 ppm (s, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 56.3, 61.1, 71.6, 71.9, 75.4, 107.4, 113.8, 120.0, 
121.8, 126.0, 126.2, 127.1, 127.4, 127.8, 128.0, 128.2, 128.4, 128.5, 128.6, 128.8, 132.0, 
136.9, 137.3, 138.0, 141.3, 151.0, 152.2, 154.1, 154.4, 191.4 ppm. 
HRMS calcd. for C36H32NaO6
+
: 583.209108 [M+Na]
+
; found: 583.208933. 
IR: ῦ= 692, 731, 744, 767, 800, 810, 841, 906, 965, 991, 1088, 1130, 1171, 1197, 1262, 1286, 
1374, 1382, 1411, 1452, 1477, 1497, 1586, 1683, 2863, 2935, 3032, 3064 cm
-1
. 
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3,3',6'-Tris(benzyloxy)-2'-ethynyl-2,4-dimethoxybiphenyl 149 
Compound 149 was prepared according to general procedure G from 
carbaldehyde 155 (130 mg, 0.23 mmol). Purification of the crude material 
thus obtained was performed by column chromatography on silica gel 
(pentane/ethyl acetate, 10/1) affording 149 as a pale yellow solid (86 mg, 
67%). 
1
H-NMR (400 MHz, CDCl3): δ = 3.20 (s, 1H), 3.74 (s, 3H), 3.89 (s, 3H), 
4.92 (d, J = 12.1 Hz, 1H), 4.98 (d, J = 12.2 Hz, 1H), 5.08 (s, 2H), 5.19 (s, 2H), 6.76 (d, J = 8.6 
Hz, 1H), 6.86 (d, J = 9.0 Hz, 1H), 6.93- 6.97 (m, 2H), 7.19- 7.28 (m, 5H), 7.31- 7.42 (m, 
6H),7.51- 7.54 ppm (m, 4H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 56.1, 61.3, 71.3, 71.6, 75.3, 79.0, 85.0, 107.1, 112.8, 
114.3, 115.4, 123.8, 125.9, 127.0, 127.1, 127.6, 127.8, 127.9, 128.3, 128.4, 128.4, 128.6, 
133.9, 137.3, 137.5, 138.1, 141.1, 151.0, 152.4, 153.8, 154.8 ppm. 
HRMS calcd. for C37H32NaO5
+
: 579.214195 [M+Na]
+
; found: 579.214523. 
IR: ῦ = 691, 726, 808, 852, 913, 970, 1007, 1065, 1094, 1137, 1172, 1203, 1222, 1265, 1288, 
1376, 1413, 1447, 1475, 1497, 1588, 1604, 2931, 3027, 3067, 3255 cm
-1
. 
5-(Benzyloxy)-4-(3-(benzyloxy)-2,4-dimethoxyphenyl)benzofuran 157 
Compound 157 was isolated as byproduct from the previous alkynylation 
reaction. Yellow oil (25 mg, 23%). 
1
H-NMR (400 MHz, CDCl3): δ = 3.59 (s, 3H), 3.92 (s, 3H), 5.01 (d, 
J = 11.9 Hz; 1H), 5.05 (d, J = 12.0 Hz; 1H), 5.10 (s, 2H), 6.47 (dd, J = 2.1, 
0.8 Hz, 1H), 6.77 (d, J = 8.6 Hz, 1H), 7.04 (d, J = 8.5 Hz, 1H), 7.07 (d, J = 
9.0 Hz, 1H), 7.23-7.27 (m, 3H), 7.30-7.38 (m, 5H), 7.41 (d, J = 8.9, 0.8 Hz, 1H),7.52-7.54 (m, 
2H), 7.58 ppm (d, J = 2.3 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 56.2, 61.3, 72.8, 75.4, 106.8, 107.3, 110.6, 112.9, 
121.1, 123.0, 126.3, 127.4, 127.6, 128.0, 128.4, 128.4, 128.5, 129.1, 137.9, 138.0, 141.3, 
145.8, 150.3, 152.1, 152.7, 153.7 ppm. 
HRMS calcd. for C30H26NaO5
+
: 489.167248 [M+Na]
+
; found: 489.167179. 
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IR: ῦ = 696, 733, 796, 843, 911, 994, 1028, 1044, 1081, 1112, 1150, 1194, 1216, 1262, 1346, 
1370, 1439, 1464, 1497, 1510, 1602, 1659, 2848, 2931, 3032 cm
-1
. 
1,4,6-Tris(benzyloxy)-5,7-dimethoxyphenanthrene 150 
A solution of 149 (78.0 mg, 0.12 mmol) in toluene (0.48 mL) was heated to 
50 °C and transferred via cannula to a Schlenk-flask charged with Au(I)-
precatalyst 97h (0.9 mg, 0.61 µmol) and silver hexafluoroantimonate 
(0.22 mg, 0.61 µmol)
[84]
. The reaction was stirred at 50 °C until full 
consumption of the starting material could be detected by TLC (4 hours). 
Then, the reaction mixture was filtered over a short pad of silica gel and the 
residue rinsed with ethyl acetate. Solvent removal in vacuo afforded a crude material, which 
was purified by column chromatography on silica gel (pentane/ethyl acetate, 9/1). White solid 
(69 mg, 89%). 
1
H-NMR (400 MHz, CDCl3): δ = 3.61 (s, 3H), 3.96 (s, 3H), 5.00 (s, 2H), 5.14 (s, 2H), 5.24 
(s, 2H), 6.98 (d, J = 7.8  Hz, 1H), 6.99 (s, 1H), 7.08 (d, J = 8.6 Hz, 1H), 7.17-7.27 (m, 
overlaps with solvent signal, 3H), 7.29-7.38 (m, 4H), 7.41-7.56 (m, 9H), 8.11 ppm (d, 
J = 8.8 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 56.1, 61.1, 71.2, 71.9, 75.9, 103.2, 107.6, 110.0, 
117.3, 120.0, 121.2, 124.9, 126.2, 127.6, 127.7, 127.8, 127.9, 128.0, 128.3, 128.3, 128.4, 
128.7, 130.8, 137.7, 138.2, 138.3, 141.4, 148.8, 151.4, 153.2, 152.2 ppm. 
HRMS calcd. for C37H32NaO5
+
: 579.214196 [M+Na]
+
; found: 579.214280 . 
IR: ῦ = 696, 733, 796, 843, 911, 994, 1028, 1044, 1081, 1112, 1150, 1194, 1216, 1262, 1346, 
1370, 1439, 1464, 1497, 1510, 1602, 1659, 2848, 2931, 3032 cm
-1
. 
Calanhydroquinone A 156 
Compound 150 (140 mg, 0.25 mmol) and (10% m/w) Pd/C (26.5 mg, 
0.025 mmol) were suspended in an ethanol/DCM mixture (3/1, 8 mL) in an 
autoclave and stirred overnight at room temperature under hydrogen 
atmosphere (20 bar). Then, the suspension was filtered over a short pad of 
Celite
®
, the residue rinsed with acetone (80 mL) and the solvent removed in 
vacuo. The crude material thus obtained was purified by column 
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chromatography on silica gel (pentane/ethyl acetate, 6/4) affording 156 as an orange solid 
(65 mg, 89%).  
1
H-NMR (400 MHz, CD3CN): δ = 2.54-2.57 (m, 2H), 2.65 (m, 2H), 3.62 (s, 3H), 3.88 (s, 
3H), 6.49 (s, 1H), 6.54 (s, 1H), 6.72 (d, J = 8.6 Hz, 1H), 6.76 (d, J = 8.8 Hz, 1H), 6.83 (s, 1H), 
8.10 ppm (s, 1H). 
13
C{
1
H}-NMR (125 MHz, CDCl3): δ = 22.7, 30.2, 56.5, 62.1, 107.8, 116.2, 117.8, 119.2, 
121.4, 125.8, 132.3, 137.3, 142.8, 145.2, 146.5, 147.9 ppm. 
HRMS calcd. for C16H16NaO5
+
: 311.088993 [M+Na]
+
; found: 311.089100. 
IR: ῦ = 731, 800, 834, 899, 929, 978, 1014, 1032, 1050, 1093, 1147, 1191, 1231, 1258, 1282, 
1329, 1356, 1385, 1455, 1499, 1559, 1609, 1646, 2851, 2925, 3226, 3408 cm
-1
. 
The spectral data measured were in agreement with those reported in the literature.
[61] 
Calanquinone C 144 
Cerium ammoniumnitrate (140 mg, 0.255 mmol) was dissolved in water 
(2 mL) and added to a solution of calanhydroquinone A 156 (37 mg, 
0.128 mmol) in THF (6 mL) over 30 minutes at room temperature. After 
extracting the reaction mixture with diethyl ether (20 mL), the organic phase 
was washed with saturated NaHCO3(aq) (2x) and water (1x). Then, the 
organic phase was dried over sodium sulfate. Subsequent solvent removal 
afforded 144 as a crude product. The crude material was purified by column chromatography 
on silica gel (pentane/ethyl acetate, 7/3). Deep red solid (25.3 mg, 69%).  
1
H-NMR (300 MHz, CDCl3): δ = 2.51-2.57 (m, 2H), 2.60-1.66 (m, 2H), 3.89 (s, 3H), 3.92 
(s, 3H), 5.52 (sbr, 1H), 6.55 (s, 1H), 6.72 (d, J = 10.1 Hz, 1H), 6.83 ppm (d, J = 10.1 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 20.5, 28.5, 56.5, 60.9, 105.6, 116.3, 131.9, 135.5, 
137.4, 137.5, 140.5, 141.0, 145.5, 149.3, 185.6, 185.9 ppm. 
HRMS calcd. for C16H14NaO5
+
: 309.073341 [M+Na]
+
; found: 309.073410. 
IR: ῦ = 834, 915, 1061, 1095, 1138, 1283, 1358, 1385, 1465, 1497, 1558, 1607, 1646, 1664, 
2848, 2927, 3402 cm
-1
. 
The spectral data measured were in agreement with those reported in the literature.
[61]
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6.5.6 Cycloisomerization of 2-(ethynylaryl)furans  
6.5.6.1 Synthesis Carbaldehydes 
2-(Furan-2-yl)benzaldehyde 167a 
A microwave vial was charged with 2-bromobenzaldehyde 135g (316 µL, 
500.0 mg, 2.70 mmol), furan-2-boronic acid (393.1 mg, 3.51 mmol), sodium 
carbonate (429.6 mg, 4.15mmol), bis(triphenylphosphine)palladium chloride 
(94.8 mg, 0.135 mmol) and an acetonitrile/water mixture (1/1, 16.2 mL).  The 
vessel was sealed with a Teflon crimp top and the suspension heated to 150 °C 
under microwave irradiation for 1.5 hours. Then brine was added and the aqueous phase was 
extracted with ethyl acetate (3x). The combined organic phases were dried over sodium 
sulfate and the solvent was removed in vacuo to afford a crude material, which was purified 
by column chromatography on silica gel (pentane/MTBE, 30/1).Yellow oil (302.7 mg, 65%). 
1
H-NMR (300 MHz, CDCl3): δ = 6.56 (dd, J = 3.5, 1.9 Hz, 1H), 6.63 (dd, J = 3.3, 0.6 Hz, 
1H), 7.41-7.46 (m, 1H), 7.58-7.70 (m, 3H), 7.98 (dd, J = 7.7, 1.3 Hz, 1H), 10.38 ppm (d, 
J = 0.8 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 111.4, 112.1, 128.2, 128.7, 128.6, 133.4, 133.6, 133.7, 
144.2, 151.4, 192.5 ppm. 
HRMS calcd. for C11H8O2
+
: 172.052432 [M]
+
; found: 172.052257. 
IR: ῦ = 671, 692, 740, 761, 823, 885, 905, 960, 1006, 1028, 1078, 1105, 1156, 1194, 1217, 
1254, 1277, 1300, 1343, 1375, 1397, 1439, 1461, 1476, 1498, 1598, 1683, 1774, 2759, 2854, 
3067, 3120, 3146 cm
-1
. 
2-(Furan-3-yl)benzaldehyde 167b 
A microwave vial was charged with 2-bromobenzaldehyde (148 µl, 234.3 mg, 
1.27 mmol), furan-3-boronic acid (170 mg, 1.52 mmol), triethylamine (529 µL, 
385 mg, 3.80 mmol), tetrakis(triphenylphosphine)palladium (117.1 mg, 
0.101 mmol) and DMF (9 mL). The vessel was sealed with a Teflon crimp top and 
the suspension was heated to 130 °C under microwave irradiation for 5 hours. 
Then the reaction was diluted with an equal amount of water, and extracted with MTBE (4x). 
The combined organic phases were washed with saturated NH4Cl(aq) (1x), brine (3x), and 
dried over sodium sulfate. Finally, the solvent was removed in vacuo and the crude material 
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was purified by column chromatography on silica gel (pentane/MTBE, 30/1) to afford 203a as 
a yellow oil (132.2 mg, 60%).
 
1
H-NMR (300 MHz, CDCl3): δ = 6.59 (dd, J = 1.8, 1.0 Hz, 1H), 7.43-7.49 (m, 2H), 7.54-
7.56 (m, 2H), 7.59-7.64 (m, 1H), 7.98-8.01 (m, 1H), 10.23 ppm (d, J = 0.7 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 112.4, 122.7, 128.0, 128.0, 130.8, 134.0, 134.2, 136.6, 
141.4, 143.7, 192.8 ppm. 
HRMS calcd. for C11H8O2
+
: 172.052433 [M]
+
; found: 172.052273. 
IR: ῦ = 659, 690, 762, 798, 824, 873, 923, 961, 1015, 1035, 1055, 1116, 1161, 1197, 1238, 
1262, 1290, 1312, 1356, 1394, 1447, 1474, 1506, 1585, 1600, 1649, 1686, 1775, 2759, 2852, 
3067, 3130, 3146 cm
-1
. 
Ethyl 3-formyl-4-(furan-2-yl)benzoate 167c 
A microwave vial was charged with ethyl 4-bromo-3-formylbenzoate 135i 
(234.0 mg, 0.91 mmol), furan-2-boronic acid (122.1 mg, 0.109 mmol), 
triethylamine (381 µL, 276.2 mg, 2.73 mmol), tetrakis(triphenyl-
phosphine)palladium (84.1 mg, 0.073 mmol) and DMF (6.5 mL). The vessel was 
sealed with a Teflon crimp top and the suspension heated to 130 °C under 
microwave irradiation for 5 hours. After this time, the reaction mixture was 
diluted with an equal amount of water and extracted with MTBE (4x). The combined organic 
phases were washed with saturated NH4Cl(aq) (1x), brine (3x), and dried over sodium sulfate. 
Removal of the solvents in vacuo afforded a residue, which was purified by column 
chromatography on silica gel (pentane/MTBE, 20/1). Yellow solid (113 mg, 51%).
 
1
H-NMR (400 MHz, CDCl3): δ = 1.42 (t, J = 7.2 Hz, 3H), 4.41 (q, J = 7.2 Hz, 2H), 6.60-6.61 
(m, 1H), 6.78 (d, J = 3.6 Hz, 1H), 7.66 (d, J = 1.8 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H), 8.25 (dd, 
J = 8.2, 1.9 Hz, 1H), 8.61 (d, J = 1.8 Hz, 1H), 10.46 ppm (s, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 14.5, 61.7, 112.6, 113.1, 128.3, 129.9, 131.5, 133.0, 
134.2, 136.5, 145.0, 150.7, 165.7, 191.8  ppm. 
HRMS calcd. for C14H12O4
+
: 244.075362 [M]
+
; found: 244.073364. 
IR: ῦ = 3147, 3119, 2996, 2974, 2910, 1772, 1707, 1677, 1602, 1577, 1550, 1499, 1476, 
1458, 1448, 1398, 1367, 1302, 1279, 1244, 1229, 1183, 1159, 1128, 1116, 1097, 1074, 1043, 
1017, 951, 928, 905, 887, 869, 858, 820, 765, 746, 710, 679 cm
-1
. 
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3-Fluoro-2-(5-methylfuran-2-yl)benzaldehyde 167d 
Compound 167d was prepared according to literature procedure in a two-step one pot 
reaction.
[85] 
A THF suspension (2 mL) of 2-methylfuran (86.3 μl, 78.5 mg, 0.96 mmol), 
bispinacoldiboron (121.5 mg, 0.48 mmol), [Ir(OMe)(COD)]2 (1.58 mg, 
2.39 µmol) and 4,4'-di-tert-butyl-2,2'-bipyridine (1.28 mg, 4.78 µmol) was 
heated to 80 °C. After the reaction was complete (18 hours, GC-MS 
monitoring), the solvent was removed in vacuo affording the literature known 
4,4,5,5-tetramethyl-2-(5-methylfuran-2-yl)-1,3,2-dioxaborolane 174.
[86]
 Then, 2-bromo-3-
fluoro-benzaldehyde (176.0 mg, 0.84 mmol), bis(dibenzylideneacetone)palladium (9.68 mg, 
0.0168 mmol), tri(o-tolyl)phosphine (10.25 mg, 0.0337 mmol), sodium carbonate (356.9 mg, 
3.36 mmol) and a THF/water mixture (9/1, 3.3 mL) were added to the crude boronic ester 174 
and the suspension was stirred for 20 h at room temperature. Filtration of the suspension over 
a short pad of Avicel
® 
and subsequent removal of solvents in vacuo gave a crude material, 
which was purified by column chromatography on silica gel (pentane/MTBE, 30/1) affording 
167d as an orange oil (117 mg, 60% over two steps). 
1
H-NMR (300 MHz, CDCl3): δ = 2.40 (s, 3H), 6.19-6.20 (m, 1H), 6.74 (t, J = 3.3 Hz, 1H), 
7.33-7.41 (m, 2H), 7.75-7.77 (m, 1H), 10.33 ppm (s, 1H). 
13
C{
1
H}NMR (75 MHz, CDCl3): δ = 13.9, 108.3, 115.4 (d, JF-C = 8.1 Hz), 120.7, 120. 9, 
123.8 (d, JF-C = 3.0 Hz), 128.7 (d, JF-C = 9.1 Hz), 135.4, 143.1, 154.8, 159.4 (d, JF-C = 251.6), 
192.1 ppm (d, JF-C = 3.5 Hz). 
19
F{
1
H}-NMR (282 MHz, CDCl3): δ = -113.1 ppm. 
HRMS calcd. for C12H10O2F
+
: 204.058657 [M+H]
+
; found: 204.058680. 
IR: ῦ = 707, 734, 778, 852, 920, 939, 1025, 1047, 1088, 1135, 1160, 1201, 1235, 1249, 1352, 
1394, 1446, 1462, 1480, 1543, 1569, 1602, 1689, 1784, 2753, 2876, 2923, 3079, 3416 cm
-1
. 
2-(Furan-2-yl)-3-methoxylbenzaldehyde 167e 
2-Chloro-3-methoxy-benzaldehyde (150 mg, 0.879 mmol), furane-2-boronic 
acid (147.6 mg, 1.319 mmol), tris(dibenzylideneacetone)dipalladium(0) 
(64.4 mg, 0.070 mmol), S-Phos (57.8 mg, 0.141 mmol) and cesium carbonate 
(487.0 mg, 1.490 mmol) were suspended in a degassed toluene/1,4-dioxane 
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mixture (1.1/1, 2.1 mL). The vessel was sealed with a Teflon crimp top and the suspension 
heated to 115 °C under microwave irradiation for 7 hours. Then, the crude material was 
filtrated over a short pad of silica and the residue rinsed with a pentane/MTBE mixture (2/1, 
50 mL). Removal of the solvents in vacuo afforded a crude product, which was purified by 
column chromatography on silica gel (pentane/MTBE, 50/1) to give 167e (118.0 mg). While 
residues of dibenzylideneacetone were still present in this material, it was used for the next 
step without further purification attempts. 
HRMS calcd. for C12H10O3
+
: 202.062997 [M]
+
; found: 202.063172. 
2-(Benzofuran-2-yl)-6-methylbenzaldehyde167f 
A microwave vial was charged with 2-bromo-6-methylbenzaldehyde 135d 
(215 mg, 1.08 mmol), benzofuran-2-ylboronic acid (227 mg, 1.40 mmol), 
sodium carbonate (172 mg, 1.62 mmol), bis(triphenylphosphine)-palladium 
chloride (38.9 mg, 0.054 mmol) and an acetonitrile/water mixture (1/1, 
6.4 mL). The vessel was sealed with a Teflon crimp top and the mixture heated 
to 150 °C under microwave irradiation for 1.5 hours. Then, brine was added 
and the aqueous phase extracted with ethyl acetate (3x). The combined organic phases were 
then dried over sodium sulfate and the solvent was removed in vacuo. The crude material thus 
obtained was purified by column chromatography on silica gel (pentane/MTBE, 15/1) 
affording 167f as a yellow solid (201 mg, 79%). 
1
H-NMR (400 MHz, CDCl3): δ = 2.63 (s, 3H), 6.87 (d, J = 0.9 Hz, 1H), 7.29 (td, J = 7.5, 7.5, 
1.0 Hz, 1H), 7.33-7.37 (m, 2H), 7.52 (d, J = 7.7 Hz, 1H), 7.54-7.56 (m, 1H), 7.63-7.65 (m, 
1H), 7.69 (d, J = 7.7 Hz, 1H), 10.31 ppm (s, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.3, 108.4, 111.5, 121.4, 123.4, 125.2, 127.2, 128.7, 
132.2, 132.4, 133.1, 133.9, 139.7, 153.1, 155.5, 194.1 ppm. 
HRMS calcd. for C16H12NaO2
+
: 259.072950 [M+Na]
+
; found: 259.072988. 
IR: ῦ = 688, 733, 747, 760, 783, 818, 836, 855, 873, 905, 939, 975, 1009, 1034, 1076, 1098, 
1112, 1141, 1167, 1183, 1238, 1259, 1298, 1309, 1349, 1382, 1408, 1425, 1444, 1456, 1474, 
1566, 1597, 1686, 2925, 2968, 3062, 3104 cm
-1
. 
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2-(Furan-2-yl)cyclohex-1-ene-1-carbaldehyde 167g 
A microwave vial was charged with 2-bromocyclohex-1-ene-1-carbaldehyde 135e 
(227 mg, 1.19 mmol), furane-2-boronic acid (268 mg, 2.40 mmol), cesium 
carbonate (1.17 g, 3.60 mmol), ammonium bromide (117 mg, 1.20 mmol), 
tetrakis(triphenyl-phosphine)palladium (416 mg 0.36 mmol) and a 1,4-
dioxane/water mixture (9/1, 10 mL). The vessel was sealed with a Teflon crimp 
top and the suspension heated to 70 °C under microwave irradiation for 7 hours. Then, brine 
was added and the aqueous phase extracted with ethyl acetate (3x). Afterwards, the combined 
organic phases were dried over sodium sulfate and the solvents were removed in vacuo. The 
crude material thus obtained was purified by column chromatography on silica gel 
(pentane/MTBE, 70/1) affording 167g as a yellow oil (144 mg, 68%). 
 
1
H-NMR (400 MHz, CDCl3): δ = 1.64-1.69 (m, 2H), 1.71-1.77 (m, 2H), 2.36-2.40 (m, 2H), 
2.58-2.62 (m, 2H), 6.47-6.48 (m, 1H), 6.51 (d, J = 3.4 Hz, 1H), 7.52 (d, J = 1.3 Hz, 1H), 
10.11 (s, 1H) ppm. 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.5, 22.2, 23.2, 29.3, 111.6, 113.2, 136.0, 143.9, 
144.2, 152.1, 193.6 ppm. 
HRMS calcd. for C11H12O2: 176.083730 [M]
+
; found: 176.083570. 
IR: ῦ = 513, 541, 594, 675, 712, 744, 802, 813, 885, 910, 962, 991, 1025, 1062, 1093, 1155, 
1198, 1228, 1245, 1277, 1395, 1431, 1450, 1486, 1608, 1656, 2859, 2932, 3119, 3296 cm
-1
. 
1-(Furan-2-yl)-3,4-dihydronaphthalene-2-carbaldehyde 167h 
A microwave vial was charged with 2-bromo-3,4-dihydronaphthalene-2-
carbaldehyde 135f (350 mg, 1.48 mmol), furane-2-boronic acid (330 mg, 
2.95 mmol), cesium carbonate (1.44 g, 4.49 mmol), ammonium bromide 
(144 mg, 1.48 mmol), tetrakis(triphenylphosphine)palladium (512 mg 
0.44 mmol) and a 1,4-dioxane/water mixture (9/1, 15 mL). The vessel was 
sealed with a Teflon crimp top and the suspension heated to 70 °C under microwave 
irradiation for 7 hours. Then, brine was added and the aqueous phase was extracted with ethyl 
acetate (3x). Afterwards, the combined organic phases were dried over sodium sulfate and the 
solvents removed in vacuo. The crude material thus obtained was purified by column 
chromatography on silica gel (pentane/MTBE, 50/1) affording 167h as a yellow solid 
(270 mg, 81%). 
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1
H-NMR (300 MHz, CDCl3): δ = 2.66-2.70 (m, 2H), 2.84-2.88 (m, 2H), 6.55-6.57 (m, 1H), 
6.61 (dd, J = 3.6, 0.4 Hz, 1H), 7.13 (dd, J = 7.7, 0.8 Hz, 1H), 7.19-7.26 (m, 2H), 7.32 (td, 
J = 7.4, 7.4, 1.4 Hz, 1H), 7.62 (dd, J = 1.9, 0.8 Hz, 1H), 9.88 ppm (s, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 21.2, 27.7, 111.3, 115.5, 126.9, 128.1, 128.3, 130.5, 
133.4, 137.1, 139.0, 142.7, 144.2, 147.9, 193.0 ppm.  
HRMS calcd. for C15H12NaO2
+
: 247.072949 [M+Na]
+
; found: 247.073002. 
IR: ῦ =  678, 724, 734, 757, 803, 833, 845, 881, 889, 906, 920, 972, 1000, 1014, 1034, 1072, 
1105, 1143, 1176, 1192, 1205, 1226, 1235, 1295, 1333, 1359, 1378, 1436, 1454, 1477, 1543, 
1557, 1601, 1655, 2748, 2836, 2857, 2882, 2952, 3069, 3129 cm
-1
. 
6.5.6.2 Synthesis of the corresponding alkynes 
2-(2-Ethynylphenyl)furan 165a 
Compound 165a was prepared according to general procedure G from 
carbaldehyde 167a (220.0 mg, 1.03 mmol). Purification of the crude material 
was performed by column chromatography on silica gel (pentane) afforded 
165a as a yellow oil (115 mg, 66%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.41 (s, 1H), 6.52 (dd, J = 3.4, 1.8 Hz, 1H), 7.22 (td, 
J = 7.7, 1.3 Hz, 1H), 7.38-7.42 (m, 2H), 7.50 (d, J = 1.5 Hz, 1H), 7.58 (dd, J = 8.3, 0.6 Hz, 
1H), 7.85 ppm (dd, J = 8.1, 1.0 Hz, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 82.2, 83.9, 109.9, 111.9, 117.3, 125.8, 127.0, 129.3, 
132.6, 135.0, 142.4, 151.9 ppm. 
HRMS calcd. for C12H8O
+
: 168.057516 [M]
+
; found: 168.057600.  
IR: ῦ = 660, 735, 756, 781, 814, 886, 901, 952, 1006, 1029, 1050, 1082, 1114, 1158, 1189, 
1214, 1255, 1276, 1288, 1378, 1430, 1478, 1498, 1561, 1599, 1631, 1735, 3065, 3119, 3146, 
3285 cm
-1
. 
3-(2-Ethynylphenyl)furan 165b 
Compound 165b was prepared according to general procedure G from 
carbaldehyde 167b (99.6 mg, 0.58 mmol. Purification of the crude material by 
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column chromatography on silica gel (pentane) afforded 165b as a yellow oil (63 mg, 64%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.27 (s, 1H), 6.84 (dd, J = 1.8, 0.9 Hz, 1H), 7.23 (td, 
J = 7.6, 7.6, 1.4 Hz, 1H), 7.37 (td, J = 7.5, 7.5, 1.5 Hz, 1H), 7.44 (ddd, J = 7.9, 1.4, 0.5 Hz , 
1H), 7.48 (t, J = 1.7 Hz, 1H), 7.58 (dd, J = 7.9, 1.4 Hz, 1H), 8.06 ppm (dd, J = 1.5, 0.9 Hz, 
1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 81.4, 83.9, 110.6, 119.8, 124.7, 126.8, 128.2, 129.3, 
134.6, 134.9, 141.3, 142.8 ppm. 
HRMS calcd. for C12H8O
+
: 168.057513 [M]
+
; found: 168.057368.  
IR: ῦ = 561, 596, 617, 657, 728, 753, 793, 871, 923, 950, 1015, 1032, 1055, 1086, 1162, 
1233, 1306, 1356, 1438, 1474, 1509, 1566, 1585, 1599, 2852, 2924, 3025, 3063, 3151, 3285  
cm
-1
. 
Methyl 3-ethynyl-4-(furan-2-yl)benzoate 165c 
Compound 165c was prepared according to general procedure G from 
carbaldehyde 167c (60.0 mg, 0.24 mmol). Purification of the crude 
material by column chromatography on silica gel (pentane/MTBE, 50/1) 
afforded 165c as a white solid (31.8 mg, 54%). 
1
H-NMR (300 MHz, CDCl3): δ = 3.46 (s, 1H), 3.92 (s, 3H), 6.54 (d, 
J = 3.5, 1.8 Hz, 1H), 7.53-7.54 (m, 1H), 7.56 (dd, J = 3.5, 0.6 Hz, 1H), 7.92 (d, J = 8.4 Hz, 
1H), 8.02 (dd, J = 8.4, 1.9 Hz, 1H), 8.25 ppm (d, J = 1.8 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 52.3, 82.9, 83.1, 112.0, 112.2, 116.9, 125.4, 128.2, 
130.1, 135.8, 136.2, 143.2, 151.0, 166.2 ppm. 
HRMS calcd. for C14H10O3
+
: 226.062994 [M]
+
; found: 226.063200.  
IR: ῦ = 655, 671, 677, 691, 733, 746, 767, 817, 848, 886, 918, 970, 1007, 1032, 1106, 1128, 
1159, 1220, 1254, 1267, 1296, 1373, 1389, 1434, 1476, 1500, 1555, 1600, 1711, 1834, 2960, 
3087, 3247 cm
-1
. 
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2-(2-Ethynyl-6-fluorophenyl)-5-methylfuran 165d 
Compound 165d was prepared according to general procedure G from 
carbaldehyde 167d (70.0 mg, 0.34 mmol. Purification of the crude material 
by column chromatography on silica gel (pentane) afforded 165d as a white 
solid (45 mg, 65%). 
1
H-NMR (300 MHz, CDCl3): δ = 2.39 (s, 3H), 3.23 (s, 1H), 6.12-6.14 (m, 
1H), 6.82 (dd, J = 2.9, 2.3 Hz 1H), 7.08-7.21 (m, 2H), 7.36-7.39 ppm (m, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 14.1, 81.3, 82.5 (d, JC-F = 4.9 Hz), 107.5 (d, JC-
F = 0.8 Hz), 113.6 (d, JC-F = 5.6 Hz), 116.9 (d, JC-F = 23.0 Hz), 121.3 (d, JC-F = 4.5 Hz), 121.9 
(d, JC-F = 14.6 Hz), 128.0 (d, JC-F = 9.4 Hz), 130.4 (d, JC-F = 3.3 Hz), 144.8 (d, JC-F = 1.8 Hz), 
152.9 (d, JC-F = 1.6 Hz), 159.4 ppm (d, JC-F = 250.2 Hz). 
19
F{
1
H}-NMR (282 MHz, CDCl3): δ = -112.74 ppm. 
HRMS calcd. for. C13H9FO
+
: 200.063743 [M]
+
; found: 200.063560.  
IR: ῦ = 664, 735, 791, 857, 922, 946, 973, 1025, 1045, 1090, 1161, 1201, 1222, 1229, 1252, 
1282, 1355, 1382, 1438, 1459, 1537, 1567, 1603, 1677, 1785, 2857, 2924, 2956, 2992, 3075, 
3292 cm
-1
. 
2-(2-Ethynyl-6-methoxyphenyl)furan 165e 
Compound 165e was prepared according to general procedure G from the 
crude carbaldehyde 167e (118.0 mg, 0.58 mmol). Purification of the crude 
material by column chromatography on silica gel (pentane/MTBE, 30/1) 
afforded the desired product 165e as a white solid (70 mg, 40% over two 
steps). 
1
H-NMR (400 MHz, CDCl3): δ = 3.12 (s, 1H), 3.86 (s, 3H), 6.52-6.53 (m, 1H), 6.72 
(d, J = 3.6 Hz, 1H), 6.97 (d, J = 7.8 Hz, 1H), 7.20-7.28 (m, 2H, overlaps with solvent signal), 
7.56 ppm (s, 1H). 
13
C{
1
H}-NMR (75 MHz, CDCl3): δ = 56.3, 80.3, 83.1, 110.9, 111.7, 112.2, 122.8, 123.1, 
126.5, 129.0, 142.1, 148.6, 157.4 ppm. 
HRMS calcd. for C13H10O2
+
: 198.068079 [M]
+
; found: 198.068225.  
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IR: ῦ = 736, 789, 812, 885, 901, 1003, 1028, 1066, 1098, 1155, 1186, 1210, 1231, 1265, 
1290, 1376, 1432, 1463, 1500, 1567, 1609, 2838, 2939, 2963, 3005, 3069, 3118, 3142, 3285 
cm
-1
. 
2-(2-Ethynyl-3-methylphenyl)benzofuran 165f 
Compound 165f was prepared according to general procedure G from 
carbaldehyde 167f (50.0 mg, 0.21 mmol). Purification of the crude material 
by column chromatography on silica gel (pentane/MTBE, 60/1) afforded 165f 
as a white solid (45 mg, 92%). 
1
H-NMR (400 MHz, CDCl3): δ = 2.55 (s, 3H), 3.74 (s, 1H), 7.22-7.27 (m, 
2H, overlaps with solvent signal), 7.29-7.33 (m, 1H), 7.36 (t, J = 7.8 Hz, 1H), 
7.52 (dd, J = 8.1, 0.8 Hz, 1H), 7.62-7.64 (d, 1H), 7.79 (d, J = 0.9 Hz 1H), 7.89 ppm (d, 
J = 8.6 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.6, 81.8, 87.8, 106.2, 111.1, 118.5, 121.5, 122.9, 
124.5, 124.8, 128.7, 129.3, 132.5, 142.8, 154.0, 154.4 ppm. 
HRMS calcd. for C17H12O
+
: 232.088816 [M]
+
; found: 232.088602.  
IR: ῦ = 738, 749, 784, 814, 854, 888, 936, 1009, 1036, 1074, 1088, 1110, 1146, 1172, 1220, 
1242, 1259, 1307, 1347, 1379, 1443, 1455, 1565, 1571, 2916, 2952, 3035, 3063, 3289 cm
-1
. 
2-(2-Ethynylcyclohex-1-en-1-yl)furan 165g 
To a solution of potassium carbonate (253.7 mg, 1.84 mmol) in methanol 
(5.6 mL) at -40 °C, the Ohira-Bestmann reagent 173 (282.1 mg, 1.47 mmol) and 
167g (129.4 mg, 0.73 mmol) in methanol (1 mL) were added. The reaction was 
subsequently warmed to 0 °C and stirred overnight at this temperature. After 
that, the solvent was removed in vacuo and the obtained residue dissolved in 
ethyl acetate and washed with brine (4x). Finally, the organic phase was dried over sodium 
sulfate, and the crude material purified by column chromatography on silica gel 
(pentane/MTBE, 30/1) affording 165g as a violet oil (60 mg, 47%). The compound was stored 
under argon at -20 °C and had to be used within 3 days to avoid decomposition. 
1
H-NMR (400 MHz, CDCl3): δ = 1.64-1.74 (m, 4H), 2.35-2.39 (m, 2H), 2.53-2.56 (m, 2H), 
3.34 (s, 1H), 6.42 (dd, J = 3.5, 1.8 Hz, 1H), 7.08 (d, J = 3.5 Hz, 1H), 7.37 ppm (d, J = 1.4 Hz, 
1H). 
6. Experimental Part                                                                                                                   .  
 
142 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 21.1, 22.3, 26.4, 31.6, 82.6, 85.8, 109.1, 111.3, 113.1, 
134.1, 141.1, 154.3 ppm. 
HRMS calcd. for C12H13O
+
: 173.096090 [M+H]
+
; found: 173.096170.  
IR: ῦ = 459, 516, 594, 609, 655, 800, 871, 876, 904, 962, 989, 1021, 1084, 1154, 1211, 1247, 
1278, 1336, 1354, 1436, 1450, 1487, 1547, 1604, 2084, 2838, 2860, 2882, 2933, 3118, 3145, 
3291 cm
-1
. 
2-(2-Ethynyl-3,4-dihydronaphthalen-1-yl)furan 165h 
Compound 165h was prepared according to general procedure G from 
carbaldehyde 167h (200.0 mg, 0.89 mmol). Purification of the crude 
material by column chromatography on silica gel (pentane/MTBE, 30/1) 
afforded 165h as a dark red oil (131 mg, 66%). The compound was stored 
under argon at -20 °C and had to be used within 3 days to avoid 
decomposition. 
1
H-NMR (400 MHz, CDCl3): δ = 2.54-2.58 (m, 2H), 2.83-2.87 (m, 2H), 3.38 (s, 1H), 6.52 
(dd, J = 3.3, 1.8 Hz, 1H), 6.82 (d, J = 2.8 Hz, 1H), 7.09-7.20 (m, 4H), 7.49 ppm (dd, J = 1.8, 
0.7 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ =27.9, 29.5, 84.5, 84.7, 110.9, 112.3, 119.0, 126.6, 
126.8, 127.6, 128.1, 133.5, 134.8, 136.7, 142.1, 151.0 ppm. 
HRMS calcd. for C16H12O
+
: 220.088816 [M]
+
; found: 220.088747.  
IR: ῦ = 736, 766, 810, 868, 884, 925, 943, 965, 985, 1016, 1042, 1078, 1101, 1149, 1183, 
1216, 1294, 1329, 1349, 1429, 1448, 1485, 1553, 1597, 1625, 1668, 1724, 2841, 2888, 2945, 
3031, 3071, 3280 cm
-1
. 
6.5.6.3 Cycloisomerization 
General procedure I: Formation of naphto-furan derivatives 
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A solution of the desired Alkyne 165 (1.0 equiv.) in 1,2-DCE (c = 0.05 M) at 50 °C was 
transferred via cannula to a prewarmed Schlenk-flask, which was already charged with Au(I)-
precatalyst 97c (0.02 equiv) and silver hexafluoroantimonate (0.02 equiv.). The reaction 
mixture was stirred at 50 °C until the reaction was finished (30 minutes) and then filtered over 
a short pad of silica gel. The residue was then rinsed with DCM and purified by column 
chromatography on silica gel affording 166. 
Naphtho[1,2-b]furan 166a 
Alkyne 165a (24.9 mg, 0.15 mmol) was treated with precatalyst 97c (3.1 mg, 
2.9 µmol) and silver hexafluoroantimonate (1.0 mg, 2.9 µmol) in 1,2-DCE 
(3.0 mL) according to general procedure I. The crude material thus obtained was 
purified by column chromatography on silica gel (pentane) affording 166a as a 
white solid (21 mg, 91%). 
1
H-NMR (400 MHz, CDCl3): δ = 6.92 (d, J = 1.8 Hz, 1H), 7.50 (t, J = 7.5 Hz, 1H), 7.60 (t, 
J = 7.6 Hz, 1H), 7.67 (s, 2H), 7.78 (d, J = 1.9 Hz, 1H), 7.95 (d, J = 9.9 Hz, 1H), 8.33 ppm (d, 
J = 8.20 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 107.8, 119.9, 120.2, 121.7, 123.1, 123.6, 125.3, 
126.5, 128.5, 131.6, 144.3, 150.8 ppm. 
HRMS calcd. for C12H8O
+
: 168.057518 [M]
+
; found: 168.057388.  
IR: ῦ = 685, 736, 785, 806, 869, 881, 945, 955, 1002, 1021, 1039, 1068, 1127, 1169, 1208, 
1268, 1321, 1391, 1438, 1454, 1468, 1511, 1592, 1700, 1748, 1807, 2857, 2932, 3019, 3055, 
3146 cm
-1
. 
Naphtho[2,1-b]furan 166b 
Alkyne 165b (32.6 mg, 0.19 mmol) was treated with precatalyst 97c (4.1 mg, 
3.8 µmol) and silver hexafluoroantimonate (1.3 mg, 3.8 µmol) in 1,2-DCE (3.9 mL) 
according to general procedure I. The crude material thus obtained was purified by 
column chromatography on silica gel (pentane) affording 166b as a pale yellow 
solid (31 mg, 94%). 
1
H-NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 1.1 Hz, 1H), 7.50 (t,J = 7.4 Hz, 1H), 7.60 (t, 
J = 7.3 Hz, 1H), 7.69 (d, J = 8.9 Hz, 1H), 7.75 (d, J = 9.0 Hz, 1H), 7.78 (d, J = 1.8 Hz, 1H), 
7.96 (d, J = 8.1 Hz, 1H), 8.16 ppm (d, J = 8.2 Hz, 1H). 
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13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 105.8, 112.7, 122.8, 123.6, 124.7, 125.4, 126.5, 
128.0, 128.9, 130.5, 144.4, 152.7 ppm. 
HRMS calcd. for C12H8O: 168.057515 [M]
+
; found: 168.057385.  
IR: ῦ = 683, 727, 787, 803, 860, 905, 952, 972, 1022, 1047, 1071, 1133, 1165, 1206, 1245, 
1269, 1320, 1347, 1385, 1448, 1515, 1584, 1628, 1734, 2849, 2926, 3059, 3115, 3146 cm
-1
. 
Methyl naphto[1,2-b]furan-7-carboxylate 166c 
Alkyne 165c (27.9 mg, 0.11 mmol) was treated with precatalyst 97c (2.5 mg, 
2.3 µmol) and silver hexafluoroantimonate (0.8 mg, 2.3 µmol) in 1,2-DCE 
(2.3 mL) according to general procedure I. The crude material thus obtained was 
purified by column chromatography on silica gel (pentane/MTBE, 20/1) affording 
the desired product 166c as a white solid (27 mg, 95%). 
1
H-NMR (400 MHz, CDCl3): δ = 4.00 (s, 3H), 6.94 (d, J = 2.1 Hz, 1H), 7.75 (q, J = 8.7 Hz, 
2H), 7.84 (d, J = 2.0 Hz, 1H), 8.19 (dd, J = 8.6, 1.6 Hz, 1H), 8.35 (d, J = 8.6 Hz, 1H), 8.71 
ppm (d, J = 1.3 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 52.4, 108.0, 120.4, 120.8, 123.6, 124.8, 125.3, 126.2, 
126.7, 130.6, 131.5, 145.4, 150.4, 167.4 ppm. 
HRMS calcd. for C14H10O3
+
: 226.06299 [M]
+
; found: 226.062770.  
IR: ῦ = 426, 442, 505, 546, 585, 605, 624, 684, 750, 791, 808, 843, 883, 917, 974, 1002, 
1044, 1067, 1104, 1130, 1194, 1263, 1292, 1320, 1369, 1402, 1421, 1437, 1464, 1502, 1576, 
1635, 1702, 1762, 1805, 2848, 2924, 2950, 2998, 3114, 3144 cm
-1
. 
9-Fluoro-2-methylnaphtho[1,2-b]furan 166d 
Alkyne 165d (13.9 mg, 0.069) was treated with precatalyst 97c (1.5 mg, 
1.39 µmol) and silver hexafluoroantimonate (0.5 mg, 1.39 µmol) in 1,2-DCE 
(1.4 mL) according to general procedure I. The crude material thus obtained was 
purified by column chromatography on silica gel (pentane/MTBE, 20/1) affording 
the desired product 166d as a white solid (12 mg, 84%). 
1
H-NMR (300 MHz, CDCl3): δ = 2.61 (s, 3H), 6.53-6.53 (m, 1H), 7.20-7.27 (m, 1H), 7.32-
7.37 (m, 1H), 7.63-7.63 (m, 2H), 7.69 ppm (dd, J = 8.7, 0.5 Hz, 1H). 
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13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 14.5, 103.5, 110.9 (d, JF-C = 19.1 Hz), 120.6 (d, JF-
C = 1.4 Hz), 122.8 (d, JF-C  = 2.9 Hz), 124.1 (d, JF-C  = 4.3 Hz), 124.3 (d, JF-C  = 7.6 Hz), 126.2 
(d, JF-C  = 0.9 Hz), 126.8, 133.2 (d, JF-C  = 5.2 Hz), 147.4 (d, JF-C  = 1.8 Hz), 155.8 (d, JF-
C =2.4 Hz), 157.1 ppm (d, JF-C  = 251.4 Hz). 
19
F{
1
H}-NMR (282 MHz, CDCl3): δ = -117.69 ppm. 
HRMS calcd. for C13H9OF
+
: 200.063741 [M]
+
; found: 200.063635.  
IR: ῦ = 688, 733, 747, 760, 783, 818, 836, 855, 873, 905, 939, 975, 1009, 1034, 1076, 1112, 
1141, 1167, 1183, 1239, 1259, 1298, 1309, 1349, 1382, 1408, 1425, 1444, 1456, 1474, 1566, 
1597, 1686, 2925, 2968, 3062, 3104 cm
-1
. 
9-Methoxynaphto[1,2-b]furan 166e 
Alkyne 165e (42.1 mg, 0.21 mmol) was treated with precatalyst 97c (4.5 mg, 
4.25 µmol) and silver hexafluoroantimonate (1.5 mg, 4.25 µmol) in 1,2-DCE 
(4.3 mL) according to general procedure I. The crude material thus obtained 
was purified by column chromatography on silica gel (pentane/MTBE, 20/1) 
affording 166e as a white solid (40 mg, 95%). 
1
H-NMR (400 MHz, CDCl3): δ =4.13 (s, 3H), 6.91 (d,J = 2.1 Hz, 1H), 7.00 (d, J = 7.8 Hz, 
1H). 7.41 (t, J = 8.0 Hz, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.65 (d, J = 8.5 Hz, 1H), 7.69 (d, 
J = 8.4 Hz, 1H), 7.85 ppm (d, J = 2.0 Hz, 1H). 
13
C{
1
H}-NMR (101 MHz, CDCl3): δ = 56.3, 105.9, 107.1, 114.1, 120.7, 121.0, 123.6, 124.2, 
125.3, 133.7, 144.5, 149.9, 154.9 ppm. 
HRMS calcd. for C13H10O
+
: 198.068083 [M]
+
; found: 198.067909.  
IR: ῦ = 434, 475, 504, 527, 589, 626, 660, 691, 733, 754, 799, 810, 867, 881, 950, 997, 1021, 
1061, 1087, 1134, 1162, 1200, 1216, 1254, 1268, 1257, 1377, 1404, 1431, 1461, 1515, 1536, 
1575, 1622, 1743, 1815, 1907, 2839, 2961, 3011, 3058, 3123, 3147 cm
-1
. 
4-Methylbenzo[d]naphto[1,2-b]furan 166f 
Alkyne 165f (31.0 mg, 0.13 mmol) was treated with precatalyst 97c
[87]
 (2.8 mg, 
2.66 µmol) and silver hexafluoroantimonate (0.9 mg, 2.66 µmol) in 1,2-DCE 
(2.6 mL) according to general procedure I. The crude material thus obtained was 
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purified by column chromatography on silica gel (pentane/MTBE, 50/1) affording the desired 
product 166f as a white solid (28 mg, 90%). 
1
H-NMR(400 MHz, CDCl3): δ = 2.79 (s, 3H), 7.39-7.43 (m, 2H), 7.46-7.50 (m, 1H), 7.53-
7.57 (m, 1H), 7.72 (d, J = 8.3 Hz, 1H), 7.94 (dd, J = 8.7, 0.7 Hz, 1H), 8.01-8.04 (m, 1H), 8.04 
(d, J = 8.7 Hz, 1H), 8.35 ppm (d, J = 8.3 Hz, 1H). 
13
C{
1
H}-NMR(101 MHz, CDCl3): δ = 20.3, 111.9, 118.3, 119.0, 119.3, 119.6, 120.4, 121.5, 
123.0, 125.1, 126.3, 127.2, 132.2, 135.2, 152.7, 156.1 ppm. 
HRMS calcd. for C17H12O
+
: 232.088815 [M]
+
; found: 232.088643.  
IR: ῦ = 436, 489, 565, 607, 682, 747, 767, 813, 909, 1010, 1032, 1069, 1088, 1118, 1150, 
1183, 1201, 1268, 1306, 1343, 1378, 1397, 1441, 1460, 1529, 1583, 2860, 2928, 2946, 2968, 
3063 cm
-1
. 
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6.6 Computational Methods 
6.6.1 General 
All calculations were performed at our department of theoretical chemistry under the direction 
of Prof. Dr. W. Thiel. 
Geometry optimizations were carried out using BP86
[88] 
functional in combination with def2-
SVP basis sets.
[89]
 In the case of gold, the 60 inner-shell core electrons were replaced by an 
effective core potential (ECP) generated for the neutral atom using quasi-relativistic methods, 
and the explicitly treated electrons were described by the standard def2-ECP basis set.
[90] 
The 
resolution-of-identity (RI) approximation
[91] 
was applied in conjunction with the appropriate 
auxiliary basis sets to speed up the calculations. This approach is computationally efficient 
and has been employed successfully in our previous computations on gold chemistry.
[92]
 All 
low-energy conformations of the substrate and the catalyst were considered during initial 
screening, and all relevant stationary points were characterized as minima or first-order 
transition states by evaluating the harmonic vibrational frequencies at the same level (RI-
BP86/def2-SVP) that had been applied for geometry optimization.  
The influence of the solvent environment (dichloromethane, dielectric constant ε = 8.93) on 
the relative energies was investigated through single-point calculations with the conductor-
like screening model (COSMO)
[93] 
at the RI-BP86/def2-SVP level. In order to evaluate the 
best estimate of the total energies, all located stationary points were re-optimized at the RI-
BP86 level employing the def2-TZVPP basis set.
[89b]
 Empirical Grimme-type dispersion 
corrections were also incorporated during this step using the latest parameterization (DFT-
D3).
[94] Relative free energies (ΔG) at standard pressure (1 bar) and 273.15K were determined 
at the RI-BP86/def2-SVP level. The required thermal and entropic contributions were 
evaluated within the rigid-rotor harmonic-oscillator approximation. All geometry 
optimizations were carried out using the TURBOMOLE (version 6.4) suite of programs.
[95] 
To gain insight into the electronic structure of the complexes, a fragment molecular orbital 
(MO) analysis was performed for selected molecules using the Amsterdam Density Functional 
(ADF) package.
[60] 
The MOs were expanded in terms of Slater-type orbitals (STO) employing 
a triple- basis set (TZP) with one polarization function. Relativistic effects were taken into 
account by the zero-order regular approximation (ZORA) approach,
[96]
 as implemented in 
ADF. 
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6.6.2 Computational Results  
Figures 6-4 sketches the frontier orbital interactions in complexes 97a-Cl and 141-Cl.   
 
Figure 6-3: Evaluated active catalysts. 
 
Figure 6-4: Frontier orbitals interactions in complexes 97a-Cl (left) and 141-Cl (right).  Shown are the LUMOs 
that are mainly responsible for the catalyst-substrate interaction and contain a very strong 6s(Au) contribution. 
The fragments 95a and (MeO)3P (left and right) were calculated at their geometries in the complexes 97-Cl and 
141-Cl.
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7 Appendix 
7.1 X-Ray 
Compound 96a 
 
 
Table 7-1: Crystal data and structure refinement of compound 96a. 
Empirical formula  C21 H34 B F4 N2 P 
Color  colorless 
Formula weight  432.28 g mol-1 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  Cc, (no. 9) 
Unit cell dimensions a = 11.811(5) Å α = 90°. 
 b = 15.362(6) Å β = 101.797(8)°. 
 c = 13.008(5) Å γ = 90°. 
Volume 2310.3(16) Å3 
Z 4 
Density (calculated) 1.243 Mg m-3 
Absorption coefficient 0.160 mm-1 
F(000) 920 e 
Crystal size 0.10 x 0.04 x 0.02 mm3 
Ɵ range for data collection 2.20 to 31.15°. 
Index ranges -17 ≤ h ≤ 17, -22≤ k ≤ 22, -18 ≤ l ≤ 17 
Reflections collected 19071 
Independent reflections 6768 [Rint = 0.0889] 
Reflections with I>2σ(I) 4970 
Completeness to Ɵ = 31.15° 99.2 % 
Absorption correction Empirical 
Max. and min. transmission 1.00 and 0.50 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6768 / 2 / 274 
Goodness-of-fit on F2 1.052 
Final R indices [I>2σ(I)] R1 = 0.0542 wR
2 = 0.1318 
C11
C15
C10
C13
C12
N2
C14
C3
P1
C1
C2
C8
C21
C22
C7
N1
C5
C26
F3
C23
F4
C4
C25
C24
B1
C9
F2
C6
F1
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R indices (all data) R1 = 0.0837 wR
2 = 0.1632 
Absolute structure parameter 0.20(10) 
Largest diff. peak and hole 0.461 and -0.675 e Å-3 
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Compound 95b 
 
 
 
Comment: Two of the isopropyl groups and both tetrafluoroborate anions are  
disordered. In addition, the crystal contains badly disordered dichloromethane. The dichloromethane 
was modelled by C, H and Cl atoms. The refined occupancies summed up to C 2.28, H 4.55 and Cl 
4.36. This approximates to 2.25 (CH2Cl2) per mole. Nether the less  
R1 = 0.0906 < 0.1, which means that the structure is possibly publishable. Out of 6 attempts to obtain 
suitable crystals this was the best result, which could be obtained. 
 
Table 7-2: Crystal data and structure refinement of compound 95b. 
Empirical formula  C
44.28H69.55B2Cl4.36F8N4P 
Color  colourless 
Formula weight  1016.90 g·mol-1  
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  orthorhombic 
Space group  P b c a, (no. 61)  
Unit cell dimensions a = 15.3679(7) Å α= 90°. 
 b = 21.1957(10) Å β= 90°. 
 c = 32.9485(16) Å γ = 90°. 
Volume 10732.4(9) Å3 
Z 8 
Density (calculated) 1.259 Mg·m-3 
Absorption coefficient 2.970 mm-1 
F(000) 4274 e 
Crystal size 0.33 x 0.24 x 0.07 mm3 
Ɵ range for data collection 2.682 to 67.845°. 
Index ranges -17 ≤ h ≤ 16, -25≤ k ≤ 25, -39≤ l ≤ 39 
Reflections collected 240324 
Independent reflections 9610 [Rint = 0.1195] 
Reflections with I>2σ(I) 7562 
Completeness to Ɵ = 67.679° 99.0 %  
Absorption correction Gaussian 
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Max. and min. transmission 0.90807 and 0.67634 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9610 / 0 / 756 
Goodness-of-fit on F2 1.103 
Final R indices [I>2σ(I)] R1 = 0.0906 wR
2 = 0.2460 
R indices (all data) R1 = 0.1077 wR
2 = 0.2598 
Extinction coefficient 0.00196(14) 
Largest diff. peak and hole 0.443 and -0.768 e·Å-3 
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Compound 95i 
 
Table 7-3: Crystal data and structure refinement of compound 95i. 
Empirical formula  C48H85F12N4PSb2 
Color  colourless 
Formula weight  1220.66 g·mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  p 21/n, (no. 14)  
Unit cell dimensions a = 14.879(2) Å α= 90°. 
 b = 30.262(5) Å β= 95.646(3)°. 
 c = 27.205(5) Å γ = 90°. 
Volume 12191(3) Å3 
Z 8 
Density (calculated) 1.330 Mg·m-3 
Absorption coefficient 0.981 mm-1 
F(000) 5008 e 
Crystal size 0.29 x 0.08 x 0.07 mm3 
Ɵ range for data collection 1.346 to 31.024°. 
Index ranges -21 ≤ h ≤ 21, 0≤ k ≤ 43, 0 ≤ l ≤ 39 
Reflections collected 38745 
Independent reflections 38745 [Rint = 0.0451] 
Reflections with I>2σ(I) 31443 
Completeness to Ɵ = 25.242° 100.0 %  
Absorption correction Gaussian 
Max. and min. transmission 0.94595 and 0.77201 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 38745 / 0 / 1222 
Goodness-of-fit on F2 1.115 
Final R indices [I>2σ(I)] R1 = 0.0435 wR
2 = 0.1141 
R indices (all data) R1 = 0.0565 wR
2 = 0.1197 
Extinction coefficient n/a 
Largest diff. peak and hole 1.340 and -1.212 e·Å-3 
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Compound 97b 
 
 
Table 7-4: Crystal data and structure refinement of compound 97b. 
Empirical formula  C76H132Au2Cl2F24N8O P2Sb4 (cell contains two  
                                                                             molecules of 97b and one ether molecule) 
Color  colorless 
 
Formula weight  2643.66 g mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/c, (no. 14)  
Unit cell dimensions a = 18.222(3) Å α = 90°. 
 b = 10.6242(15) Å β = 92.535(3)°. 
 c = 27.563(4) Å γ = 90°. 
Volume 5330.9(13) Å3 
Z 2 
Density (calculated) 1.647 Mg m-3 
Absorption coefficient 3.903 mm-1 
F(000) 2588 e 
Crystal size 0.22 x 0.04 x 0.02 mm3 
Ɵ range for data collection 2.055 to 28.363°. 
Index ranges -24 ≤ h ≤ 24, -14≤ k ≤ 14, -36 ≤ l ≤ 36 
Reflections collected 126469 
Independent reflections 13286 [Rint = 0.0855] 
Reflections with I>2σ(I) 10302 
Completeness to Ɵ = 25.242° 99.9 %  
Absorption correction Gaussian 
Max. and min. transmission 0.93 and 0.61 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 13286 / 0 / 554 
Goodness-of-fit on F2 1.055 
Final R indices [I>2σ(I)] R1 = 0.0501 wR
2 = 0.1197 
R indices (all data) R1 = 0.0724 wR
2 = 0.1307 
C15
C39
C40
F7
F8
C38
C14
C13
C11
C10
F9
C41
Sb2
N2
C37
F12
C12
C36
C2
F11
F10
F3
F4
C1
C35B
F2
P1
C35A
C3
C25
C9
C7
Sb1
N1
C21
Au1
C33B
F5
C6
C32B
C33A
C23
C32A
C22
C24
N12C8
F1
F6
C4
C34B
N11
Cl1
C30B
C29
C26
C34A
C30A
C5
C27
C31A
C31B
C28
C50
C54
O1
C51
C53
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Largest diff. peak and hole 3.5 and -2.1 e Å-3  
Compound 97c 
 
Table 7-5: Crystal data and structure refinement of compound 97c. 
Empirical formula  C
44
H
68
AuB
2
ClF
8
N
5
P 
Color  colourless 
Formula weight  1104.04 g·mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P b c a, (no. 61)  
Unit cell dimensions a = 14.720(2) Å α= 90°. 
 b = 17.611(3) Å β= 90°. 
 c = 38.084(6) Å γ = 90°. 
Volume 9872(3) Å3 
Z 8 
Density (calculated) 1.486 Mg·m-3 
Absorption coefficient 3.133 mm-1 
F(000) 4480 e 
Crystal size 0.11 x 0.09 x 0.07 mm3 
Ɵ range for data collection 1.069 to 26.439°. 
Index ranges -18 ≤ h ≤ 18, -22≤ k ≤ 22, -47≤ l ≤ 46 
Reflections collected 204020 
Independent reflections 10150 [Rint = 0.0510] 
Reflections with I>2σ(I) 8558 
Completeness to Ɵ = 25.242° 100.0 %  
Absorption correction Gaussian 
Max. and min. transmission 0.82715 and 0.70856 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10150 / 0 / 576 
Goodness-of-fit on F2 1.065 
Final R indices [I>2σ(I)] R1 = 0.0313 wR
2 = 0.0723 
R indices (all data) R1 = 0.0406 wR
2 = 0.0774 
Extinction coefficient 0 
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Largest diff. peak and hole 3.207 and -1.089 e·Å-3 
Compound 107f 
C6 C7
C4
C5
C9C8
C10
C13
C3
C14
C11
C12
C16
C2
C1
C15
 
 
Table 7-6: Crystal data and structure refinement for compound 107f. 
Empirical formula  C16 H14 
Color  colourless 
Formula weight  206.27 g mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P 21, (no. 4) 
Unit cell dimensions a = 8.3090(8) Å α = 90°. 
 b = 8.0817(7) Å β = 108.2270(10)°. 
 c = 8.7050(8) Å γ = 90°. 
Volume 555.22(9) Å3 
Z 2 
Density (calculated) 1.234 Mg m-3 
Absorption coefficient 0.069 mm-1 
F(000) 220 e 
Crystal size 0.39 x 0.36 x 0.16 mm3 
Ɵ range for data collection 2.46 to 34.97°. 
Index ranges -13 ≤ h ≤ 13, -12≤ k ≤ 13, -14 ≤ l ≤ 14 
Reflections collected 19639 
Independent reflections 4809 [Rint = 0.0396] 
Reflections with I>2σ(I) 4635 
Completeness to Ɵ = 34.97° 99.9 %  
Absorption correction Gaussian 
Max. and min. transmission 0.99 and 0.97 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4809 / 1 / 147 
Goodness-of-fit on F2 1.085 
Final R indices [I>2σ(I)] R1 = 0.0360 wR
2 = 0.1003 
R indices (all data) R1 = 0.0381 wR
2 = 0.1029 
Absolute structure parameter 0(8) 
Largest diff. peak and hole 0.438 and -0.194 e Å-3 
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Compound 107j 
C6
C7
C5
C17 C18
C8
C16
C4
C22
C3
C23C9
C21
C19
C15
C2
C20
C10
C24
C26
C1
C11
C25
C14
C12
C13
 
 
Table 7-7: Crystal data and structure refinement for compound 107j. 
Empirical formula  C26 H18 
Color  colourless 
Formula weight  330.40 g mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  P21/n, (no. 14)  
Unit cell dimensions a = 8.9259(3) Å α = 90°. 
 b = 12.5274(11) Å β = 105.646(5)°. 
 c = 16.0569(10) Å γ = 90°. 
Volume 1728.93(19) Å3 
Z 4 
Density (calculated) 1.269 Mg m-3 
Absorption coefficient 0.072 mm-1 
F(000) 696 e 
Crystal size 0.46 x 0.30 x 0.25 mm3 
Ɵ range for data collection 2.63 to 33.10°. 
Index ranges -13 ≤ h ≤ 13, -19≤ k ≤ 19, -24 ≤ l ≤ 24 
Reflections collected 35362 
Independent reflections 6570 [Rint = 0.0302] 
Reflections with I>2σ(I) 5307 
Completeness to Ɵ = 33.10° 99.9 %  
Absorption correction Gaussian 
Max. and min. transmission 0.98and 0.96 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6570 / 0 / 235 
Goodness-of-fit on F2 1.115 
Final R indices [I>2σ(I)] R1 = 0.0460 wR
2 = 0.1293 
R indices (all data) R1 = 0.0600 wR
2 = 0.1381 
Largest diff. peak and hole 0.577 and -0.594 e Å-3 
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Compound 156 
 
 
Table 7-8: Crystal data and structure refinement for compound 156. 
Empirical formula  C
16
H
16
O
5
 
Color  colourless 
Formula weight  288.29 g·mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  p 21/n, (no. 14)  
Unit cell dimensions a = 7.4040(11) Å α = 90°. 
 b = 9.3488(14) Å β = 90.669(3)°. 
 c = 20.526(3) Å γ = 90°. 
Volume 1420.7(4) Å3 
Z 4 
Density (calculated) 1.348 Mg·m-3 
Absorption coefficient 0.100 mm-1 
F(000) 608 e 
Crystal size 0.473 x 0.146 x 0.080 mm3 
Ɵ range for data collection 1.984 to 28.538°. 
Index ranges -9 ≤ h ≤ 9, -12≤ k ≤ 12, -27≤ l ≤ 27 
Reflections collected 32312 
Independent reflections 3606 [Rint = 0.0389] 
Reflections with I>2σ(I) 3017 
Completeness to Ɵ = 25.242° 100.0 %  
Absorption correction Gaussian 
Max. and min. transmission 0.99236 and 0.96919 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3606 / 0 / 204 
Goodness-of-fit on F2 1.037 
Final R indices [I>2σ(I)] R1 = 0.0378 wR
2 = 0.1026 
R indices (all data) R1 = 0.0475 wR
2 = 0.1089 
Extinction coefficient 0 
Largest diff. peak and hole 0.489 and -0.227 e·Å-3 
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Compound 144 
 
Table 7-9: Crystal data and structure refinement for compound 144. 
Empirical formula  C
16
H
14
O
5
 
Color  orange 
Formula weight  286.27 g·mol-1  
Temperature  100 K 
Wavelength  0.61992 Å 
Crystal system  orthorhombic 
Space group  P b c a, (no. 61)  
Unit cell dimensions a = 16.566(3) Å α = 90°. 
 b = 7.5009(15) Å β = 90°. 
 c = 21.041(4) Å γ = 90°. 
Volume 2614.5(9) Å3 
Z 8 
Density (calculated) 1.455 Mg·m-3 
Absorption coefficient 0.109 mm-1 
F(000) 1200 e 
Crystal size 0.032 x 0.025 x 0.005 mm3 
Ɵ range for data collection 2.730 to 28.551°. 
Index ranges -22 ≤ h ≤ 25, -11≤ k ≤ 11, -32≤ l ≤ 32 
Reflections collected 108289 
Independent reflections 4979 [Rint = 0.0617] 
Reflections with I>2σ(I) 3900 
Completeness to Ɵ = 21.836° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0 and 0.3142 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4979 / 0 / 195 
Goodness-of-fit on F2 1.069 
Final R indices [I>2σ(I)] R1 = 0.0477 wR
2 = 0.1316 
R indices (all data) R1 = 0.0641 wR
2 = 0.1466 
Extinction coefficient 0 
Largest diff. peak and hole 0.369 and -0.317 e·Å-3 
 
Diffraction data were collected at the P11 beamline of the Petra III synchrotron facility 
Hamburg. 
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Compound 166c 
 
 
Table 7-10: Crystal data and structure refinement for compound 166c. 
Empirical formula  C14H10O3 
Color  colourless 
Formula weight  226.22 g·mol-1  
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  MONOCLINIC 
Space group  p 21, (no. 4)  
Unit cell dimensions a = 7.6215(3) Å α = 90°. 
 b = 6.1218(2) Å β = 104.1171(15)°. 
 c = 11.6856(4) Å γ = 90°. 
Volume 528.75(3) Å3 
Z 2 
Density (calculated) 1.421 Mg·m-3 
Absorption coefficient 0.824 mm-1 
F(000) 236 e 
Crystal size 0.30 x 0.07 x 0.06 mm3 
Ɵ range for data collection 3.900 to 67.297°. 
Index ranges -9 ≤ h ≤ 9, -7≤ k ≤ 6, -13 ≤ l ≤ 13 
Reflections collected 12502 
Independent reflections 1771 [Rint = 0.0379] 
Reflections with I>2σ(I) 1684 
Completeness to Ɵ = 67.297° 99.9 %  
Absorption correction Gaussian 
Max. and min. transmission 0.95884 and 0.83568 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1771 / 1 / 156 
Goodness-of-fit on F2 1.049 
Final R indices [I>2σ(I)] R1 = 0.0422 wR
2 = 0.1081 
R indices (all data) R1 = 0.0441 wR
2 = 0.1099 
Absolute structure parameter -0.1(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.173 and -0.229 e·Å-3
C14
O3
C13
C7
C8
C6
C5
C11
C9
C10
C12
C4
O1
C3
C1
C2
O2
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7.2 NMR-Spectra 
1
H-NMR (400 MHz, CDCl3): Compound 112 
 
13
C-NMR (101 MHz, CDCl3): Compound 112 
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1
H-NMR (400 MHz, CDCl3): Compound 96a 
 
13
C{
1
H}-NMR (101 MHz, CDCl3): Compound 96a 
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31
P{
1
H}-NMR (162 MHz, CDCl3): Compound 96a 
 
 
1
H-NMR (400 MHz, CDCl3): Compound 96b 
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13
C{
1
H}-NMR (CDCl3, 101 MHz): Compound 96b 
 
31
P{
1
H}-NMR (CDCl3, 162 MHz): Compound 96b 
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1
H-NMR (400 MHz, CD3CN): Compound 95b 
 
13
C{
1
H}-NMR (101 MHz, CD3CN): Compound 95b 
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31
P{
1
H}-NMR (CD3CN, 162 MHz): Compound 95b 
 
1
H-NMR (400 MHz, CD2Cl2): Compound 95e
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13
C{
1
H}-NMR (101 MHz, CD2Cl2): Compound 95e 
 
31
P{
1
H}-NMR (162 MHz, CD2Cl2): Compound 95e 
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1
H-NMR (300 MHz, CDCl3): Compound 95g 
 
13
C{
1
H}-NMR (101 MHz, CDCl3): Compound 95g 
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31
P{
1
H}-NMR (122 MHz, CDCl3): Compound 95g 
 
19
F{
1
H}-NMR (282 MHz, CDCl3): Compound 95g 
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1
H-NMR (300 MHz, CD3CN): Compound 95h 
 
 
13
C{
1
H}-NMR (CD3CN, 75 MHz): Compound 95h 
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31
P{
1
H}-NMR (CD3CN, 122 MHz): Compound 95h 
 
 
19
F{
1
H}-NMR (CD3CN, 282 MHz): Compound 95h 
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1
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[84]
 Small amounts of AgSbF6 can be transferred into the vessel by making a stock solution of 
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results in missing resonances of two quartenary 
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C-atoms, which couple with the 
31
P-nucleus. 
Despite the noise level 23 mg of Au-complex 97e were used for this measurement, which was 
sufficient for the successful measurement of the 
13
C-spectra of all other Au(I)-compounds 97. 
While an increase of the scan-number to 60000 leads to a decreased noise level, the 
aforementioned 
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C-signals remain missing. Because the samples used in these attempts 
contained solvent impurities and no additional information was obtained, these spectra are not 
displayed here.  
